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ABSTRACT 
ABSTRACT 
Individuals with personality disorders (PD), suffer from a range of 
longstanding difficulties with interpersonal relating, self-organization, 
emotional instability, and problematic behaviors. Just under half of all people 
with psychiatric disorders, have a co-existing chronic physical illness.
However, less attention has been paid the physical health outcomes of 
individuals living with these disorders in the general population, or their 
treatment seeking behaviors. In absence of these data, we do know those living 
with PD encounter disability and suffer significantly. The aims of this thesis,
were to investigate the prevalence of PDs, and associations with physical 
health comorbidities, and health service utilization, in population-based 
samples (≥20 years), from Australia, and the United States (US).
Data was collected (2011-2014) and analyzed as part of the most recent follow-
up of the Geelong Osteoporosis Study (GOS). A final sample of 768 women 
(≥20 years) were recruited. Psychiatric disorders were assessed using semi-
structured clinical interviews (SCID-I/NP and SCID-II), and physical health 
conditions were determined from a combination of clinical, anthropometric, 
medical and medication histories, and supplemented with self-reported 
information. A comprehensive range of information regarding 
sociodemographic, lifestyle, health risk factors and socioeconomic status were 
also assessed. The GOS data were linked with Medicare (Australia) to ascertain 
health service utilization. 
ABSTRACT 
Data was also utilized from Wave 2 (2004- 2005) of the National 
Epidemiologic Survey on Alcohol and Related Condition (NESARC), a 
nationally representative population-based survey of US adults aged ≥20 years 
(n=34,653). Psychiatric disorders were assessed (AUDADIS-IV); physical 
health conditions and sociodemographic information were documented by self-
self-report. 
After standardization, 22.7% (95% CI 18.8-26.7) of women were identified 
with one or more PDs, with Cluster C PDs being the most prevalent with 
17.7% (95% CI 14.2-21.3), followed by Cluster A with 6.7% (95% CI 3.9-9.5) 
then Cluster B with 4.6% (95% CI 3.3-5.9. The prevalence was highest for 
each PD Cluster among the youngest age group (20-29 years), with high levels 
of psychiatric comorbidity detected. 
A synthesis of the data (systematic review), identified that there was not only 
limited evidence, but a conflicting level of evidence for some individual PDs 
with physical health conditions, namely cardiovascular disease (CVD) and 
arthritis. Furthermore, in analyses examining data from the NESARC, younger 
individuals with schizoid and schizotypal PDs were associated with increased 
risk of CVD and arthritis. Both older and younger individuals with these 
disorders had an increased risk of diabetes and gastrointestinal diseases. With 
the exception of histrionic PD, all individual PDs were consistently associated 
with increased odds of at least one physical comorbidity. Finally, analyses 
derived from the GOS extended the current understandings of associations 
between PDs and physical health comorbidities, by investigating previously 
ABSTRACT 
unexplored associations. Novel associations were evident, suggesting an 
increased risk of gastro-oesophageal reflux disease for individuals with Cluster 
A PDs, syncope and/or seizures for individuals with B PDs, and recurrent 
headaches for individuals with Cluster C PDs. These associations did not 
appear to be explained by comorbidity with other psychiatric disorders, health 
risk factors or sociodemographic factors. 
Finally, Cluster C PDs were associated with increased utilization of mental 
health-related services provided by GPs, and individuals with Cluster A PDs 
were associated with increased utilization of physical health-related services 
provided by GPs. 
These findings underscore the increased physical morbidity, and potential 
burden on health services, attributable to PD. Thus, improving our 
understanding of the physical health consequences of PD is important for 
management and secondary prevention of comorbidities. From a public health 
perspective it is also essential to anticipate health and disability needs of 
individuals with PD in the population and for bridging the gap between 
physical and psychiatric health systems. 
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CHAPTER ONE: INTRODUCTION 
Individuals who demonstrate features, symptoms and behaviors of personality 
disorders (PDs), suffer from a range of longstanding difficulties with 
interpersonal relating, self-organization, emotional instability, and problematic 
behaviors [American Psychiatric Association (APA), 2013]. These personality 
problems cause significant levels of distress to the individual, which also 
frequently have a profound effect on family and friends. The enduring nature 
of some of the symptoms and behaviors of PD often result in chronic 
difficulties, which can persist across the lifespan (Newton-Howes et al., 2015). 
The disability and suffering endured by individuals living with PD is
substantial, which is underscored by the frequently co-occurring presence of 
other psychiatric disorders that often include mood, anxiety, eating, and 
substance misuse disorders. Clinically-based studies have identified that PDs 
are among the most frequently treated psychiatric disorders, with 
approximately half of psychiatric patient’s being diagnosed (Zimmerman, et 
al., 2005). 
Not only are PDs common in psychiatric settings, data from population-based 
studies, predominantly from the United States (US) (Grant et al., 2004; 
Lenzenweger et al., 2007; Samuels et al., 2002) and the United Kingdom (Coid 
et al., 2006), have reported that PDs in the community are also relatively 
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common. Yet, in the Australian general population-setting, current prevalence 
data and socio-demographic correlates of PDs are largely unknown, 
particularly beyond the use of screening instruments to identify PDs (Jackson 
& Burgess, 2000). 
It is now well understood that depression is associated with increased risk of a 
range of physical health conditions – notably cardiovascular diseases (CVD). 
(Van der Kooy et al., 2007). However, there is a paucity of data investigating 
associations between PDs and physical health comorbidities, in the general 
population. To date, there is evidence to suggest that some individual PDs, 
particularly borderline PD, appear to be associated with increased risk of CVD 
(Lee et al., 2010; Moran et al., 2007), and other physical health conditions 
including hypertension, hepatic disease, gastrointestinal disease, arthritis, and 
venereal diseases (El-Gabalawy et al., 2010). However, less is known 
regarding the effects of the other forms of PD on physical health, and data to 
date have been limited by the use of self-reported information to inform the 
presence of physical health conditions. 
PDs and associated mental and physical comorbidity (the presence of 
coexisting disorders during a defined period of time) , might also lead to high 
public healthcare service utilization, contributing to high burden on healthcare 
professionals spanning general practitioners (GPs), psychiatrists, psychologists, 
and allied healthcare professionals. 
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From an economic and public health perspective, it is essential to plan for and 
anticipate health and disability needs in the population and for bridging the gap 
between physical and psychiatric health systems.  
 
1.1. Defining personality disorders 
 
PDs are characterized by enduring patterns of thinking and behaviors which are 
relatively inflexible, pervasive, and maladaptive. According to the Diagnostic 
and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) (APA, 
2000) and DSM, fifth edition (DSM-5) (APA, 2013) the general criteria for PD 
are: 
 
A) An enduring pattern of inner experience and behavior that deviates 
markedly from the expectations of the individual’s culture. The pattern is 
manifested in two (or more) of the following areas: (1) cognition, (2) 
affectivity, (3) interpersonal functioning, (4) impulse control. B) The 
enduring pattern is inflexible and pervasive across a broad range of 
personal and social situations. C) The enduring pattern leads to 
clinically significant distress or impairment in social, occupational, or 
other important areas of functioning. D) The pattern is stable and of long 
duration, and its onset can be traced back to at least adolescence or 
early adulthood. E) The enduring pattern is not better accounted for as a 
manifestation or consequence of another mental disorder. F) The 
enduring pattern is not due to the direct physiological effects of a 
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substance (e.g., a drug of abuse, a medication) or a general medical 
condition (e.g., head trauma) (APA, 2013; p.645). 
There are 10 individual DSM-IV PDs that were retained for the current version 
of the DSM-5 that can be categorized into PD Clusters, based on similar 
clinical features of the individual PDs (Table 1): These are: Cluster A - odd 
and/or eccentric disorders (paranoid, schizoid, and schizotypal PDs), Cluster B 
- dramatic, emotional or erratic disorders (antisocial, borderline personality 
disorder, histrionic and narcissistic PDs), and Cluster C – anxious and/or 
fearful disorders (avoidant, dependent, and obsessive-compulsive PDs), with a 
category for PD not otherwise specified (APA, 2013). In addition, there is 
some support for the classification of PDs into Clusters A, B, and C using 
confirmatory factory analysis in a representative, population-based sample of 
the US (Cox et al., 2012). 
5Table 1: Clinical descriptions for DSM-IV and DSM-5 PDs (APA, 2013)
Cluster A Odd/eccentric PDs
Paranoid A pervasive distrust and suspiciousness of others such that their 
motives are interpreted as malevolent.
Schizoid A pervasive pattern of detachment from social relationships and 
a restricted range of expression of emotions in interpersonal 
settings.
Schizotypal A pervasive pattern of social and interpersonal deficits marked 
by acute discomfort, reduced capacity for close relationships, as 
well as cognitive or perceptual distortions and eccentricities of 
behavior.
Cluster B Dramatic/Emotional/Erratic PDs
Antisocial A pervasive pattern of disregard for and violation of the rights of 
others.
Borderline A pervasive pattern of instability and interpersonal relationships, 
self-image, affects, and control over impulses.
Histrionic A pervasive pattern of excessive emotion and attention seeking.
Narcissistic A pattern of grandiosity (in fantasy or behavior), need for 
admiration, lack of empathy.
6Cluster C Anxious/fearful PDs
Avoidant A pervasive pattern of social inhibition, feelings of 
inadequacy and hypersensitivity to negative evaluation.
Dependent A pervasive pattern and excessive need to be taken care of, 
which leads to submissive and clinging behavior and fears of 
separation.
Obsessive-
compulsive
A pervasive pattern of preoccupation with orderliness, 
perfectionism, and mental and interpersonal control, at the 
expense of flexibility, openness, and efficiency.
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1.2. The history of personality disorder classification 
 
Progress in defining personality pathology has evolved through the 
development of the instruments and applications of these instruments in 
clinical psychology and psychiatric settings (Lenzenweger & Clarkin, 2005). 
From an epidemiological perspective, the classification of psychiatric disorders 
(including PDs), diseases and other public health problems developed, in part, 
alongside the need to collect statistical information including prevalence and 
mortality data to inform the public health management of these diseases and 
guide clinical utility (Grob, 1985). 
 
Historically, the formation of the United Nations in 1945, led to population 
level approaches to tackling global health issues; including the forming of 
constitution of the World Health Organization (WHO) in 1948, which resumed 
accountability for International Classification of Diseases (ICD) (previously 
the International List of Causes of Death, dating back to the 1850’s) (Stengel, 
1959).  
 
Post World War II, the US Army and The Veterans Administration developed 
nomenclature to describe the presentation of psychological, somatic, and 
personality difficulties that the service persons and veterans of war were 
experiencing (Raine, 1952). Also, there was a need to investigate socio-
environmental factors as they related to assessing needs for public healthcare 
services (Grob, 1985).  
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These events influenced revisions of prior editions of the WHO ICD, which led 
to the inclusion of diagnostic categories for mental disorders for the first time 
in the ICD-6. In 1952 the APA Committee of Nomenclature and Statistics 
released the first edition of the DSM (DSM-I) that included specific categories 
for PDs (APA, 1952). Subsequently, there was a demand to improve the 
taxonomy of these disorders in order to assist clinicians with achieving greater 
clinical outcomes by utilizing categories with greater diagnostic validity, which 
was seen in the release of the ICD-8 and DSM-II (1968), and later improved in 
the ICD-9 and DSM-III/-R (1980/1984) (APA, 1987). The coordinated release 
of the DSM-III was designed to correspond to the diagnostic codes of the 
WHO ICD-9, however the focus of the ICD-9 remained largely on producing 
epidemiological data (APA, 1980). 
 
By comparison, development of the DSM-III was designed to aid both 
researchers and clinicians with the inclusion of a multi-axial system (Axis I: 
Clinical Disorders, Axis II: Personality Disorders, Mental Retardation, Axis 
III: General Medical Conditions, Axis IV: Psychosocial and Environmental 
Problems, Axis V: Global Assessment of Functioning), validated diagnostic 
criteria, which derived from empirical fieldwork, and the development of semi-
structured clinical interviews to improve the reliability of diagnoses for 
enhanced clinical utility and research purposes (APA, 1980). Moreover, the 
ICD-9 was then modified in the US (ICD-9 for Clinical Modification).  
 
As inconsistencies emerged for both the DSM-III and versions of the ICD-9, 
the Task Force for DSM-IV and work group conducted empirical research 
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programs comprising of literature reviews, data collection and analysis, and 
multi-site field trials for developing the subsequent editions. The improvements 
of the DSM-IV and DSM-IV-TR included: rectifying factual errors, updated 
review of current available evidence, cost analyses for educational value, and 
development in coordination with the ICD classification and coding systems 
(APA, 2000).
The current ICD-10 defines 10 specific PDs: paranoid, schizoid, dissocial, 
emotionally unstable: impulsive type and borderline type, histrionic, 
anankastic, anxious (avoidant), dependent, and other specified PD (WHO, 
2010). The most distinct differences between the DSM-IV PDs and the ICD-10 
PDs are the names of the diagnostic categories (obsessive-compulsive PD cf.
anankastic) used to represent the pervasive patterns of perfectionism, 
inflexibility and preoccupation with detail and orderliness. Additionally, there 
are two specific DSM-IV/DSM-5 PDs (narcissistic and schizotypal PDs), 
which are not included in the ICD-10 (APA, 2013; WHO, 2010).
There was considerable departure from prior editions in the development of the 
DSM-5, including the deletion of the multi-axial structure of previous editions 
(PDs previously separated on “axis II” from other psychiatric disorders) (First, 
2010; Skodol et al., 2011). It has been suggested that the integration of PDs 
with the other psychiatric disorders might aid better recognition of these 
disorders in both hospital, psychiatric, and clinical psychology settings (Skodol
et al., 2011). 
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The diagnostic approach of the DSM is a categorical model. This approach 
assumes that the individual classes of these disorders are clinically 
distinguishable from other classes of disorders (APA, 2013). This approach 
was arguably criticized for rigid thresholds, which might not adequately reflect 
patients’ presentation of symptoms (Skodol et al., 2011). An alternative model 
to the current categorical approach, which was proposed by the DSM-5 task 
group was a hybrid categorical-dimensional model (Skodol et al., 2011). This 
model was based on the assumption that personality pathology occurs across 
variations of normal-abnormal ranges of functioning, rather than representing 
categorically distinct (present and absent) syndromes (Skodol et al., 2011). 
Moreover, according to the proposed model, a clinician would diagnose PD by 
ranking specific traits, according to symptom presentation and severity (Skodol 
et al., 2011). 
 
Newton-Howes et al., (2014) have also expressed criticisms of the categorical 
approach, who rather conceptualize PD as a heterogeneous but nonetheless 
unitary disorder represented by core personality dysfunction, with variability 
which takes in to account both adaptive and maladaptive personality features. 
Others have suggested that it might be both clinically meaningful and 
appropriate for research purposes to examine the individual features and/or 
criterions of PDs using the current diagnostic approach available (Zimmerman 
et al., 2012).  
 
Despite ongoing debate in the field regarding the classification of PD (First, 
2010; Newton-Howes et al., 2014; Skodol et al.), the DSM-IV criteria was 
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retained for the DSM-5, and thus remains the current standard diagnostic 
criteria, despite revisions to other classes of mental disorders. 
1.3. Overview of the thesis 
This thesis describes the epidemiology of PDs in a population based-sample of 
women, and also from a nationally, representative sample of the US 
population. It comprises seven original manuscripts covering the prevalence of 
personality disorders, and their association with physical and mental health 
disorders and health service utilization. 
Chapter Two identifies and critically analyses key population-based 
epidemiological studies investigating the prevalence of PDs, and their 
association with mental and physical disorders, and health service utilization in 
the form of a literature review (Manuscript I.). The findings of the review 
indicated that PDs are relatively common, with a comparison of data being 
presented from population-based studies derived predominantly from the US 
and the United Kingdom. The review also suggests that physical health 
comorbidities of individuals living with PD in the general population have not 
been thoroughly investigated, which is concerning from a public health 
perspective. The literature to date also suggests that PDs are among the most 
frequently treated psychiatric disorders; yet it remains unclear whether 
individuals with PD also frequently utilize services for physical health-related 
problems. It is discussed that an improved evidence base is needed for future 
planning of healthcare resource allocation. 
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After identifying the gaps in the literature, the rationale for the thesis is 
presented in the form of a published comment (Manuscript II.). The rationale 
highlights the important clinical and public health significance of the topic of 
the thesis, including that the lack of progress in the reduction of the prevalence, 
and associated disability of other psychiatric disorders in the population might 
be that we have continued to neglect the role of PDs at a population level. 
Chapter Three describes the methodology of the two studies utilized in this 
thesis; the Geelong Osteoporosis Study (GOS) located in south-eastern 
Australia, and the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC), a population-based survey of the US population. 
Chapter Four investigates the prevalence of PDs, age distribution, and the 
comorbidity of other mental disorders in the GOS (Manuscript III). Prevalence 
data were determined from the study population, and standardized using a 
direct method of standardization according to the 2011 census data for 
Australian population figures. Approximately one in five women were 
identified with any one or more PDs, with high levels of psychiatric 
comorbidity detected. Importantly, younger individuals appeared to have the 
highest proportion of PDs. These data highlight that early detection of PD 
might have important public health implications. 
Chapter Five assesses associations between PDs and physical health conditions 
in the form of a systematic review (Manuscript IV), and in separate studies 
derived from the NESARC (Manuscript V), and the GOS (Manuscript VI). 
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This Chapter demonstrates that the increased risk for physical health conditions 
among individuals with Clusters A, B and C PDs varies. Recognizing the 
importance of the added physical disability attributed by PD is important for 
the detection, monitoring, and the development of integrated treatment 
approaches of mental and physical comorbidities including PD. 
Chapter Six examines associations between PDs and healthcare service 
utilization (mental and physical health-related services) in a data linkage study 
using the GOS data and data routinely collected from Medicare (Australia) 
records (Manuscript VII). Among the major findings were that general 
practitioners appeared to be a key treatment contact for individuals with PDs. 
The findings from this study underscore the increased burden on the public 
healthcare system accounted for by individuals with PD, and might be useful 
for healthcare service planning and delivery. 
Chapter Seven summarizes the key findings of the thesis, with respect to the 
literature to date. Limitations and direction for future studies are presented.
Chapter Eight concludes the thesis. 
14
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2.1 Manuscript I: Literature Review 
Quirk, S.E., Berk, M., Chanen, A.M., Koivumaa-Honkanen H., Brennan-
Olsen, S.L., Pasco, J.A., & Williams, L.J. (2015). Population prevalence of 
personality disorder and associations with physical health comorbidities and 
health care service utilization: A review. Personality disorders: Theory 
Research Treatment, (published online ahead of print) 
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Abstract
Personality disorder (PD), outcomes of diverse comorbid physical health 
conditions, and the associated burden on health service resources have seldom 
been studied at a population level. Consequently, there is limited evidence that 
might inform a public health approach to managing PD and associated mental 
and physical disability. A review was conducted of population-based studies 
examining the prevalence of PD and associations between physical 
comorbidities and service utilization. The prevalence of any PD were common 
(4.4%-21.5%) among populations spanning England, Wales, Scotland, Western 
Europe, Norway, Australia, and the United States. Preliminary evidence 
supports associations between PDs from Cluster A and Band physical 
comorbidities, namely cardiovascular diseases and arthritis. PD appears to 
increase healthcare utilization, particularly in primary care. In order to facilitate 
rational population health planning, further population studies are required. 
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POPULATION PREVALENCE OF PERSONALITY DISORDER AND 
ASSOCIATIONS WITH PHYSICAL HEALTH COMORBIDITIES AND 
HEALTH CARE SERVICE UTILIZATION: A REVIEW. 
Introduction
Personality disorder (PD) is now considered to be a heterogeneous but 
nonetheless unitary disorder (Newton-Howes et al., 2015) which has been 
traditionally described as 10 categorically distinct disorders – paranoid, 
schizoid, schizotypal, antisocial, borderline, histrionic, narcissistic, avoidant, 
dependent, obsessive-compulsive (American Psychiatric Association [APA]),
2013). Personality pathology encompasses features that are believed to be 
relatively pervasive and enduring across individuals’ intra- and interpersonal 
experiences (APA, 2013). Historically, the notion of temporal stability has 
been a defining criterion in the diagnosis of PD since publication of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM in 1952 (APA,
1952). Yet burgeoning evidence indicates that some specific forms of PD have 
been shown to be less stable than the DSM-IV-TR and its predecessors 
suggest. Moreover, some specific forms of PD (i.e. paranoid, schizoid, 
dependent, histrionic, and narcissistic), were diagnostic categories in 
consideration of being omitted, in part citing reasons due to the insufficient 
levels of epidemiological and/or evidence describing pathophysiological 
mechanisms for these disorders, and questionable clinical utility (Skodol et al., 
2011). Yet the DSM-5 Task Force and Work Groups were unable to achieve 
consensus regarding the proposed hybrid model of 5 PD types, to be rated 
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dimensionally, and thus 10 specific PD categories were retained from the 
DSM-IV-TR (Skodol et al., 2011). 
PD in the general population is common, studies from the United Kingdom of 
Great Britain (England, Wales, and Scotland), Norway, and Australia indicate 
the prevalence of any categorical PD range between 4.4% (Coid et al., 2006) 
and 13.4% (Torgersen, Kringlen, & Cramer, 2001). Data from the United 
States (US) shows that PD is highly prevalent, with studies indicating the 
prevalence for any categorical PD range 9.0-21.5% (Lenzenweger, Lane, 
Loranger, & Kessler, 2007; Trull, Jahng, Tomko, Wood, & Sher, 2010). 
PDs as a group, and borderline PD in particular are known to cause significant 
mental and physical disability (Grant et al., 2004; Jackson & Burgess, 2000) 
and are frequently associated with high usage of medical and mental health 
service resources (Coid et al., 2009; Jackson & Burgess, 2004; Powers & 
Oltmanns, 2012). Some have suggested the burden might be high for general 
practitioner (GP) consultations (Jackson & Burgess, 2004), particularly for 
problems associated with borderline PD (Coid et al., 2009). Critically, patients 
with primary PD diagnoses who were identified as users of mental health-
related services have been shown to have markedly reduced life expectancies 
(Fok et al., 2012). Yet, it remains unclear whether individuals with other 
specific types of PD are likely to frequently utilize mental health related-
services, or those services performed by GPs. 
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There is emerging evidence that also suggests PD might contribute to  adverse 
physical health related outcomes, with preliminary cross-sectional evidence 
revealing PD is associated with increased risk of a variety of physical health 
comorbidities (El-Gabalawy, Katz, & Sareen, 2010; Goldstein et al., 2008; 
Moran et al., 2007; Powers & Oltmanns, 2013; Quirk et al., 2015). 
Longitudinal associations reveal the risk might be particularly notable for 
cardiovascular disease and cardiovascular disease related mortality (Lee et al., 
2010). Yet, there is currently a paucity of data, and further studies are required, 
particularly investigating these associations in the general population. This is 
emphasized by the notion that the measurement of PD is often neglected in 
large scale epidemiological studies, potentially giving the misleading 
impression that PD is unimportant from a public health perspective. This might 
also be underscored by the fact that PDs from Cluster A including paranoid and 
schizoid which were proposed to be omitted from the DSM-5 remain the most 
infrequently studied PDs, particularly in the general population setting. 
Thus, PD remains a considerable public health burden, and there have been 
calls for PD to be recognized as a major contributor to population mental 
health and disease burden, in their own right (Coid 2003; Quirk, Williams, 
Chanen, & Berk, 2015; Torgersen, 2012; Tyrer et al., 2010) 
Yet, there remains limited epidemiological evidence which might be utilized to 
inform public health approaches to manage PD and associated mental and 
physical disability. One reason for this might be that predisposing pathological 
personality traits continue to be overlooked in clinical practice (Newton-Howes 
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et al., 2015). Moreover, the stigmatizing attitudes held towards individuals with 
PD by some healthcare professionals might also influence the level of funding 
granted for PD research in the US, compared to other forms of psychiatric 
illness, namely bipolar disorder (Zimmerman & Gazarian, 2014). 
 
The purpose of this review is to discuss pertinent epidemiological studies of 
PD in the general population. First, we collate the evidence regarding the 
overall population prevalence of categorical PD from key epidemiological 
studies (Table 1). Second, we discuss the evidence regarding physical health 
comorbidities and associations with medical and mental health service resource 
utilization. To summarize, recommendations for future studies are proposed in 
order to better our public health understanding of PD, and to benefit those in 
the population who live with these disorders. 
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Table 1: Prevalence (%) of personality disorders in the reviewed population-based studies 
Samuels 
et al., 
(1994)
Samuels 
et al., 
2002)
Lee et 
al.,
(2010)
Lenzenweger 
et al., 
(2007)
Grant 
et al., 
(2004)
Grant 
et al., 
(2008)
Stinson 
et al., 
(2009)
Trull 
et al., 
(2010)
Coid
et al., 
(2006)
Torgersen 
et al., 
(2001)
Jackson 
et al., 
(2000)
Huang
et al., 
(2009)
DSM personality disorders, %
Cluster A 0.0/ 0.1* 2.1 0.9 5.7 4.4 NS‡ NS‡ 2.1 1.6 NS‡ NS‡ 3.6††
Paranoid 0.0/ 0.0* 0.7 0.0 NS‡ NS‡ NS‡ NS‡ 1.9 0.7 2.4 NS‡ NS‡
Schizoid 0.0/ 0.0* 0.9 0.9 NS‡ 3.1 NS‡ NS‡ 0.6 0.8 1.7 NS‡ NS‡
Schizotypal 0.0/0.1* 0.6 0.0 NS‡ NS‡ NS‡ NS‡ 0.6 0.06 0.6 NS‡ NS‡
Cluster B 4.0 /5.4* 4.5 10.0 1.5 NS‡ NS‡ NS‡ 5.5 1.2 NS‡ NS‡ 1.5††
Antisocial 1.5/1.8* 4.1 1.7 0.6 3.6 NS‡ NS‡ 3.8 0.6 0.7 NS‡ NS‡
Borderline 0.4/0.5* 0.5 1.7 1.4 NS‡ 5.9 NS‡ 2.7 0.7 0.7 NS‡ NS‡
Histrionic 2.1 / 0.2 10.9 NS‡ 1.8 NS‡ NS‡ 0.3 § 2.0 NS‡ NS‡
 25 
 
3.6* 
Narcissistic 0.0 /0.0* 0.03 0.0 NS‡ NS‡ NS‡ 6.2 1.0 § 0.8 NS‡ NS‡ 
Cluster C 1.9/4.0* 2.8 3.7 6.0 NS‡ NS‡ NS‡ 2.3 2.6 NS‡ NS‡ 2.7†† 
Avoidant 0.0/0.0* 1.8 0.0 NS‡ 2.4 NS‡ NS‡ 1.2 0.8 5.0 NS‡ NS‡ 
Dependent 0.1/0.2* 0.1 0.4 NS‡ 0.5 NS‡ NS‡ 0.3 0.1 1.5 NS‡ NS‡ 
Obsessive-
compulsive 
1.7/3.4* 0.9 3.3 NS‡ 7.9 NS‡ NS‡ 1.9 1.9 2.0 NS‡ NS‡ 
Any PD 5.9 / 
9.3*† 
9.0 13.3 9.1 14.8 NS‡ NS‡ 9.1 4.4 13.4\\ NS‡ 6.1†† 
ICD personality disorders: prevalence, % 
Paranoid  0.3 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 1.3 NS‡ 
Schizoid  1.1 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 1.9 NS‡ 
Impulsive   0.9 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 1.3 NS‡ 
Borderline  0.1 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 1.0 NS‡ 
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Histrionic  0.05 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 0.5 NS‡ 
Dissocial  2.3 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ § NS‡ 
Anankastic  0.8 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 3.1 NS‡ 
Anxious  0.2 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 2.3 NS‡ 
Dependent  0.1 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 1.0 NS‡ 
Any PD  5.1 NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ NS‡ 6.6 NS‡ 
 
*Provisional cases of PD 
† Any PD includes DSM-III passive-aggressive PD  
‡Not stated/investigated 
§ No cases reported in study 
\\ Any PD Includes passive-aggressive, self-defeating, and sadistic PDs  
†† Multiple imputation derived prevalence of personality disorders pooled across countries Colombia, Lebanon, Mexico, Nigeria, 
People’s Republic of China, South Africa, United States, Western Europe
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Population prevalence 
The National Institute of Mental Health (NIMH) Epidemiological 
Catchment Area (ECA) longitudinal study. The NIMH Baltimore 
Epidemiological Catchment Area Program is a multi-site program and is 
considered a landmark study in the field of psychiatric epidemiology (Robins 
& Regier, 1991). Previously, prevalence and service usage data were 
considered to derive from clinical populations. Categorical DSM-III PDs were 
assessed in the Second Wave of the Eastern Baltimore Mental Health Survey in 
1981 (n= 810 residents, aged 18-64 years) (Samuels, Nestadt, Romanoski, 
Folstein, & McHugh, 1994). The weighted prevalence of receiving a 
categorical PD diagnosis was 5.9%, and 9.3%with the inclusion of provisional 
cases, respectively (Samuels et al., 1994). Cluster B PDs were the most 
common (5.1%), followed by Cluster C (4.0%), and then Cluster A (0.1%). In 
regard to socio-demographic correlates, individuals who were separated or 
divorced had the highest rates of PD, and a higher proportion were male (not 
significant) (Samuels et al., 1994). Self-reported indicators of socio-economic 
status, such as household income and highest level of education achieved did 
not appear to be associated with PD in this population (Samuels et al., 1994). 
A sub-sample (n=742, 34-94 years) were re-interviewed as part of the Hopkins 
Epidemiology of Personality Disorder Study follow-up survey (1997-1999) 
(Samuels et al., 2002). 9.0% of the sample were diagnosed with any PD, and 
Cluster A and B were most common among younger men. In this sample, 
individuals with Cluster A PDs were less likely to be married, and more likely 
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to be separated or divorced, and males with Cluster B PDs were less likely to 
have completed high school (Samuels et al., 2002). Younger individuals were 
also more likely to be identified with borderline PD, compared with the older 
age groups.  
 
In Wave 4 (2004), categorical diagnoses were re-analyzed within the remaining 
sample (n=244) showing that 13.3% of the remaining sample could be 
diagnosed with any categorical PD (Lee et al., 2010). Dimensional ratings of 
the assessments from Wave 2 were also estimated and mean trait scores were 
estimated. As with previous analyses, Cluster B PDs were most common 
(mean traits = 5.22, SD =7.48), followed by cluster C (mean traits = 2.29, SD 
=2.26), then cluster A (mean traits = 0.67, SD =2.35) (Lee et al., 2010). The 
remaining sample differed only slightly with regard to socio-demographic 
variables when compared with the original sample. The re-analyzed data 
provided the first dimensional ratings of DSM-III PDs, and which described 
associated socio-demographic correlates. 
 
Limitations included that during the development of the study methodology, 
there were no validated diagnostic instruments for DSM-III for research 
settings, the inclusion of which might have improved the quality of the study 
design (Lee et al., 2010; Samuels et al., 1994; Samuels et al., 2002). Given the 
low prevalence of Cluster A PDs detected, it is also possible that selection 
biases might have affected how well samples from these studies represented 
the underlying population. 
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National Comorbidity Survey. National Comorbidity Survey (NCS) was a 
representative community-based household survey of mental state disorders 
and correlates in the US (Kessler & Merikangas, 2004). The epidemiological  
data from the NCS-R (replicated) utilized the more contemporary DSM-IV and 
International Classification of Diseases-10 Version (ICD-10) diagnostic 
criteria, compared with the original survey which use the DSM-III-R 
(Lenzenweger et al., 2007). Between 2001 and 2003, a sub-sample (n=5,692) 
completed Part 1 of the survey, which assessed for mental state disorders 
(described as “core mental disorders”), and Part 2, which included assessment 
of PD (Lenzenweger et al., 2007) Respondents were screened using the 
International Personality Disorder Examination (IPDE), and a probability sub-
sample (clinical reappraisal sample n = 214) were administered a semi-
structured interview. Multiple imputation (MI) methods were used to predict 
US population prevalence estimates with 9.1% (11.9% clinical reappraisal 
sample), of the sample meeting criteria for any categorical PD (Lenzenweger et 
al., 2007). The authors suggested that a strength of the study was that applying 
MI methods likely produced less biased, and more conservative and reliable 
findings, compared with prior studies. Being younger and having a lower level 
of education was associated with a diagnosis for cluster B PDs, and being 
unemployed was specifically associated with borderline PD.  Men were more 
likely than women to receive a diagnosis of antisocial PD (Lenzenweger et al., 
2007). 
 
National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC). Between 2001-2002 and 2004-2005, The National Institutes of 
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Health/National Institute on Alcohol Abuse and Alcoholism (NIAAA) 
conducted Waves 1 and 2 of the NESARC, respectively. In total, 43,093 
respondents (aged ≥18 years), representative of the US population, were 
surveyed in face-to-face interviews. Categorical PDs were assessed using the 
Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV 
Version (AUDAIDIS-IV); a diagnostic interview schedule developed by the 
NIAAA for administration by experienced lay interviewers (Grant et al., 2003; 
Ruan et al., 2008). 
In Wave I, , avoidant, dependent, obsessive-compulsive, paranoid, schizoid, 
histrionic, and antisocial PDs were assessed (Grant et al., 2004), and the 
remaining three DSM-IV PDs that included schizotypal, narcissistic, and 
borderline were assessed in Wave 2 (Grant et al., 2008; Pulay et al., 2009; 
Stinson et al., 2008).The overall prevalence of any categorical PD yielded from 
these studies was 21.5%. 
The diagnostic algorithms used in the NESARC, require one criterion causing 
significant distress or impairment in functioning in addition to meeting 
diagnostic criteria, to determine a diagnosis of categorical PD. Alternatively, 
Trull and colleagues argue the threshold for diagnosing PDs is low, and has 
potentially inflated the prevalence in the survey (Trull et al., 2010). 
Consequently, Trull and colleagues re-estimated the prevalence of PD 
requiring that distress and/or impairment was present for each individual 
criterion to be assessed, and indicated that 9.1% had any categorical PD (Trull 
et al., 2010). The prevalence estimates reported in the re-analyzed data proved 
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to be more in line with other US national surveys, such as the NCS-R (9.0%) 
(Lenzenweger et al., 2007). In addition to their discussion of the need for more 
stringent thresholds, Trull and colleagues raised another key issue, which 
future studies might use self-report scales to assess for dysfunction, in order to 
further validate diagnoses (Trull et al., 2010). Yet, the NESARC has provided a 
rich data source that has provided a rare opportunity to investigate the 
population-based study of PD and comorbidities. 
 
The National Psychiatric Surveys of Great Britain. The National Survey of 
Psychiatric Morbidity was a national survey that originally recruited and 
interviewed respondents (n= 10,108, aged 16-65 years) from households across 
the United Kingdom of Great Britain (England, Wales and Scotland) (Jenkins 
et al., 1997). During phase II, trained graduate psychologists interviewed 628 
participants with the Structured Clinical Interview for DSM-IV Axis II PDs 
(SCID-II) (Coid et al., 2006). Weighted prevalence estimates revealed that 
4.4% of the sample met criteria for any categorical PD (Coid et al., 2006), 
producing the most conservative prevalence estimates to date. Gender 
differences were observed, with more men being diagnosed with PD across all 
specific PDs, apart from avoidant PD, which was more prevalent in women 
(Coid et al., 2006). Having a PD diagnosis was associated with being separated 
from a partner and being unemployed (Coid et al., 2006). Of note, this is the 
only population study to include participants under the age of 18 years (lowest 
age included was 16 years). Potential reasons for the low prevalence estimates 
include sampling procedures, and that the use of the SCID-II and more 
stringent thresholds derived fewer diagnoses.  
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Personality disorders in the community: data from Norway. Torgersen and 
colleagues reported the first epidemiological data from Norway (Torgersen et 
al., 2001). A community-based sample of 3,590 participants (aged 18-65 years) 
was identified via the National Register of Oslo between 1994 and 1997. 
Psychiatric interviews were conducted with 2,053 respondents by a 
combination of experienced health care professionals (including nurses, 
medical students, and interviewers) using the Structured Interview for DSM-
III-R Personality (SIDP-R) (Pfhol, et al., 1989). The overall prevalence 
reported for any PD was 13.4%. Men were more often diagnosed with 
schizoid, antisocial, narcissistic and obsessive-compulsive PDs, and women 
were often diagnosed with avoidant, histrionic and dependent PDs, and those 
with PDs were more likely to live alone and achieve lower levels of education 
(Torgersen et al., 2001).
Personality disorders in the community: data from Australia. Australian 
National Survey of Mental Health and Wellbeing (NSMHWB) is the only 
epidemiological study to date that has estimated the population prevalence of 
PD in Australia (Jackson & Burgess, 2000, 2002, 2004). Experienced lay 
interviewers administered the 59-item self-report screening questionnaire from 
the ICD-10 version of the International Personality Disorder Examination 
(IPDE) (Loranger et al., 1994) to a nationwide sample of 10,461 participants. 
The survey indicated that approximately 6.5% of the Australian population 
screened positive to any ICD-10 PD (Jackson & Burgess, 2000). Consistent 
with the reviewed studies, gender differences existed within this sample, with 
more men being diagnosed with impulsive and anakastic PDs (cf. DSM-5
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obsessive-compulsive PD) and more women being diagnosed with anxious and 
dependent PDs. However, employment status and birth country were not 
associated with a PD diagnosis. While this study provided the first national 
data on the prevalence of PD in any country, the use of the ICD-10 IPDE 
screening instrument as a diagnostic instrument, rather than a semi-structured 
interview is a limitation, yet presents an opportunity for future Australian 
epidemiological studies. 
 
World Health Organization Mental Health Surveys. As part of the World 
Health Organization Mental Health Surveys, sub-samples of individuals from 
selected households were screened for personality disorder following primary 
phase of psychiatric interviewing for mental disorders of interest (Huang et al., 
2009). Cross-national (Belgium, France, Germany, Italy, The Netherlands, 
Spain, China, Colombia, Lebanon, Mexico, Nigeria, and South Africa) 
prevalence estimates for any PD differed conservatively, with the overall 
prevalence for any PD being reported as ~6.1% (Huang et al., 2009). The 
surveys also revealed that probable cases of PD were associated with 
functional impairment across all 13 countries (Huang et al., 2009). Thus, if 
practicable, it appears that it might be warranted to consider including the 
assessment of PD as part of primary phase assessment in the Mental Health 
Surveys (Huang et al., 2009). 
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Summary of population prevalence studies 
The variation in the prevalence reported across all studies, are likely due to the 
different methods used to assess personality disorder and also the sampling 
procedures of surveys. As an exemplar, the NCS-R (and PD 9.0%) utilized a 
two stage sampling procedure, and PD was assessed as secondary mental 
disorders of interest with a reduced sample (Part II). To compare, in the 
NESARC, pooling the diagnoses from both Waves yields the overall 
prevalence reported by Trull and colleagues (9.1% vs 21.5%) (Trull et al., 
2010), however these disorders were assessed across two separate cross-
sectional surveys and time-points. Furthermore, interviewers across all studies 
administering the diagnostic instruments had varying levels of skills including 
medical students, nurses, psychiatrists and lay interviewers which might affect 
diagnostic validity or introduce measurement biases. 
Currently, age-stratified prevalence data and socio-demographic correlates are 
lacking for PD which are required for mental health service planning. The 
expression and associated difficulties of PD are likely to differ across the life 
course (including young and elderly people) (Newton-Howes et al., 2015), and 
this is supported by data which indicates that more severe personality
pathology is associated with younger age (Yang, et al., 2010). Furthermore, 
younger patients have also been shown to be more likely to report impulsive 
behaviors including suicidal behaviors and affective instability (Morgan, et al.,
2013), which might have implications for the management of PD. 
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Physical health comorbidities 
The WHO and the Global Burden of Disease Study, identifies cardiovascular 
disease including ischemic heart disease and stroke, chronic respiratory 
diseases, diabetes and cancers being among the top 10 leading causes of death 
worldwide (Lozano et al., 2012). Furthermore, musculoskeletal conditions are 
the second greatest cause of disability on a global scale, thus promoting calls to 
prioritize musculoskeletal health alongside high prevalence non-communicable 
diseases (Horton, 2012; Vos et al., 2012). 
A progressing public health agenda in recent decades has been on 
conceptualizing the integration of mental and chronic physical health 
prevention and management with a focus on some of these chronic disease 
groups (O'Neil et al., 2015). However PD has been mostly omitted from these 
discussions, and physical health comorbidities remain unmeasured in many 
psychiatric epidemiological studies and ignored in clinical settings. For 
example, there has been considerable improvement to guidelines, among many 
nations, which recommend screening for depressive and anxiety symptoms in 
patients with cardiovascular diseases, which aims to improve psychiatric 
detection and outcomes in cardiovascular populations, and improve integrated 
treatment of comorbidities (Colquhoun et al., 2013; Tully & Higgins, 2014). 
While PD are not routinely screened in these settings, recent data suggests that 
such screening may be warranted with approximately 30% of patients admitted 
to hospital for end stage cardiovascular diseases (heart failure patients) being 
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identified as having PD (Tully & Selkow, 2014). Those with PD were also 
more likely to have complex psychiatric and physical comorbidities, including 
alcohol associated causes of cardiomyopathy (Tully & Selkow, 2014). 
However, there are a few cohort studies which investigate associations between 
PDs and increased risk for physical health comorbidities; particularly in the 
general population. 
Longitudinal cohort studies
Children in the Community Study. As part of the Children in the Community 
Study (Bernstein, et al., 1996; Chen et al., 2009), the household survey of 
mothers and their offspring in the US (upstate New York), investigated PD 
among youths (n=736, 9-18 years, mean age 13.7 years) in 1983 and self-
reported physical health outcomes at various follow-up phases (1985-1986, 
1991-1994, 2001-2004). PD was assessed using a combination of semi-
structure interviews (mother or youth) including the NIMH Diagnostic 
Interview Schedule for Children (Costello, et al., 1984) and Disorganizing 
Poverty Interview (Krogan, et al., 1978); in addition to items modified from the 
Personality Diagnostic Questionnaire (Hyler et al., 1988) and the screening 
version of the Structured Clinical Interview for DSM-III-R Personality 
Disorders (Spitzer & Williams, 1986). Predetermined algorithms derived 
diagnoses which were categorized according to either moderate or severe 
symptom levels (Bernstein et al., 1996). Presence of severe physical health 
conditions including musculoskeletal, neurological, chronic respiratory, 
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chronic gastrointestinal, urinary, and cardiovascular diseases, severe allergies, 
hearing or vision problems, cancer, and diabetes were assessed by via self-
report (youths) (Chen et al., 2009). 
Key findings included those with any PD at baseline were shown to have 
increased risk of having any serious physical illness by mean ages of 16-33 
years (1.48 95%CI 1.02-2.14) compared to youths without any 
psychopathology (Chen et al., 2009). For youths with any PD and any 
comorbid mental state disorder, the increased odds for serious physical illness 
were higher again (1.67 95%CI 1.08-2.56) (Chen et al., 2009). These models 
adjusted pertinent socio-demographic variables including age, gender, race, 
marriage status, education, and family socio-economic status), and smoking, 
physical activity, and body mass index (BMI), indicating that the risk is 
particularly elevated among those with PD, and not explained by risky health 
behaviors such as smoking alone (Chen et al., 2009). 
Epidemiological Catchment Area (ECA) longitudinal study. In the general 
adult population, the only longitudinal investigations of PD and physical health 
outcomes in adults derived from the NIMH ECA longitudinal study (previously 
described); the Baltimore ECA Program. In this study, associations between 
any PD and PD Clusters (categorical and dimensional traits) and incident self-
reported CVD were investigated among 244 respondents (1982-2010) (Lee et 
al., 2010). The major findings to emerge were that Cluster B PDs were 
associated with an approximate four-fold increased risk of incident CVD 
(OR4.14, 95%CI 1.41-12.14), after adjustment for age, diabetes, and smoking 
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frequency, but not mental state disorders (Lee et al., 2010). Dimensionally 
rated Cluster B traits were also associated with incident CVD (OR1.07, 95%CI 
1.02-1.12), as was for borderline PD (OR1.23, 95%CI 1.01-1.51) (Lee et al., 
2010). The study reported lack of sufficient statistical power to analyze 
associations with specific PDs, particularly those from Cluster A, and calls 
were made for further large scale epidemiological studies to undertake these 
analyses (Lee et al., 2010). 
 
Cross-sectional studies 
 
British National Survey of Psychiatric Morbidity. As part of the British 
National Survey of Psychiatric Morbidity, cross-sectional associations were 
found between those screening positive for any PD (as determined by the 
SCID-II questionnaire) and self-reported stroke (OR 1.9, 95%CI 1.0-3.5), and 
ischemic heart disease (OR 1.4, 95%CI 1.0-1.9) after adjusting for the 
covariates of age, sex, occupation, smoking and alcohol use, and hypertension 
or diabetes (Moran et al., 2007). Specifically, avoidant, obsessive-compulsive 
and borderline PDs were associated with stroke, and avoidant, paranoid, 
schizotypal, schizoid and borderline PDs were associated with ischemic heart 
disease (Moran et al., 2007) Notable findings were strong associations which 
emerged borderline PD and ischemic heart disease (OR 7.2, 95% CI 2.1-24.3) 
(Moran et al., 2007), which warrants further exploration. 
 
NESARC. Analyses conducted as part of Wave 1 (2001-2002) of the 
NESARC (n=43,093) reported that categorical antisocial PD was associated 
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with self-reported CVD (defined as coronary heart disease) (OR1.5, 95%CI, 
1.05-2.22) (Goldstein et al., 2008). Adjustments were applied for pertinent 
socio-demographic variables, socioeconomic status, pathological gambling, 
BMI, heaviest period of lifetime intake of ethanol, frequency of drug use and 
heaviest period of lifetime drug use, number of cigarettes smoked per day 
during past recent year of smoking, and PD other than antisocial (Goldstein et 
al., 2008). 
Analyses conducted as part of Wave 2 (2004-2005) of the NESARC 
(n=34,653) reported borderline PD was associated with self-reported CVD (OR 
1.68, 99%CI 1.40–2.02) and arteriosclerosis/hypertension (OR 1.46, 99%CI 
1.23–1.73) (El-Gabalawy et al., 2010) These associations were adjusted for 
pertinent confounders including mood and anxiety disorder, and PDs other than 
borderline, in addition to socio-demographic variables (El-Gabalawy et al., 
2010). In separate analyses, among younger adults (≤55 years), increased risk 
for CVD was reported for those with any PD from Cluster A (OR1.36 99%CI 
1.14-1.63), Cluster B (OR.1.27 99%CI 1.07-1.50), and Cluster C (1.23 99%CI 
1.03-1.46) (Quirk et al., 2015). Younger adults with specific PDs were also 
associated with CVD, including borderline (OR1.47 99%CI 1.17-1.85), and 
obsessive-compulsive (1.25 99%CI 1.04-1.50); and all ages with schizoid (OR 
1.50 99%CI 1.20–1.89), schizotypal (OR 1.64 99% CI 1.34–2.02), and 
narcissistic (OR 1.20 99%CI 1.01–1.42) (Quirk et al., 2015). Similarly, these 
associations were adjusted for pertinent socio-demographic variables, and were 
not explained by other past-year mental state disorders. 
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McWilliams and colleagues conducted the first study to examine PDs and self-
reported arthritis in the general population, as part of Wave 1 of the NESARC 
(McWilliams, et al., 2008) There was a cross-sectional association between 
arthritis and each PD examined, with the exception of dependent (antisocial, 
avoidant, obsessive-compulsive, paranoid, schizoid, and histrionic PD) (OR 
1.40-2.06, 95%CI 1.23-2.48) (McWilliams et al., 2008). These associations 
were observed after adjusting for potential confounders such as gender, marital 
status, income, age, and presence of physical health conditions other than 
arthritis, one or more depressive or anxiety disorders in the previous year, and 
one or more alcohol or substance related disorders in the previous year 
(McWilliams et al., 2008). 
Further analyses from Wave 1 of the NESARC reported that men with 
antisocial PD had increased odds of arthritis (OR 2.20 95%CI, 1.69-2.76), as 
did women to a lesser extent (OR 1.40 95%CI, 1.03-1.96) (Goldstein et al., 
2008). As part of Wave 2 of NESARC, arthritis was associated also with 
borderline PD (OR 1.56 95%CI 1.31-1.85) (El-Gabalawy et al., 2010), and 
separate analyses revealed associations particularly among younger adults (<55 
years) with schizoid (OR 1.62 95%CI 1.16–2.26), and schizotypal (OR 1.58 
95%CI 1.18–2.13) PDs (Quirk et al., 2015). 
These studies utilizing data from the NESARC have also reported associations 
between PD and increased risk for other self-reported physical health 
conditions including hepatic disease, venereal disease, obesity (El-Gabalawy et 
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al., 2010), gastrointestinal diseases, and diabetes (El-Gabalawy et al., 2010; 
Quirk et al., 2015). 
St. Louis Personality and Aging Network (SPAN). The SPAN study is a 
community-based study (St Louis area; US), designed to investigate the impact 
the effect of personality on later life outcomes (55-64 years), particularly health 
(Oltmanns & Gleason, 2011). In this study (n=1,051, aged 55– 64 years), PD 
was investigated using a multi-source approach of self-, informant- and 
interviewer-rated assessments (SIDP-IV and Multisource Assessment of 
Personality Pathology), and physical health conditions were assessed via self-
report (Powers & Oltmanns, 2013). Associations were significant for self-
reported borderline features and heart disease (OR 4.02, 95%CI 1.46–11.06),
but not for informant- or interviewer-rated borderline features (Powers & 
Oltmanns, 2013), potentially suggesting that those with PD identified via self-
report, perceived their mental and cardiovascular health to be worse. Strong 
associations with arthritis were also reported for interviewer-rated borderline 
PD features (OR 2.64, 95%CI 1.06–6.57), and informant-rated borderline 
features (OR 1.76, 95%1.05–2.95) (Powers & Oltmanns, 2013). These 
associations were adjusted for important socio-demographic variables (age, 
education, marital status, race), other lifetime mental disorders (MDD, alcohol 
dependence, drug dependence), and PD other than borderline PD (Powers & 
Oltmanns, 2013). Borderline PD features were not associated with diabetes 
across all sources of ratings. 
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A full mediating effect was observed across all sources of ratings for 
associations between borderline PD and arthritis, indicating that obesity might 
be one pathway explaining these relationships (Powers & Oltmanns, 2013).
Australian NSMHWB. As part of the Australian NSMHWB, respondents 
were asked to self-report (yes/no) whether they had the following medical 
conditions: asthma, chronic bronchitis, anemia, high blood pressure, heart 
trouble, arthritis, arthritis, kidney disease, diabetes, cancer, stomach or 
duodenal ulcer, chronic gallbladder or liver trouble, or hernia or rapture and 
were screened for PDs as previously described (Jackson & Burgess, 2004). 
Those identified with probable PD were approximately twice as likely to have 
one or more physical health conditions if they had comorbid paranoid PD (OR 
2.10, 95%CI 1.1-4.4) or anxious PD (OR 1.80, 95%CI 1.1-3.0), compared with 
those without PD (Jackson & Burgess, 2004). However, odd ratios and 
confidence intervals were not provided for specific physical health conditions. 
Summary of associations between PD and physical health conditions 
Taken together, the extant data suggest that a positive relationship exists 
between Cluster A and Cluster B PDs, with a range of self-reported physical 
health comorbidities, notably CVDs and arthritis. While we did not statistically 
pool the data, associations across the studies appear to be similar in a similar 
range to the combined risk for depression and the outcome of myocardial 
infarctions (OR=1.60, 95%CI 1.34-1.92), as reported in a systematic review 
and meta-analyses (Van der Kooy et al., 2007). However, with majority of 
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these studies being cross-sectional, it is premature to establish personality 
pathology as a risk factor for these diseases.  
 
Of potential significance, the DSM-5 was proposed to retain only the 
diagnostic category for schizotypal PD; due to it being considered a severe 
form of PD. However, separate analyses from large scale epidemiological 
studies have now demonstrated that paranoid, schizoid, and schizotypal PDs 
appear to be independently associated with chronic and burdensome physical 
health conditions. The reconsideration of the public health importance of these 
disorders might be timely, in light of an increasing evidence base. However, 
these associations require replications in other populations, adjusting for 
potentially confounding variables. Specifically, additional studies are required 
to examine associations which extend those findings largely derived from the 
NESARC.  
 
It appears there is currently considerable heterogeneity in the approach to 
measuring PD, particularly among these epidemiological population-based 
studies. It is noteworthy that all studies relied on self-reported diagnosis of a 
physical condition by a health professional. However, the current evince base 
suggests that is warranted for high quality cohort studies with the capability to 
ascertain more reliable diagnoses regarding both PD and physical 
comorbidities to further these investigations. This might provide an evidence 
base for considering whether PD should be integrated in an approach to control 
and better manage physical comorbidities for individual with these disorders. 
Furthermore, there appears to be a lack of data examining associations between 
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PD and the outcomes of cancers and chronic respiratory diseases, which is 
concerning from a public health perspective. 
 
It is not yet clear how screening for PD in primary healthcare settings might be 
practicable, given that individuals with PD have been shown to have complex 
psychiatric and physical comorbidities and needs, while also taking into 
account the added burden on primary care physicians. Yet, there are brief and 
reliable screening instruments including the Iowa Personality Disorder Screen 
(Langbehn et al., 1999), which might be useful for future considerations. 
Alternatively, screening for health risk factors in individuals with a diagnosed 
history of PD might be possible for secondary prevention of chronic physical 
illness. Finally, the mechanisms and direct role of PD pathology in the etiology 
and expression of these physical health comorbidities are not well understood, 
beyond investigating obesity as one important potential pathway. These 
findings suggest that there remains uncertainty in the literature in regards to the 
association between PD and physical health comorbidities. 
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Healthcare service utilization 
 
Clinical studies have shown that adults with PD, particularly borderline PD, 
have high levels of usage of healthcare resources, and high rates of 
polypharmacy and hospital admissions (Bender et al., 2001; Zanarini, 
Frankenburg, Hennen, & Silk, 2004). Moreover, patients with borderline PD 
frequently present to health services due to suicidal behaviors including suicide 
threats and/or attempts (Paris & Zweig-Frank, 2001; Zanarini et al., 2008).  
 
Similarly, in a 6-month follow-up study, community-based residents (n=608, 
55-64 years) were assessed for PD using the SIDP-IV and provided self-
reported information on indicators of health service utilization including: 
number of visits to a physician’s office in the last 6 months, visits to 
emergency departments, overnight stays in hospital, outpatient procedures, 
psychiatrist/psychologist visits, and medication use (number of current 
prescription medications, usual dosage, reason for use, and duration) (Powers 
& Oltmanns, 2012). Any PD was predictive of healthcare service utilization 
and greater use of medications, and this pattern was also observed for 
borderline PD features (Powers & Oltmanns, 2012). 
 
An earlier study, conducted as part of the British National Survey of 
Psychiatric Morbidity, reported that PD was associated with more primary care 
consultations, attendance at counselling services and psychiatric admission 
(Coid et al., 2006). However, most of the associations were nullified after 
adjusting for the confounders of age, sex, marital status and social class, 
alcohol misuse, drug dependency, affective and anxiety disorders, and 
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functional psychosis (Coid et al., 2006). The exception was that individuals 
with a diagnosis of Cluster C PD were more likely to be prescribed 
psychotropic medication and to receive counselling services (after the above 
adjustments) (Coid et al., 2006). In a separate study, associations between help 
seeking among those with borderline PD were significant only for General 
Practitioner (GP) consultations (Coid et al., 2009). Additionally, data from the 
NCS-R revealed that individuals with Cluster B PDs utilized general medical 
providers most frequently, yet associations were not sustained once adjusting 
for socio-demographic variables and past 12-month psychiatric disorders 
(mood, anxiety, impulse-control, substance use disorders) (Lenzenweger et al., 
2007). 
 
A similar pattern was demonstrated in a study utilizing data from the 
Australian NSMHWB whereby those with PD and other psychiatric 
comorbidities were more likely to present to a GP when the consultation was 
mental health related (Jackson & Burgess, 2002). It is also noteworthy that 
individuals with PD and other mental comorbidities did not frequently present 
to psychiatrists for physical health consultations (Jackson & Burgess, 2002). 
These studies suggest that there might be a reliance on GP services for a 
variety of mental and physical health problems relating to PD. 
 
Currently, it is uncertain whether all categorical PDs are associated with 
increased usage of healthcare services, and the type of services most utilized, 
particularly in the general population. Studies that draw on large national 
health administrative datasets might also provide important information 
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regarding the out-of-pocket costs of those with PDs, as well as direct and 
indirect costs to society. This is important from public health perspective, as a 
more substantial evidence base would assist public health planning and service 
delivery practices by providing indicators of both met and unmet needs for 
individuals living with PD. 
 
Strengths and Limitations 
 
Notwithstanding some of the notable methodological strengths of the reviewed 
studies, there are opportunities to include PD at the forefront of 
epidemiological research. Indeed, the lack of support for some PDs being 
retained in the proposed DSM-5 model might be underscored by the paucity of 
data, rather than an absence of clinical and public health importance regarding 
the features underlying these disorders. 
 
The NESARC has considerably progressed the population-based study of 
categorical PD in the US population, particularly in regard to investigating 
physical health comorbidities. However, given that new algorithms have been 
proposed to reduce the suggested inflated prevalence of categorical PD, it 
might be practicable for future studies utilizing the comprehensive data source, 
to replicate prior studies utilizing these new algorithms. Furthermore, others 
have suggested that due to PD being diagnosed at different time points, it 
precludes the valid investigation of longitudinal associations and direct 
comparisons among PD (Verges et al., 2014). Also, given that most of the 
evidence to date derives from cross-sectional study designs, these longitudinal 
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studies are necessary. Moreover, many chronic physical health conditions share 
clustering of risk factors that include smoking, physical inactivity, poor eating 
habits and alcohol misuse. Little is known regarding health behavior profiles of 
those living with PD, which serve as precipitating factors for disease onset. 
Additionally, further studies are needed which examine the potentially 
mediating or moderating effects of these modifiable lifestyle behaviors in the 
relationship between PD and physical health outcomes. 
Finally, by utilizing existing infrastructure such as national health 
administrative data registries or through the development of large-scale data 
linkage projects, might enable the much needed investigation of associations 
between PD, physical comorbidities and use of medical and mental health 
resources among the population. 
While this review provides an important and comprehensive discussion of the 
literature, we acknowledge that it is premature to draw conclusions of the 
evidence based on our findings. As such, additional systematic reviews and/or 
meta-analyses that apply a critical examination of confounding variables in 
multivariate models, and assessment of the validity of the included studies 
might complement and extend our findings in the future. 
Conclusion 
It is clear that PD warrants inclusion as part of primary phrase assessments in 
cohort studies with robust methodological designs. The available data suggest 
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that PD appears to have a substantial association with physical health 
outcomes, however the evidence base is limited. If there is indeed a causal 
relationship between PD and increased risk for chronic physical health 
conditions, stronger evidence will inform prevention and early intervention 
strategies that might manage risk factors to improve long-term health outcomes 
for people living with PD. Furthermore, the effect of PD on medical and 
mental health resource use beyond primary care is not well understood. Further 
studies are required that support the improvement of public health planning and 
clinical practice by providing information regarding the nature of these 
disorders, associated comorbidities and the effects they might have on 
healthcare services. Such an evidence-base is needed for rational population 
healthcare planning. 
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Despite increasing rates of diagnosis and treatment 
of mental state disorders, the burden of disability 
due to disorders such as major depressive, anxiety, 
bipolar, substance misuse, and psychotic disorders has 
not substantially decreased and might be increasing.1 
One potential reason for the insuﬃ  cient progress2 in 
reduction of the prevalence, duration, and associated 
disability of these mental disorders in the population 
might be that we have continued to neglect the eﬀ ect 
of personality disorder at a population level.
Population-based epidemiological studies conﬁ rm 
that personality disorder is common and is associated 
with substantial overall disability. Estimated prevalence 
rates for any personality disorder vary between 
countries: 4·4% in the UK,3 13·4% in Norway,4 and 9·1% 
and 21·5% in the USA.5,6 Cross-national prevalence data 
from WHO Mental Health Surveys for any personality 
disorder in western European developed countries 
yields an overall prevalence of 6·1% across samples 
(range of 2·4%–7·9%).7 Probable cases of personality 
disorder were associated with functional impairment in 
all 13 European countries surveyed, a picture consistent 
with US data.
Substantial clinical and population-based research 
shows that personality disorder is not only associated 
with chronic impairments in interpersonal and 
adaptive functioning,8,9 but also that it predicts poor 
outcomes in diverse psychiatric comorbidities, and poor 
engagement in and adherence to treatment.10 Although 
substantial progress has been made in the treatment 
of borderline personality disorder, treatment of this 
disorder has rarely resulted in demonstrable change 
in functional capacity in patients.8,9 Additionally, little 
attention has been paid to treatments for other forms 
of personality disorder.
The covert eﬀ ects of additional disability and morbidity 
due to personality disorder are underscored by the fact 
that personality disorder is one of the most common 
comorbidities in clinical practice. 
For example, about half of patients receiving 
treatment for common mental state disorders—namely, 
major depression and anxiety—also suﬀ er from a 
comorbid personality disorder.11 Some of the persistent 
dysphoria, anxiety, unhappiness, and disability 
experienced by many individuals who seem to be 
partial responders to treatment or treatment resistant 
might be due to the personality factors that serve as 
predisposing or perpetuating factors for their distress. 
There is also potentially a substantial, and yet 
covert role for the eﬀ ect of personality disorder on 
medical comorbidity. Although those with mental 
disorders commonly also suﬀ er from co-occurring 
chronic physical illnesses, personality disorder has 
not been thoroughly investigated as one of these 
disorders. Population-based epidemiological research 
has shown that individual personality disorders are 
associated with an increased risk of a range of physical 
health comorbidities (eg, adjusted odd ratios for 
associations between borderline personality disorder 
and cardiovascular disease range from 1·47 to 7·2),12–14 
similar to the association seen between depression 
and cardiovascular disease. 
Personality disorder and population mental health
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The burden of disease and societal costs of personality 
disorder in relation to mental and physical health is 
potentially high. Some of the economic burden might 
be related to high levels of help-seeking behaviours in 
people with personality disorders, leading to increased 
direct medical costs.15 In view of the fact that depression 
has emerged as a robust risk factor for cardiometabolic 
disorders, in addition to a host of other physical 
health conditions, determination of speciﬁ c physical 
health eﬀ ects of personality disorder is fundamental 
for management and might also be important for 
secondary prevention of comorbidities. Thus far, 
limited data are available, being derived chieﬂ y from 
the USA and the UK, and little is known regarding the 
physical health of individuals with personality disorder 
in other populations. 
Thus, personality disorder seems to have a consistent 
adverse eﬀ ect on interpersonal and adaptive functioning, 
physical health outcomes, and quality of life. However, 
research eﬀ orts that might inform policies for reducing 
the population burden of mental and physical ill health, 
such as the Global Burden of Disease Study, largely ignore 
the presence of these disorders. Our expectations for 
improving population mental and physical health would 
beneﬁ t from improvement of our understanding of the 
contribution that personality disorder makes toward 
such outcomes. Personality disorder might be a crucial, 
yet unrecognised, factor underpinning the failure to 
see expected gains from treatment programmes. To 
reduce the burden of disease incurred by mental and 
physical disorders and to close treatment gaps,2 rational 
population health-care planning demands high quality 
and up-to-date population prevalence, associated 
comorbidity, and health care needs data for those living 
with personality disorder. Personality disorder deserves 
recognition as an independent and direct contributor to 
and moderator of population mental and physical health, 
alongside mental state disorders. Our reconsideration 
of the conceptualisation of the contributors to mental 
ill health is timely, and, thus, are our expectations of the 
plasticity of population mental health. 
Shae E Quirk, Lana J Williams, Andrew M Chanen, 
*Michael Berk 
IMPACT Strategic Research Centre, School of Medicine, Deakin 
University, Barwon Health, Geelong, VIC 3220, Australia (SEQ, LJW, 
MB); Orygen, The National Centre of Excellence in Youth Mental 
Health, Parkville, VIC, Australia (AMC, MB); Centre for Youth Mental 
Health, The University of Melbourne, Parkville, VIC, Australia (AMC, 
MB); and The Florey Institute of Neuroscience and Mental Health, 
The University of Melbourne, Parkville, VIC, Australia (MB)
mikebe@barwonhealth.org.au 
SEQ is supported by a National Health and Medical Research Council (NHMRC) 
of Australia Postgraduate Scholarship (GNT1076347). LJW has received Grant/
Research support from Eli Lilly, Pﬁ zer, The University of Melbourne, Deakin 
University, and is supported by a NHMRC Career Development Fellowship 
(GNT1064272). AMC has received research funding from the NHMRC, Australian 
Research Council, Colonial Foundation, The University of Melbourne, and the 
New South Wales Department of Health. MB has received Grant/Research 
Support from the National Institute of Health (USA), Simons Foundation, CRC 
for Mental Health, Stanley Medical Research Institute, Medical Beneﬁ ts Fund, 
NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol-Myers 
Squibb, Eli Lilly, GlaxoSmithKline, Organon, Novartis, Mayne Pharma, Servier 
and AstraZeneca. He has been a paid consultant for AstraZeneca, Bristol-Myers 
Squibb, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck and Pﬁ zer and a paid 
speaker for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen 
Cilag, Lundbeck, Organon, Pﬁ zer, Sanoﬁ  Synthelabo, Solvay and Wyeth and is 
supported by a NHMRC Senior Principal Research Fellowship (GNT1059660).
1 Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease 
attributable to mental and substance use disorders: ﬁ ndings from the 
Global Burden of Disease Study 2010. Lancet 2013; 382: 1575–86.
2 Jorm AF. Why hasn’t the mental health of Australians improved? The need 
for a national prevention strategy. Aust N Z J Psychiatry 2014; 48: 795–801.
3 Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of 
personality disorder in Great Britain. Br J Psychiatry 2006; 188: 423–31.
4 Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders 
in a community sample. Arch Gen Psychiatry 2001; 58: 590–96.
5 Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality 
disorders in the National Comorbidity Survey Replication. Biol Psychiatry 
2007; 62: 553–64.
6 Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality 
disorder diagnoses: gender, prevalence, and comorbidity with substance 
dependence disorders. J Pers Disord 2010; 24: 412–26.
7 Kessler RC. DSM–IV personality disorders in the WHO World Mental Health 
Surveys. Br J Psychiatry 2009; 195: 46–53. 
8 Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline 
personality disorder: psychopathology and function from the Collaborative 
Longitudinal Personality Disorders study. Arch Gen Psychiatry 2011; 68: 827–37.
9 Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and 
stability of sustained symptomatic remission and recovery among patients 
with borderline personality disorder and axis II comparison subjects: 
a 16-year prospective follow-up study. Am J Psychiatry 2012; 169: 476–83.
10 Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome 
of depression: meta-analysis of published studies. Br J Psychiatry 2006; 
188: 13–20.
11 Zimmerman M, Rothschild L, Chelminski I. The Prevalence of DSM-IV 
Personality Disorders in Psychiatric Outpatients. Am J Psychiatry 2005; 
162: 1911–18.
12 Quirk SE, El-Gabalawy R, Brennan SL, et al. Personality disorders and 
physical comorbidities in adults from the United States: data from the 
National Epidemiologic Survey on Alcohol and Related Conditions. 
Soc Psychiatry Psychiatr Epidemiol 2014; published online Oct 15. 
DOI:10.1007/s00127-014-0974-1.
13 Lee HB, Bienvenu OJ, Cho S-J, et al. Personality disorders and traits as 
predictors of incident cardiovascular disease: ﬁ ndings from the 23-year 
follow-up of the Baltimore ECA Study. Psychosomatics 2010; 51: 289–96.
14 Moran P, Stewart R, Brugha T, et al. Personality disorder and cardiovascular 
disease: results from a national household survey. J Clin Psychiatry 2007; 
68: 69–74.
15 Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ. 
The economic burden of personality disorders in mental health care. 
J Clin Psychiatry 2008; 69: 259–65.
Co
rd
el
ia
 M
ol
lo
y/
Sc
ie
nc
e 
Ph
ot
o 
Li
br
ar
y 
AIMS 
55
2.3  Aims of the thesis
The aims of this thesis by publication are to investigate: 
I. The prevalence of: 
a) Any DSM-IV PDs
b) Clusters A (paranoid, schizoid, schizotypal), B (histrionic,
narcissistic, borderline, antisocial), and C (avoidant, dependent, 
obsessive-compulsive) 
c) Individual PDs (paranoid, schizoid, schizotypal, histrionic,
narcissistic, borderline, antisocial, avoidant, dependent, 
obsessive-compulsive); and 
II. Associations between PDs (any, Clusters, and individual) with:
a) Physical health comorbidities
b) Mental and physical health-related service utilization
56
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3.1  Study design 
This thesis utilizes cross-sectional data derived from two population-based 
studies: The GOS located in south-eastern Australia (Manuscripts III, VI, and 
VII), and the NESARC, a nationally representative survey of the US 
population (Manuscript V) (Appendices I-III). 
3.2  The Geelong Osteoporosis Study 
The GOS is an on-going population-based cohort study, originally designed to 
investigate the epidemiology of osteoporosis. The GOS has since expanded to 
investigate a range of diseases including psychiatric disorders in both men and 
women. For the purpose of this thesis, data were collected and analyzed from 
women participating in the most recent follow-up phase (2011-2014). 
3.2.1 Study region
The GOS study is located within the Barwon Statistical Division (BSD), a 
geographically defined area surrounding the City of Greater Geelong, Victoria 
in south-eastern Australia. Defined by the Australian Bureau of Statistics 
(ABS), the BSD includes the Australian Electoral Commission Divisions of 
Corio, and specific sections of Corangamite and Lalor. The population profile 
of the BSD includes urban, semi-urban and rural residents, and it has been 
demonstrated to reflect the characteristics of the general Australian population 
in regards to sociodemographic and socioeconomic factors such as age 
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distribution, marital status, birth country, levels of education and income and 
employment status (Pasco, Nicholson, & Kotowicz, 2012). As such, samples 
drawn from the study region are deemed well-suited for extrapolation to 
national levels. 
3.2.2 Recruitment and sampling procedures 
The GOS, population-based cohort study was established via an age-stratified, 
random, sampling method (Pasco et al., 2012). The Australian Electoral 
Commission provides a comprehensive listing of residents, which provides a 
robust resource for recruitment purposes due to the compulsory nature of 
voting in Australia. Originally, GOS participants (aged 20-94 years) were 
randomly selected from the Commonwealth of Australia Electoral Rolls for the 
BSD and recruitment occurred between 1994 and 1997. There were 100 
women recruited in each 5-year age stratum (20-24 years, 25-29 years, 30-34 
years, 35-39  years, 40-44 years, 45-49 years, 50-54 years, 55-59 years, 60-64 
years, 65-69 years), with a minimum of 200 women between 70-79 years and
≥80 years (Pasco et al., 2012). Of the eligible women who were invited to 
participate in the GOS baseline assessments (1994-1997; n=2,390), 1,494 
consented and participated, achieving a response rate of 77.1% (Pasco et al., 
2012). 
The GOS women have returned for biennial assessments. At the 10 year follow 
up (2004-2008), a new group of younger women were recruited (n=881 & 
n=246; 20-29 years) to allow for continued investigation spanning the full adult 
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range. These women were recruited as per sampling methods previously 
described (Pasco et al., 2012). 
 
Eligible women who completed the baseline visit and/or subsequent follow-up 
phases, were invited to participate in the 15 year follow up. Of the original 
sample of 1,494 and the additional sample 246 women recruited at the 10 year 
follow up, 849 provided consent and participated in the current follow-up 
phase, with a response of 75.4% for eligible women. Of the 849 women who 
participated, 81 women did not have complete psychiatric data, and thus a 
sample of 768 (68.2%) women was investigated in this thesis. Further details 
regarding participation, attrition and sample characteristics are present in 
Manuscript III. 
 
3.2.3 Data collection 
 
3.2.3.1  Psychiatric data 
 
The Structured Clinical Interview for DSM-IV-TR Research Version, Non-
patient edition (SCID-I/NP) is a validated semi-structured clinical interview 
which assesses the major DSM-IV-TR mental disorders (First, Spitzer, Gibbon, 
& Williams, 2002). The SCID-I/NP was designed to be administered to 
individuals who might not necessarily identify as being a patient (e.g. 
psychiatric, general or medical patient), which makes it an ideal interview 
schedule to administer in population-based epidemiological studies and 
research settings.  
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The GOS study utilized the SCID-I/NP to assess for lifetime mood disorders 
including major depressive disorder, minor depression, dysthymia (current 
only), mood disorder due to a medical condition, substance induced mood 
disorder, and bipolar disorder (I, II & not otherwise specified). Lifetime 
anxiety disorders that were assessed include panic disorder (with and without 
agoraphobia), agoraphobia, social phobia, specific phobia, obsessive-
compulsive disorder, generalized anxiety disorder, post-traumatic stress 
disorder, and anxiety disorder not otherwise specified. Data on lifetime eating 
disorders (anorexia, bulimia and binge eating disorder) and substance use 
disorders (alcohol abuse, alcohol dependence, non-alcohol abuse and non-
alcohol dependence) were also collected. Prior history of psychiatric 
hospitalizations was also documented. The interviewers strictly adhered to the 
SCID instructions outlined the in the training procedures and User’s manual 
(First et al., 2002). 
The Structured Clinical Interview for DSM-IV Axis II personality disorders 
(SCID-II) is a validated semi-structured clinical interview that was also utilized 
in the GOS to assess DSM-IV/DSM-5 PDs including paranoid, schizoid, 
schizotypal, histrionic narcissistic, borderline, antisocial, avoidant, dependent, 
and obsessive-compulsive PDs (First, et al., 1997). 
Reliability studies using joint interview and observer methods have shown the 
SCID-II yields fair-good reliability ranges for categorical diagnoses of the 
following DSM-IV personality disorders: avoidant (ϰ=0.83-0.97), dependent 
(ϰ=0.83-0.86), obsessive-compulsive (ϰ=0.83-0.87), paranoid (ϰ=0.93), 
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schizoid (ϰ=0.91), schizotypal (ϰ=0.91), histrionic (ϰ=0.92), narcissistic 
(ϰ=0.98), borderline (ϰ=0.91), (ϰ=0.78-0.98)(Zanarini et al., 2000; Maffei et 
al., 1997). The interviewers strictly adhered to the SCID-II training, 
instructions, and protocols (First et al., 1997). 
 
  3.2.3.2 Anthropometry 
  
Body weight was assessed using electronic scales and height using a wall-
mounted stadiometer to the nearest 0.1kg and 0.1cm, respectively. Participants 
were provided and dressed in hospital gowns, and were asked to take off 
footwear. These measurements were used to generate Body Mass Index (BMI) 
determined by weight in kilograms divided by height in meters, squared [BMI= 
kg/(m2)] (WHO, 2000). BMI was categorized using internationally 
recommended cut-off points to determine those with obesity (Table 2) (WHO, 
2000). Circumferences of the waist (minimal abdominal) and hip (maximum 
gluteal) were also measured using an anthropometric tape measure to the 
nearest 0.1cm (Lohman, Roche, & Martorell, 1988). For these measurements, 
participants were instructed to stand erect, with their body weight evenly 
distributed, with arms extended out in a horizontal position. Systolic and 
diastolic blood pressure was measured (seated) using an automatic arm blood 
pressure monitor.  
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Table 2: International classification of BMI cut-off points for adults, adapted 
from the World Health Organization (WHO, 2000) 
 
WHO Classification 
BMI (kg/m2) Principal Cut-off 
points 
Underweight <18.5 
Normal Range 18.5 - 24.9 
Overweight ≥25.0- 29.9 
Obese ≥30.00 
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3.2.3.3 Blood collection 
 
Blood was collected following an overnight fast and blood glucose measured. 
 
3.2.3.4 Assessment of physical health conditions 
 
The presence of physical health conditions (lifetime) was ascertained via self-
reported questionnaires (Appendices IV-V), and confirmed with medical 
records, medication use and/or anthropometric clinical data, where possible. 
Participants provided detailed lists and/or containers of current and prior use of 
medications (Appendix VI). Self-reporting a diagnosis of physical health 
conditions by a health professional has also been shown to demonstrate good 
concordance with medical records (Baumeister et al., 2010). 
 
Physical health conditions were categorized and examined in the following 
disease groups: 
 
i) Arthritis: self-reported osteoarthritis, ankylosing spondylitis, 
psoriatic arthritis, rheumatoid arthritis, or treated gout 
(medications used for gout or hyperuricaemia).  
 
ii) Thyroid disorders: self-reported or treated (thyroid hormones 
and anti-thyroid medications) hyperthyroidism, hypothyroidism, 
Graves’ disease, Hashimoto’s disease, thyroiditis and/or other 
thyroid conditions.  
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iii) Metabolic disorders: self-reported, treated diabetes (oral 
hypoglycemic medications and insulin preparations) and/or 
fasting blood sugar level 7 mmol/L or higher, obesity (BMI >30 
kg/m2), self-reported or treated hypercholesterolemia 
(cholesterol-lowering medications); self-reported, treated 
hypertension (antihypertensive, beta-adrenergic blocking agents 
and diuretics), and/or or a systolic blood pressure of >140 
mmHg or diastolic blood pressure of >90 mmHg.  
 
iv) Gastrointestinal diseases: self-reported gastrointestinal diseases 
including peptic ulcer, chronic gastritis, and causes of 
malabsorption (pancreatitis, gastric surgery, chronic diarrhea, 
irritable bowel syndrome, inflammatory bowel syndrome and/or 
coeliac disease).  
 
v) Gastro-esophageal reflux disease (GORD): indicated by self-
report 
 
vi) CVD: hypertension (previously defined), self-reported or treated 
(beta-adrenergic blocking medications, diuretics, anti-
arrhythmic, anti-angina, cardiac inotropic medications, 
adrenergic stimulants, or other cardiovascular medications), 
stroke, transient ischemic attack (TIA), ischemic 
cardiomyopathy, arrhythmia, and/or other valve and vascular 
diseases.  
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vii) Syncope and seizures: self-reported epilepsy, blackouts, fainting
and dizzy spells 
viii) Recurrent headaches/migraine: indicated by self-report
ix) Pulmonary diseases: self-reported asthma, emphysema, and/or
chronic bronchitis. 
x) Psoriasis: indicated via self-report.
xi) Liver diseases: self-reported fatty liver, hepatitis, cirrhosis
and/or liver failure. 
xii) Cancers: self-reported malignant tumor, non-melanoma skin
cancer, and/or other cancers.
3.2.3.5 Questionnaire information and other assessments 
Smoking and habitual physical activity status was obtained by self-reported 
questionnaires. 
Sociodemographic information examined in this thesis included: age, marital 
status, highest level of education achieved, and country of birth. Age and 
country of birth was documented at time of assessment. Self-reported marital 
status and highest level of education achieved was ascertained by indicating a 
response to the following: 
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Marital status:  
 
i) Single and/or never married 
 
ii) Married 
 
 
iii) Living in de facto relationship and/or living with partner 
 
iv) Separated and/or divorced 
 
v) Widowed 
 
Highest level of education:  
 
i) Never attended school 
 
ii) Primary school 
 
iii) Some secondary school 
 
iv) Completed secondary school (e.g. Year 12; Victorian Certificate 
of Education; Higher School Certificate; Matriculation) 
 
v) TAFE/Trade/Apprenticeship 
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vi) University 
 
vii) Other post-secondary training and/or qualification 
 
In order to determine socioeconomic status (SES), ABS software was used to 
determine the Socio-Economic Index for Areas (SEIFA) from 2011 ABS 
Census data (ABS, 2011). SEIFA values summarize the socioeconomic 
characteristics of individuals within a geographically defined area, providing 
measures that rank the level of disadvantage according to individuals’ access to 
economic and social resources. The Index of Relative Socioeconomic 
Advantage and Disadvantage (IRSAD) summarizes the economic and social 
conditions of individuals within an area including high and low income, levels 
of education and qualifications (no qualifications to completion of a tertiary 
degree or higher), type of occupation (unskilled employment to professional 
positions), degree of wealth (e.g. owning a car, or number of bedrooms in a 
dwelling). The relative SES of participants according to the IRSAD was 
ascertained by categorizing the sample into quintiles, whereby a lower score 
indicated relatively greater disadvantage (Quintile 1), and a higher score 
indicated relatively greater advantage (Quintile 5). 
 
  3.2.3.6 Medicare Benefits Schedule 
 
GOS data were linked with data routinely collected by Medicare (Australia) 
according to the Medicare Benefits Schedule (MBS) (DoHA, 2011). The 
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information that was extracted includes those services performed typically in 
the public, primary (i.e. the first health service visited by patients with a health 
concern), and higher primary healthcare setting by GPs for physical health-
related problems, and services for mental health-related problems performed by 
psychiatrists, psychologists, and allied health care professionals (but not 
provided in hospitals). 
 
Specifically, the parameters that were included were: 
 
i) Date of Service: defined the date that the service provider 
performed the service as per the MBS, enabling the 
investigation of time of service relative to time of assessment. 
 
ii) Medicare Item Number: is a number provided by Medicare 
which was used to identify the type of completed service that 
was performed by a health care provider, as per the MBS 
 
iii) Medicare Item Category: This parameter was used to group 
similar services associated with a particular health care 
professional (e.g. GP) according to the MBS hierarchy of 
categories, groups and subgroups. 
 
3.2.3.7 Ethical considerations 
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This study has ethical approval from Barwon Health Research Ethics 
Committee as a sub-study (92/01_E7 and 00/56_E2) approved under (92/01) 
(Pasco JA), DUHREC 2013-320, and Department of Human Services 
(Appendix I).
Prior to commencement of the study, all participants were thoroughly briefed 
regarding the objectives and nature of the most recent follow-up phase, even if 
they had participated in previous phases. Eligible participants were provided 
with the opportunity to ask questions or seek clarification regarding any 
components of the study prior to providing written and informed consent 
(Appendices II-III.). 
Consent forms were filed and stored in security protected facilities, in archived 
rooms located at Barwon Health. All electronic data were stored in password 
protected databases, accessible to approved research personnel only. In 
accordance with the Australian Code for the Responsible Conduct of Research, 
information will be retained for a minimum of 7 years. Participating in 
individual components of any of the follow-up was entirely voluntary, as per 
previous phases of the GOS. Participants are free to withdraw from the study at 
any time. 
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3.3 National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC) 
The NESARC is a nationally representative population-based survey of US
adults aged ≥20 years. Wave 1 of the survey was conducted between 2001 and 
2002 (n=43,093) and was funded by The National Institutes of Health/National 
Institute. Wave 2 was conducted between 2004 and 2005 (n=34,653). Data was 
collected by face-to-face, computer-assisted interviews conducted in the 
households of the respondents. The NESARC remains the largest population-
based study designed to investigate the epidemiology of alcohol and tobacco 
use disorders, other mental disorders and associated burden. 
3.3.1 Recruitment and sampling procedures 
The NESARC sample consisted of population-based adults from the US who 
were living in households and non-acute and/or other institutional settings 
including college/university residences, group and/or boarding housing, 
military personnel currently living off-base, and relatively stable residency in 
accommodations such as hotels, shelters, and/or housing for workers [National 
Institute on Alcohol Abuse and Alcoholism (NIAAA), 2006]. 
The Census Supplementary Survey was the source for the sampling frame for 
selecting households of the NESARC sample. A systematic process was used 
to select households, and one adult was randomly selected from each sample 
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household (National Institute on Alcohol Abuse and Alcoholism, 2006). Prior 
to commencement of the survey, potential eligible respondents were provided 
information in writing about the description of the survey, including the nature 
of the use of statistical data derived, voluntary participation, and Federal 
confidentiality laws for identifiable survey information (NIAAA, 2006).  
 
Respondents who provided written informed consent to participate in the 
NESARC were then interviewed (NIAAA, 2006). 
 
3.3.2 Data collection  
 
The NESARC collected information regarding current and past alcohol 
consumption, alcohol and tobacco use disorders, illicit drug misuse, health and 
lifestyle information, and associated utilization of alcohol-related and other 
treatment services (NIAAA, 2006). In addition, the NESARC collected 
information to obtain diagnoses for psychiatric disorders based on the DSM-IV 
criteria including mood, anxiety, and PDs (NIAAA, 2006). 
 
3.3.2.1 Psychiatric data  
 
DSM-IV-TR PD (paranoid, schizotypal, schizoid, borderline, histrionic, 
narcissistic, antisocial, avoidant, dependent, and obsessive-compulsive PDs) 
were assessed using the Alcohol Use Disorders and Associated Disabilities 
Interview Schedule IV (AUDADIS-IV). This instrument is a validated semi-
structured interview designed for administration to the general population by 
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lay interviewers. The interview schedule was developed by The National 
Institutes of Health/NIAAA (Grant et al., 2003). Other 12 month psychiatric 
disorders including, MDD, dysthymia, mania or hypomania, panic disorder 
with and without agoraphobia, social phobia, specific phobia, generalized 
anxiety disorder, and post-traumatic stress disorder, alcohol abuse and 
dependence, nicotine dependence, and other non-alcohol substance abuse and 
dependence were assessed using the AUDADIS-IV. Test–retest reliability 
coefficients for the AUDAIDIS-IV psychiatric disorders are reported in 
Manuscript V. 
 
3.3.2.2 Physical health conditions 
 
Self-reported diagnosis by a healthcare professional of a range of health 
conditions in the past year was collected.  The following disease groups 
included: 
 
i) CVD: self-reported hardening of the arteries/ arteriosclerosis, 
high blood pressure/hypertension, chest pain/angina pectoris, 
rapid heartbeat/tachycardia, heart attack/myocardial infarction, 
stroke, and/or any other form of heart disease. 
 
ii) Gastrointestinal diseases: Self-reported stomach ulcer, gastritis,  
 
iii) Arthritis: assessed via self-report 
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iv) Diabetes: assessed via self-report
3.3.2.3 Sociodemographic information 
Socio-demographic data was documented by self-report and included: age, sex, 
race/ethnicity (e.g. White, non-Hispanic; Black, non-Hispanic; American 
Indian/Alaska Native, non-Hispanic; Asian/Native Hawaiian/Other Pacific 
Islander, non-Hispanic; Hispanic, any race), education (e.g. no formal 
schooling; completed grade k/1 or 2; completed grade 3 or 4; completed grade 
5 or 6; completed grade 7; completed grade 8; some high school/grades 9-11; 
completed high school; graduate equivalency degree; some college/ no degree); 
completed associate or other technical 2-year degree; completed
college/bachelor's degree; some graduate or professional studies/completed 
bachelor's; completed master's degree or higher graduate degree, household 
income (e.g. less than $5,000; $5,000 to $7,999, $8,000 to $9,999; $10,000 to 
$12,999; $13,000 to $14,999; $15,000 to $19,999;  $20,000 to $24,999; 
$25,000 to $29,999; $30,000 to $34,999; $35,000 to $39,999; $40,000 to 
$49,999; $50,000 to $59,999; $60,000 to $69,999; $70,000 to $79,999; 
$80,000 to $89,999; $90,000 to $99,999; $100,000 to $109,999; $110,000 to
$119,999; $120,000 to $149,999; $150,000 to $199,999; $200,000 or more), 
and marital status (e.g. married, living with someone as if married, widowed, 
divorced, separated, never married).
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3.4 Statistical analyses
Statistical analyses were performed using Minitab (Version 14), IBM SPSS 
Statistic (Version 22), and Stata (Version 13). 
3.4.1 GOS data 
3.4.1.1 Groupings 
Any PD was categorized by the presence of any one or more DSM-IV/DSM-5 
PDs including avoidant, dependent, obsessive-compulsive, paranoid, 
schizotypal, schizoid, histrionic, narcissistic, borderline, and/or antisocial PDs. 
The 10 individuals PDs were also categorized into any Clusters A (paranoid, 
schizotypal, schizoid), any Cluster B (histrionic, narcissistic, borderline, 
antisocial) and any Cluster C (avoidant, dependent, obsessive-compulsive). 
Those who were identified as having a lifetime history of major depressive 
disorder, minor depression, dysthymia, mood disorder due to a general medical 
condition, bipolar disorders, or substance induced mood disorder were grouped 
as any lifetime mood disorder. Moreover, individuals who were identified with 
a history of panic disorder (with and without agoraphobia), agoraphobia, social 
phobia, specific phobia, obsessive-compulsive disorder, generalized anxiety 
disorder, post-traumatic stress disorder, anxiety disorder due to a general 
medical condition, substance induced anxiety disorder and anxiety disorder not 
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otherwise specified were groups as any lifetime anxiety disorder. Similarly, 
individuals with a lifetime history of anorexia nervosa, bulimia nervosa and 
binge eating disorder were grouped as any lifetime eating disorders. Finally, 
those identified with alcohol abuse and/or dependence disorders were grouped 
as lifetime alcohol use disorder, and those identified with non-alcohol abuse 
and/or non-alcohol dependence were grouped as lifetime non-alcohol use 
disorders.  
 
Individuals were groups as having experienced, psychiatric hospitalization 
(ever), if they indicated ever being a patient in a psychiatric hospital at the time 
of the interview. Psychotropic medication use (ever) was grouped according to 
the MIMS pharmaceutical database. 
 
Smoking status (yes/no) was defined as current or lifetime cigarette smoking. 
Physically active (yes/no), was defined by a positive response for items 
pertaining to light to vigorous activity on a regular basis. 
 
Physical health conditions were grouped according the disease groups detailed 
previously in the methodology, and are described in detail in Manuscript IV. 
 
Mental and physical health-related service utilizations in the publically 
available healthcare system were grouped according to the MBS (DoHA, 
2011). Specifically, MBS items were used to generate the following variables 
(Britt et al., 2013): 
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i) Mental health related services performed by GPs 
 
ii) Mental health-related services performed by psychiatrists 
 
iii) Mental health-related services performed by clinical psychologists 
 
iv) Mental health-related services performed by other psychologists 
 
v) Mental health-related services performed by allied healthcare 
professionals 
 
vi) Any mental health-related service 
 
vii) Physical health-related services performed by GPs 
 
Specific services performed by each healthcare service provider are 
documented in detail in Manuscript VII. 
 
3.4.1.2 Univariate analyses 
 
Differences between those with and without any PD on sociodemographic and 
physical health characteristics including age, height, weight, BMI, SES, 
hypertension, smoking status, physically active, marital status, country of birth, 
highest level of education achieved, prior psychiatric hospitalization, and 
psychotropic medication use were investigated. For non-parametric variables, 
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differences between those with and without any PD and unadjusted age, 
weight, and BMI were examined using Mann–Whitney U or Kruskall Wallis 
tests, and unadjusted analyses examining height were performed using two-
sample t-tests. Cross-tabulations with chi squares tests examined unadjusted 
associations between any PD, and the categorical variables 
3.4.1.3 Prevalence of personality disorders: Manuscript III 
The lifetime prevalence of PDs and 95% confidence intervals was determined 
from the study population and standardized to the 2011 census data from the 
ABS for population figures for Australia (ABS, 2012). Prevalence by age 
groups were also determined. Lifetime comorbidity with mood, anxiety, 
substance, and non-alcohol substance use disorders, and prior psychiatric 
hospitalizations and psychotropic medication use was investigated using cross-
tabulations. 
3.4.1.4 Physical health comorbidities in women with 
personality disorders: data from the Geelong Osteoporosis 
Study: Manuscript VI 
Unadjusted and adjusted logistic regression models examined associations 
between any PD, Cluster A, Cluster B, and Cluster C with lifetime physical 
health conditions in comparison to those without PDs (any, Cluster A, Cluster 
B, Cluster C). Details regarding each model are detailed in Manuscript VI. 
Interactions between the exposure variables (PD variables), each predictor 
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variable (age, SES, BMI, smoking status, physical activity, psychotropic 
medication use, and lifetime psychiatric disorders) and the outcome variables 
(arthritis, thyroid disorders, metabolic disorders, gastrointestinal diseases, 
GORD, CVD, syncope and seizures, recurrent headaches, pulmonary diseases, 
psoriasis, liver diseases, cancers, and physical morbidity) were also examined. 
 
  3.4.1.5 Utilization of health services by women with 
personality disorder: a population-based study: Manuscript 
VII 
 
Any PD, Cluster A, Cluster B. and Cluster C with the outcome variables (any 
mental health-related services, mental health-related serviced performed by 
GPs, and physical health-related service performed by GPs, respectively) were 
investigated using unadjusted and adjusted negative binomial regression 
models. Details regarding each model are presented in Manuscript VII. 
Interactions between the exposure variables (PD variables), any lifetime 
psychiatric disorder and the outcomes variables (healthcare service utilizations) 
were also investigated.  
 
3.4.2 NESARC data 
 
3.4.2.1 Groupings 
 
An any PD variable was generated pooling diagnoses from Waves 1 and 2 
including avoidant, dependent, obsessive-compulsive, paranoid, schizoid, 
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histrionic, borderline, schizotypal, narcissistic and antisocial PDs. PD clusters 
were generated as previously described. 
Past-year psychiatric disorders were generated and were grouped as past year 
mood disorder (major depression, dysthymia, mania or hypomania); any past 
year anxiety disorder (panic disorder with and without agoraphobia, social 
phobia, specific phobia, generalized anxiety disorder, and post-traumatic stress 
disorder); any past year substance use disorder (alcohol abuse and 
dependence, nicotine dependence, and other non-alcohol substance abuse and 
dependence).
Past-year physical health conditions were grouped as CVD
(arteriosclerosis/hypertension, chest pain/angina pectoris, heart 
attack/myocardial infarction, rapid heartbeat/ tachycardia, and/or any other 
form of heart disease), diabetes, gastrointestinal disease (including stomach 
ulcer and/or gastritis), and arthritis.
Unadjusted and adjusted logistic regression models examined the relationship 
between exposure variables of interest (any PD, PD Clusters, and each specific 
PD) with past-year physical health conditions. Interactions with a dichotomous 
age variable (<55, ≥55 years old) were performed first in the unadjusted 
models. Where the interactions were significant, data were stratified (<55, ≥55 
years old) and the analyses were performed for each age for each age group. 
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CHAPTER FOUR: PREVALENCE OF PERSONALITY 
DISORDERS 
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4.1 Manuscript III. 
Quirk, S.E., Berk, M., Pasco, J.A., Brennan-Olsen, S.L., Chanen, A.M., 
Koivumaa-Honkanen, H., Burke, L., Jackson, H.,  Hulbert, C.,  Olsson, C., 
Moran, P., Stuart, A.L., & Williams,  L.J. Prevalence, age distribution and 
comorbidity of personality disorders in a sample of Australian women. 
Australian and New Zealand Journal of Psychiatry (provisionally accepted) 
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Abstract
Objective: We aimed to describe the prevalence and age distribution of 
personality disorders (PDs) as well as their comorbidity with other psychiatric 
disorders in an age-stratified sample of Australian women aged ≥20 years. 
Method: Individual PDs (paranoid, schizoid, schizotypal, histrionic, 
narcissistic, borderline, antisocial, avoidant, dependent, obsessive-compulsive), 
and lifetime mood, anxiety, eating, and substance misuse disorders were 
diagnosed utilizing validated semi-structured clinical interviews (SCID-I and 
SCID-II). The prevalence of PDs and clusters were determined from the study 
population (n=768), and standardized to the Australian population using the 
2011 Australian Bureau of Statistics census data. Prevalence by age and the 
association with mood, anxiety, eating and substance misuse disorders was also 
examined. 
Results: The prevalence of PDs in Australian women was 22.7%. Cluster C 
personality disorders (17.7%) were more common than Cluster A (6.7%) and 
Cluster B personality disorders (4.6%). Of the individual personality disorders, 
obsessive-compulsive (10.3%), avoidant (9.3%), paranoid (5.5%) and 
borderline (4.2%) were among the most prevalent. The prevalence of other PDs 
was low (≤1.8%). PDs were most common among the younger (20-29 years) 
and mood and anxiety disorders were the most common comorbid lifetime 
psychiatric disorders. 
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Conclusions: Approximately one in five women were identified with a PD, 
emphasizing that PDs are relatively common in this study population. A 
thorough understanding of the distribution of PDs and psychiatric comorbidity 
in the general population is crucial to assist allocation of health care resources 
to individuals living with these disorders. 
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PREVALENCE, AGE DISTRIBUTION AND COMORBIDITY OF 
PERSONALITY DISORDERS IN A SAMPLE OF AUSTRALIAN 
WOMEN 
Introduction
Currently, little is known regarding the prevalence, distribution and associated 
characteristics of personality disorder (PD) and their comorbidity with other 
psychiatric disorders in the general Australian population. Clinically-based 
evidence indicates that PDs are highly prevalent (45.5%) among psychiatric 
patients (Zimmerman et al., 2005), and are a consistent driver of impairments 
in social and occupational functioning (Gunderson et al., 2011; Zanarini et al., 
2012), and a key risk factor for suicide-attempts (Ansell et al., 2015; Zanarini 
et al, 2008). Despite the high levels of psychiatric comorbidity and associated 
functional impairment reported among those with PD in clinically-based 
studies, these comorbidities have remained largely unmeasured in the general 
Australian population. 
European population-based studies have shown the prevalence of PD to range 
between 4.4% (England, Scotland, and Wales) (Coid et al., 2006) and 13.4% 
(Norway) (Torgersen et al., 2001). The World Health Organization (WHO) 
Mental Health Surveys from Western European countries suggest that the 
pooled prevalence for any probable PD cases is approximately 6.1% (Huang et 
al., 2009). In the United States (US), the prevalence of PD has been reported to 
range between 9.0% and 21.5%, being somewhat higher than other countries 
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(Grant et al., 2008; Grant et al., 2004; Lenzenweger et al., 2007; Pulay et al., 
2009; Stinson et al., 2008; Trull et al., 2010). Despite methodological 
heterogeneity, these population-based studies demonstrate that not only are 
PDs common, but they are also associated with overall disability (Grant et al., 
2004; Jackson & Burgess, 2002; Trull et al., 2010), disruptions to employment, 
reduced income, poor social functioning (Coid et al., 2009; Lenzenweger et al., 
2007; Sareen et al., 2011; Trull et al., 2010; Yang et al., 2010), and premature 
mortality (Fok et al., 2012). 
 
It is also well known that sex disparities exist in mental health, namely 
depression and anxiety, with approximately one in three Australian women 
being affected in their lifetime (Williams et al., 2010). There is a suggestion 
that some individual PDs might be particularly prevalent among women, for 
example obsessive-compulsive and avoidant PDs (Grant et al., 2004; Jackson 
& Burgess, 2000; Torgersen et al., 2001; Trull et al., 2010); however, further 
research is needed.  
 
To date, the prevalence of PDs among the general Australian population has 
been informed by the 1997 National Survey of Mental Health and Wellbeing 
(NSMHW). Jackson & Burgess reported that 6.5% of the Australian population 
(6.1% in women) screened positive for PD using the International Personality 
Disorder Examination (IPDE) screening questionnaire (59 items; true/false) 
(Jackson & Burgess, 2000). This survey also emphasized the significant 
disability associated with PD, underscored by frequent self-reported utilization 
of health-care services (Jackson & Burgess, 2002; Jackson & Burgess, 2004). 
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The survey was limited by the restricted age-range assessed and by the use of a 
screening questionnaire to identify PD, which was later described as being too 
brief to adequately detect cases and not validated for this purpose (Jackson & 
Burgess, 2000). 
Good quality epidemiological data are vital for increasing the knowledge base 
of the healthcare sector, and thus guiding public health planning and delivery 
of services. Of equal importance, is information regarding the distribution and 
presentation of mental ill-health across the lifespan (Newton-Howes et al., 
2015). Given the paucity of current and robust epidemiological data, we aimed 
to report the prevalence and age distribution of PD, PD clusters, and individual 
PDs, along with comorbid mood, anxiety, substance, and eating disorders, in a 
representative, age-stratified sample of Australian women aged ≥20 years.
Methods 
Participants 
This study examined data collected from women enrolled in the Geelong 
Osteoporosis Study (GOS), an on-going, population-based cohort study 
originally established to describe the epidemiology of osteoporosis in 
Australia. The scope of the study has since expanded to examine the complex 
interface between a broad range of physical and mental health conditions. 
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Study participants were originally selected at random (1993-1997) from the 
Commonwealth of Australia Electoral Commission (AEC) rolls for the Barwon 
Statistical Division (BSD) located in south-eastern Australia, using an age-
stratified sampling method. The BSD is representative of the wider Australian 
population in terms of pertinent socio-demographic profiles (Pasco et al., 
2012).
Originally, 1,494 women participated in GOS baseline assessments (1994-
1997), and an additional sample of 246 was recruited (2006-2008) aged 20-29 
years using the same sampling method (Pasco et al., 2012). Further details of 
the study have been published elsewhere (Pasco et al., 2012; Williams et al., 
2010). Of the remaining women who were eligible to participate, 849 returned 
for the assessment phase conducted 2011-2014. Frequencies for reasons lost to 
follow-up according to each age group (predicted age at follow up) are reported 
in Table 1. 
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Table 1: Frequencies for reasons lost to follow-up according to each age group (predicted age at follow up) 
 
Non-participation Age groups, years 
 All 
n=1740 
20-29 
n=45 
30-39 
n=267 
40-49 
n=216 
50-59 
n=223 
60-69 
n=233 
70-79 
n=205 
≥80 
n=551 
Death 392 0 4 1 8 8  23 348 
Emigration 94 2 27 27 11 13 4 10 
Unable to be contacted 128 4 38 25  20 9 11 21 
Personal reasons 124 3 19 15 19 23 19 26 
Old age/unable to cope 78 0 1 0 2 2 10 63 
Illness 21 0 1 1 2 5 4 8 
Time constraints 36 1 20 8  5 1 1 0 
Too far to travel 5 0 1 0 2 1 0 1 
Failure to keep appointment 4 0 1 3 0 0 0 0 
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Language barrier 1  0  0  0  1  0  0  0  
No reason provided 8  3  3  0 0  2  0  0  
Total attrition 891  13  115 80  69  65 72  477  
 
Values are presented as n= 
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Of those 849 women, 768 provided Structured Clinical Interview for 
Diagnostic and Statistical Manual of Mental Disorders (DSM) Axis I 
Disorders, non-patient edition (SCID-I/NP) and Structured Clinical Interview 
for DSM-IV Axis II personality disorders (SCID-II) data and were thus 
included in the current analyses. Ethics approval was provided by the Barwon 
Health Human Research Ethics Committee, and Deakin University Human 
Research and Ethics Committee. All participants provided written informed 
consent. 
Psychiatric Assessments 
DSM-IV psychiatric diagnoses were obtained using validated semi-structured 
clinical interviews (First et al., 1997; First et al., 2002). Reliability studies 
using a combination of joint interview and observer methods have shown the 
SCID I (Zanarini et al., 2000) and SCID-II yields fair to good reliability ranges 
for categorical diagnoses (Maffei et al., 1997; Zanarini et al., 2000). Interviews 
were conducted by personnel with postgraduate qualifications in psychology, 
who were trained under the supervision of a psychiatrist using live and 
videotaped interviews as recommended by First et al. The SCID-I/NP was used 
to assess the presence of lifetime: 
i) mood disorders i.e., major depressive disorder (MDD), minor
depression, dysthymia, mood disorder due to a general medical 
condition, substance induced mood disorder or bipolar disorder [I, 
II, not otherwise specified (NOS)]; 
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ii) anxiety disorders i.e., panic disorder, agoraphobia, social phobia, 
specific phobia, obsessive-compulsive disorder, generalized anxiety 
disorder (current only), anxiety disorders due to a general medical 
condition, substance induced anxiety disorder and anxiety disorders 
NOS; 
 
iii) eating disorders i.e., anorexia/bulimia nervosa, binge eating 
disorder ; 
 
iv) substance use disorders i.e., alcohol and non-alcohol substance use 
disorders  (dependence and abuse); 
 
The SCID-II was used to assess the lifetime presence of: 
 
v) personality disorders i.e., paranoid, schizotypal, schizoid, 
histrionic, narcissistic, borderline, antisocial, avoidant, dependent, 
and obsessive-compulsive. 
 
Socio-demographic information 
 
Pertinent socio-demographic information was ascertained from self-reported 
questionnaires and included: age, country of birth, marital status, and highest 
level of education attained. The Index of Relative Socio-economic Advantage 
and Disadvantage (IRSAD) was used to determine the relative socioeconomic 
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conditions of individuals and households at the area-level, as previously 
published (Brennan et al., 2009; Williams et al., 2011). ABS software was 
utilized to derive the Socio-Economic Index For Areas (SEIFA) scores, 
providing a summary index that indicates both relative advantage and 
disadvantage at the small geographically defined area-level. A lower score on 
the IRSAD indicated relatively greater disadvantage (Quintile 1), and a higher 
score indicated relatively greater advantage (Quintile 5). 
Other assessments 
Participants provided detailed lists and/or containers of current and prior use of 
medications, which were categorized according to the classification system of 
MIMS pharmaceutical database (MIMS Australia Pty Ltd, 2015). Height and 
weight were measured to the nearest 0.1 cm and 0.1 kg, respectively. 
Information regarding history of psychiatric hospitalizations was also collected 
during the interviews. 
Statistical analyses 
“Any PD” was generated by the presence of any one or more categorical PDs; 
“Clusters A” included any categorical paranoid, schizotypal, or schizoid PDs; 
“Cluster B” any categorical histrionic, narcissistic, borderline, or antisocial 
PDs; “Cluster C” any categorical avoidant, dependent, or obsessive-compulsive 
PDs (American Psychiatric Association, 2013). Differences between those with 
and without a PD on the socio-demographic variables were investigated using 
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Mann–Whitney U, t-test, Kruskall Wallis, or the Chi-square test where 
appropriate. Cross tabulations were used to examine the proportion of those 
with and without any PD and lifetime psychiatric disorders, prior psychiatric 
hospitalizations, and psychotropic medication use (ever). Age-stratified 
frequencies for any PD and clusters was determined for each 10-year age 
stratum (20-29, 30-39, 40-49, 50-59, 60-69, 70-79, ≥80 years). The overall 
prevalence estimates of any PD, clusters and individual PDs were determined 
from the study population and a direct method of standardization was applied 
using total population numbers ascertained from the Australian Bureau of 
Statistics 2011 census data (Age by Sex; Cat. No. 2001.0) (Australian Bureau 
of Statistics, 2012). Statistical analyses were performed using Minitab 
Statistical Software (Version 17; Minitab, State College, PA, USA). 
Results 
Characteristics of participants, overall, and according to PD status, are shown 
in Table 2. It can be seen that women with PD were younger compared with 
those without, and a higher proportion were likely to be single/never married, 
and have a lifetime history of other psychiatric disorders, prior psychiatric 
hospitalizations, and be currently using psychotropic medications. 
Psychotropic medication use was most frequent among those with Cluster A 
PDs (54.3%), then Cluster B (47.6%), and Cluster C PDs (32.3%), with prior 
psychiatric hospitalizations being: 14.3%, 28.6%, and 6.2%, respectively. No 
differences were observed for education, SES or country of birth between those 
with and without PDs. 
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Table 2: Characteristics of the participants, presented for the whole group, and according to PD status 
Total sample Any personality disorder
(n=768) No (n=611) Yes (n=157) P value
Age, years 56.8 (42.8-69.1) 58.1 (43.6-70.5) 52.8 (38.4-63.4) 0.001
Weight, kg 71.6 (62.3-83.9) 70.3 (62.0-82.7) 77.0 (65.7-87.9) 0.001
Height, cm 162.0 (6.4) 161.78 (6.33) 162.72 (6.61) 0.112
Current psychotropic medication use 184 (24.7) 131 (22.2) 53 (34.2) 0.003
Prior psychiatric hospitalization 26 (3.4) 13 (2.1) 13 (8.3) 0.001
Socioeconomic status 0.581
Quintile 1 (most disadvantaged) 116 (15.1) 87 (14.2) 29 (18.5)
Quintile 2 87 (11.3) 67 (11.0) 20 (12.7)
Quintile 3 295 (38.4) 240 (39.3) 55 (35.0)
Quintile 4 143 (18.6) 113 (18.5) 30 (19.1)
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Quintile 5 127 (16.5) 104 (17.0) 23 (14.7)  
Marital Status    0.001 
Single/never married 60 (7.8) 42 (6.9) 18 (11.5)  
Married/ Living with partner 541 (70.4) 440 (72.0) 101 (64.3)  
Separated/divorced 86 (11.2) 58 (9.5) 28 (17.8)  
Widowed 81 (10.6) 71 (11.6) 10 (6.4)  
Level of completed education    0.457 
Primary school 23 (3.0) 20 (3.3) 3 (1.9)  
Some secondary school 291 (37.9) 238 (39.0) 53 (33.8)  
Completed secondary school 123 (16.0) 96 (15.6) 28 (17.8)  
Post-secondary/other qualification 331 (43.1) 258 (42.2) 73 (46.5)  
Country of birth    0.493 
Australia and New Zealand 667 (86.9) 531 (86.9) 136 (86.6)  
UK of Great Britain & Northern Ireland 53 (6.9) 39 (6.4) 14 (8.9)  
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Europe 38 (5.0) 33 (5.4) 5 (3.2)  
Other 10 (1.3) 8 (1.3) 2 (1.3)  
Lifetime psychiatric disorders     
Any lifetime psychiatric disorder 353 (46.0) 238 (39.0) 111 (73.3) <0.001 
Any mood disorder 292 (38.0) 192 (31.4) 100 (63.7) <0.001 
Any anxiety disorder 180 (23.4) 109 (17.8) 71 (45.2) <0.001 
Any eating disorder 35 (4.6) 17 (2.8) 18 (11.5) <0.001 
Any non-alcohol substance use disorder 17 (2.2) 7 (1.1) 10 (6.4) <0.001 
Alcohol use disorder 16 (2.1) 4 (0.7) 12 (7.7) <0.001 
 
Values are presented as median (interquartile range), mean (± SD), or n (%); Missing data: weight n=25; height n=26; 
psychotropic medication use n=22 
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After standardization, the overall prevalence of any PD in Australian women 
was 22.7% (95% CI=18.8-26.7) (Figure 1). Cluster C PDs were the most 
prevalent with 17.7% (95% CI=14.2-21.3), followed by Cluster A with 6.7% 
(95% CI=3.9-9.5) then Cluster B with 4.6% (95% CI=3.3-5.9). Of the 
individual PDs, obsessive-compulsive and avoidant PDs were the most 
common with 10.3% (95% CI=7.5-13.0) and 9.3% (95% CI=6.6-11.9) meeting 
criteria respectively, followed by: paranoid 5.5% (95% CI=2.8-8.2), borderline 
4.2% (95% CI=1.7-6.6), schizotypal 1.8% (95% CI=0.4-3.3), dependent 1.2% 
(95% CI=-0.1-2.5), schizoid 0.8% (95% CI=1.2-1.3), narcissistic 0.4% (95% 
CI=0.0-0.7) and antisocial PD 0.1% (95% CI=-0.1-0.4). 
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Figure 1: Prevalence of personality disorders standardized to the Australian 
population (2011) (error bars represent 95% CI) 
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Table 3 presents the frequencies of those with PD according to age. PDs were 
most common among the younger women (20-29yr), and declined thereafter, 
with 8.5% of those aged over 80 years meeting criteria. The pattern across the 
age groups appeared to be more consistent for the Cluster C PDs than the other 
two clusters. 
Of those with a PD, 73.3% reported a lifetime history of psychiatric disorders. 
Mood disorders were the most prevalent comorbidity (63.7%), followed by 
anxiety disorders (45.2%). Other comorbidities reported by those with a PD 
included: eating (11.5%), alcohol use (7.7%) and non-alcohol substance use 
(6.4%) disorders. 
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Table 3: Frequencies of PD according to age groups 
Age, groups 
(years)
Whole group Any PD Cluster A Cluster B Cluster C
20-29 29 9 (31.0%) 5 (17.2%) 4 (13.8%) 6 (20.7%)
30-39 135 34 (25.2%) 11 (8.2%) 5 (3.7%) 22 (16.3%)
40-49 117 27 (23.1%) 4 (3.4%) 4 (3.4%) 23 (19.7%)
50-59 157 35 (22.3%) 7 (4.5%) 4 (2.6%) 32 (20.4%)
60-69 149 29 (19.5%) 7 (4.7%) 3 (2.0%) 24 (16.1%)
70-79 122 18 (14.8%) 1 (0.8%) 1 (0.8%) 17 (13.9%)
80> 59 5 (8.5%) 0 (0) 0 (0) 5 (8.5%)
Values are presented as n= (row %)
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Discussion 
This study provides information regarding the prevalence, age distribution and 
comorbidity associated with PDs in a population-based sample of women. The 
key findings to emerge from these data were: i) approximately one in five 
women were estimated to have a PD; ii) PDs were most prevalent among the 
younger age group, and; iii) mood and anxiety disorders were the most 
prevalent comorbid lifetime psychiatric disorders among those with PDs. These 
data highlight that PDs are relatively common among the general population, 
and that there is a significant burden of associated psychiatric comorbidity. 
Data from US population-based studies utilizing semi-structured clinical 
interviews also suggest that the prevalence of PDs ranges between 9.0% and 
21.5% (Grant et al., 2008; Grant et al., 2004; Pulay et al., 2009; Stinson et al., 
2008; Trull et al., 2010). The National Epidemiologic Survey on Alcohol and 
Related Conditions (n=43,093; ≥18 years) yielded a prevalence of 21.5% 
(pooled from two cross-sectional Waves) using the Alcohol Use Disorder and 
Associated Disability Schedule-IV (Grant et al., 2008; Grant et al., 2004; Pulay
et al., 2009; Stinson et al., 2008); although this was substantially reduced 
(9.0%) when more stringent criteria for PD was utilized (Trull et al., 2010). 
The National Comorbidity Survey-Replicated (NSC-R) screened population-
based respondents using the International Personality Disorder Examination 
(IPDE) screener and interviewed a probability sub-sample (n=214) with a 
semi-structured clinical interview yielding a prevalence of 9.1% for any PD 
(Lenzenweger et al., 2007). In a series of semi-structured clinical interviews 
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administered as part of the longitudinal Children in the Community study, the 
cumulative prevalence of PD had reached 28% in adults by mean age of 33 
years (14.6% mean age 14 years, 18.1% 16 years, 22 years 25.7%) (Johnson et 
al., 2008).  In Norway, a household survey of respondents recruited from the 
National Register Oslo (n=3,590; 18-65 years) yielded a prevalence of 13.4% 
for any PD using the Structured Interview for DSM-III-R Personality 
administered by experienced health care providers (Torgersen et al., 2001). 
Considerably lower prevalence estimates have also been reported. The 
household survey of United Kingdom (UK) of Great Britain (England, Wales 
and Scotland), reported a prevalence  of 4.4% (3.4% for women only) in a 
sample of 628 men and women aged 16-65 years, using the same diagnostic 
tool as was utilized in the current study (Coid et al., 2006). Our prevalence data 
are also markedly higher than previous studies utilizing screening instruments 
(Jackson & Burgess, 2000; Huang et al., 2009), with the heterogeneity among 
instruments and interviewers likely to explain some of the variation in 
prevalence reported. 
Individual personality disorders 
Consistent with the studies from the US, UK, and Norway, Cluster C PDs were 
more prevalent, than Clusters A or B PDs (Coid et al., 2006; Lenzenweger et 
al., 2007; Torgersen et al., 2001). Specifically, our data are concordant with 
prior studies that have demonstrated that obsessive-compulsive and avoidant 
are the most prevalent PDs among women in the general population (Grant et 
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al., 2004; Jackson & Burgess, 2000; Torgersen et al., 2001; Trull et al., 2010). 
In fact, the overall prevalence of PDs in the current study was largely 
attributable to cases of obsessive-compulsive PD (10.3%). Clinically-based 
data also indicate that obsessive-compulsive, avoidant, and borderline PDs are 
among the most common PDs in psychiatric patients receiving treatment 
(Zimmerman et al., 2005). 
Prior studies have reported that the prevalence of obsessive-compulsive PD 
among women ranges between 1.3-7.9% (Jackson & Burgess, 2000; Coid et 
al., 2006; Grant et al., 2004). Given the nature of obsessive-compulsive PD, 
continued participation in research studies such as the GOS, might be expected
and might account for the overrepresentation of this PD in the current study. 
Furthermore, obsessive-compulsive PD features have been shown to be more 
stable over time compared with other PDs and mental state disorders such as 
MDD (Grilo et al., 2004).  Inconsistent associations between obsessive-
compulsive PD and disability have been previously reported (Grant et al., 
2004), suggesting that both higher and lower functioning individuals with this 
disorder can meet threshold criteria. Clinically-based data also indicates that 
whilst patients with obsessive-compulsive PD show little improvement over 
time on measures of psychosocial functioning, these patients suffered less 
impairment compared with other PDs (Skodol et al., 2005). 
In contrast, borderline PD is considered a severe form of PD, which was higher 
in the current study (4.6%) than previously reported. A prior examination of 
PD in an Australia population-based study of younger adults (n=1520; mean 
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age 24.1 years), indicated the prevalence of borderline PD (assessed using the 
ICD-10 version of the Standardized Assessment Personality) was 3.5% 
(n=1145; any PD 18.6%), with more young women being identified than young 
men (Moran et al., 2006). 
Avoidant PD was more prevalent in our study than the previously reported 
range of 0.7-2.76% (Coid et al., 2006; Grant et al., 2004; Jackson & Burgess, 
2000). One possible explanation might be associated with the central feature of 
this disorder being “a desire to be accepted, despite hypersensitivities to 
rejection” (APA, 2013). Most of the participants enrolled in the GOS have 
participated in numerous follow-up appointments, thereby potentially reducing 
perceived potential dangers or threats. Furthermore, given the high comorbidity 
and criterion overlap between avoidant PD and anxiety disorders, in particular 
social phobia, it is possible that some cases of avoidant PD might have been 
better accounted for by social phobia.  On the whole, it remains likely that 
Cluster C PD features such as a desire to please and perfectionism might drive 
higher rates of retention in a long-term cohort study. On the other hand, high 
impulsivity and related Cluster B features might result in low retention in this 
study, providing a falsely low prevalence. It is also likely that the low 
prevalence of antisocial PD in the current study are due to sex differences, with 
other studies reporting the prevalence of antisocial PD being higher among 
men (Lenzenweger et al., 2006). 
Cluster A PDs were the next most prevalent as a group, with paranoid PD 
being the most common in this Cluster (5.5%). This pattern was similarly 
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reported in the NSC-R (Lenzenweger et al., 2007), Great Britain Household 
Survey (Coid et al., 2006) and the NESARC (Grant et al., 2004); however our 
study reported higher prevalence for each PD Cluster. Still, consistent with 
these prior studies, the prevalence of the remaining individuals PDs in the 
current study was low (all ≤1.8%). Whilst Cluster A PDs have been shown to 
be more prevalent than Cluster B PDs, the latter have received greater 
attention, and Cluster A PDs remain relatively under-studied in general 
population settings. 
Age distribution 
In the present study, a higher proportion of PDs were observed among the 
younger age group. Specifically, the proportion of those with PD was highest 
in the youngest age group (31.0%, 20-29 years), decreasing among the older 
age groups (25.2%, 30-39 years; 23.1%, 40-49 years; 22.3%, 50-59 years; 
19.5%, 60-69 years; 14.8%, 70-79 years; 8.5%, ≥80 years). Prior studies have 
also reported that those with PD tend to be younger (Coid et al., 2006; Jackson 
& Burgess, 2000; Torgersen et al., 2001). Until recently, there have been few 
studies examining the prevalence of PD across the full adult lifespan. Data 
from the NESARC reported age-stratified prevalence for PDs among adults 
aged 55 years and over (women: 16.1% 55-64 years; 11.6% 65-74 years; 9.4% 
75-84 years, 8.7% 85+ years) (Reynolds et al., 2015). Consistent with the 
current study, it was also reported that the prevalence of Clusters A and B PDs 
appeared to decline with age but Cluster C PDs remained relatively stable 
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(9.18% 55-59 years; 6.72% 65-74 years; 4.56% 75-84 years, 5.98% 85+ years) 
(Reynolds et al., 2015). 
The features characteristic of Cluster B PDs, such as symptoms and behaviors 
associated with impulsivity and affective instability have been shown to be 
particularly characteristic among younger adults (Zanarini et al., 2008), and are 
susceptible to a fluctuating course (Gunderson et al., 2011; Zanarini et al., 
2012; Zanarini et al., 2008), suggesting “burn out” of these behavioral features 
over time. A number of studies have further highlighted the clinical differences 
between the presentation of symptoms among younger adults who present with 
borderline PD including impulsivity, affective instability and increased severity 
of symptoms being associated with younger age (Yang et al., 2010; Zanarini et 
al., 2008); in contrast, older adults appear more likely to experience chronic 
emptiness, and reduced features of impulsivity and affective instability 
(Morgan et al., 2013). Other clinical-based studies indicate that Cluster C PD 
features are more enduring (Ferro et al., 1998; Grilo et al., 2004; Durbin and 
Klein, 2006).
Finally, increasing age is a known risk factor for poorer physical functioning 
and physical morbidity. Physical health problems and psychiatric comorbidity 
are also commonly reported among older adults (El-Gabalawy et al., 2011). It 
is possible that the higher prevalence of PD observed in the current sample, 
might be associated with poorer physical health status. Currently, one can only 
speculate upon the developmental trajectory of PD across lifespan from the 
current cross-sectional data, with longitudinal analyses needed to investigate 
MANUSCRIPT III. 
111
age-related patterns as they emerge from adolescence through to middle and 
older adulthood. 
Lifetime comorbidities 
Among those with any PD, the lifetime comorbidity with any mental state 
disorder in the present study was 73.3%, concordant with prior Australian data 
reporting 40.9%-77.8% (Jackson & Burgess, 2002). We identified mood 
(63.7%) and anxiety disorders (45.2%) as the most common comorbidity 
disorders, being consistent with previous clinical- (Zimmerman et al., 2005) 
and population-based data (Jackson & Burgess, 2000). We also reported 
comorbid alcohol and other non-alcohol substance use disorders (7.7% and 
6.4%, respectively). According to the clinically-based US Collaborative 
Longitudinal Personality Disorders Study, up to 85% of those with PDs are 
reported to suffer from mood disorders, particularly recurrent MDD 
(Gunderson et al., 2008). Conversely, the clinically-based (n=391 outpatients) 
Rhode Island Methods to Improve Diagnostic Assessment and Services study 
(Zimmerman et al., 2005) reported that 31.4% of the patients with mood 
disorders and other psychiatric conditions had at least one PD.
In the current study, those with PD also reported a markedly higher proportion 
of comorbid lifetime eating disorders compared with those without PD (11.5% 
vs. 2.8%). In comparison with other psychiatric disorders, the investigation of 
comorbid eating disorders has received less attention. Interestingly, a study 
examining consecutive patients receiving treatment for eating disorders 
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(n=545, aged 18-54years) found that certain PD features were more common 
among specific sub-types of eating disorders than others (Godt, 2008). Godt 
(2008) found that Cluster B PDs were more common (15.1%) among those 
with bulimia nervosa - purging type, Cluster C PDs more common (28.6%) 
among those with bulimia nervosa - non-purging-type, whereas the prevalence 
of Cluster A PDs was relatively low (≤2.3%) across all subtypes of eating 
disorders. 
 
Sociodemographic correlates 
 
Consistent with several population-based studies (Jackson & Burgess, 2000; 
Coid et al., 2006; Huang et al., 2009; Torgersen et al., 2001), those with a PD 
in our study were more likely to be single/never married or separate/divorced 
than those without. They also tended to be more socially disadvantaged (not 
significant). Others have reported that those with PD are particularly likely to 
be living in urban areas (Coid et al., 2006; Torgersen et al., 2001), face 
unemployment, and have lower levels of educational attainment (Coid et al., 
2006; Jackson & Burgess, 2000; Torgersen et al., 2001). 
 
Strengths and limitations 
 
A major strength of the current study is the comprehensive psychiatric 
assessments that were used to identify PDs and psychiatric comorbidities. 
Additionally, we investigated a random, age-stratified, population-based 
sample, spanning the full adult age-range. We also utilized a robust measure of 
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relative advantage and disadvantage (IRSAD) that extends prior studies that 
have relied on self-reported information alone to measure SES. As such, the 
current study provides a valuable contribution to the literature given the 
paucity of good quality epidemiological data derived from the general 
Australian population. 
There are also potentially important limitations to consider when interpreting 
our data. First, the psychiatric profile of GOS non-respondents may have 
differed from responders. Also, we cannot exclude the possibility of 
differential loss to follow-up, in relation to PDs, over the course of the study. 
These factors combined might have impacted on how well our sample 
represented the underlying population. Given that there is a paucity of prior 
data collected utilizing the same assessment tool, comparisons of our data with 
other populations in Australia should be made with caution. Furthermore, we 
cannot rule out that both recall and information bias were introduced when 
administering the semi-structured clinical interviews, despite strict adherence 
to protocols. For example, standard questioning requires the participants to 
recall experiences over their lifetime, and the nature of recalling past events 
might have led to differential misclassification. Furthermore, others have 
suggested there might be a sub-group of individuals with PD in the general 
population that are higher functioning, characterized by absence of comorbidity 
with other mental disorders and help-seeking behaviors (Coid et al., 2009), 
which might contribute to bias in the prevalence of PD (Jackson & Burgess, 
2000). Whilst we provided a comprehensive assessment of psychiatric 
disorders, less prevalent (none the less important) disorders including psychotic 
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and cognitive disorders were not assessed. Lastly, these data are cross-
sectional, thereby precluding examination of the longitudinal trajectory of PD. 
 
Future directions and conclusions 
 
First, complementary data are needed regarding the prevalence of PD among 
Australian men, as we examined women in the current phase only. Second, 
further investigations are warranted regarding associations between PD 
clusters, and individual PDs with mental state disorders, particularly eating 
disorders, where there are few data. There also remains a need for more in-
depth investigations into the SES profile of PD among both women and men, 
in order to further identity sub-groups of the population who might be at risk of 
PD, and also to understand the needs of those with PD living with social 
disadvantage. Finally, we suggest that further investigations are required 
regarding the associated disability among those with PD in the general 
Australian population, as well psychiatric and physical comorbidities and 
associated help-seeking behaviors, in order to address needs for therapeutic 
intervention (Quirk et al., 2015). In conclusion, these data emphasize that PDs 
are relatively common among the Australian population, and provides much 
needed epidemiological data that might inform and guide public health 
planning and delivery of services. 
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CHAPTER FIVE: ASSOCIATIONS BETWEEN 
PERSONALITY DISORDERS AND PHYSICAL HEALTH 
COMORBIDITIES 
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Abstract
Common mental state disorders are associated with a range of physical health 
conditions. However, associations between personality disorder (PD) and 
physical health conditions are much less understood. We conducted a 
systematic review to evaluate the current evidence base regarding associations 
between PDs and cardiovascular disease (CVD), chronic respiratory diseases, 
cancers and musculoskeletal disorders. A computerized search strategy was 
performed using Medline, CINAHL and PsycINFO, to identify relevant studies 
published between 1960 and 2012. Methodological quality was rated for each 
study and a synthesis of the data was performed. Four studies met the pre-
determined eligibility criteria. When rated against the criteria for evidence, our 
synthesis found limited evidence for associations between a range of PDs and 
CVD and arthritis; and conflicting evidence between dimensional antisocial 
and borderline PD features and CVD. There is a suggestion that some 
personality disorders are associated with CVD and arthritis, however the 
evidence base was limited. Further studies, specifically high quality cohort 
studies, are still required to identify any potential causal association between 
PD and physical health conditions particularly for cancers and chronic 
respiratory diseases. 
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A SYSTEMATIC REVIEW OF PERSONALITY DISORDER AND 
CHRONIC PHYSICAL HEALTH CONDITIONS IN THE GENERAL 
POPULATION.
Introduction
While the prevalence of personality disorder (PD) is known to be 
disproportionately higher among psychiatric patients (Zimmerman, et al., 
2005). PDs in the general population have been shown to be common and are 
estimated to range between 4.4%-21.5% (Coid et al., 2006; Grant et al., 2004; 
Jackson & Burgess, 2000; Trull et al., 2010). PD is a significant contributor to 
disability in the population (Coid et al., 2006; Grant et al., 2004; Jackson & 
Burgess, 2002), and leads to considerable social disadvantage, including 
barriers housing and lower income Fazel, et al., 2008; Sareen, et al., 2011). 
The economic burden of personality disorder on mental health care appears to 
be higher than the burden imposed by some common mental state disorders; 
this is plausibly related to high levels of help-seeking behaviors related to 
direct medical costs (Soeteman et al., 2008). Furthermore, there are some data 
to suggest that the prevalence of PD might be greater in patients with chronic 
physical health condition (cancers, respiratory conditions, and arthritis (Bauer 
& Duijsens, 1998; Derogatis et al., 1983; Ekselius, Eriksson, von Knorring, & 
Linder, 1996; Marcenaro et al., 1999).
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Although personality traits have long been hypothesized to mediate health and 
lifestyle behaviors, and influence outcomes in cardiovascular disease (CVD) 
and cancers (Mommersteeg & Pouwer, 2012; Shekelle et al., 1985; Stürmer, 
Hasselbach, & Amelang, 2006), it has not been thoroughly investigated 
whether an association exists between categorical diagnoses of PD and 
physical health conditions from common and chronic disease groups. 
In recent years, there has also been an increasing focus on mental and physical 
health comorbidities in light of burgeoning evidence that common mental 
disorders have been shown to be risk factors for many common chronic 
physical health conditions, notably incident CVD (Van der Kooy et al., 2007). 
CVD, along with cancers, chronic respiratory conditions and musculoskeletal 
disorders are of increasing focus for public health priority interventions due to 
the rising burden of cost, illness and injury, including osteoporotic fractures, to 
the population (Borgstrom et al., 2006; Hernlund et al., 2013; Muka et al., 
2015).
There is now sufficient evidence indicating that while those with PD 
demonstrate age-related declines in psychopathology, underlying personality 
traits follow a relatively persistent temporal course Newton-Howes et al., 
2015). Going beyond what is known regarding associations between common 
mental state disorders and increased risk for physical health conditions, PD 
might also lead to potentially harmful effects on physical health. Recently, 
large, population-based studies, conducted primarily in the United Kingdom 
(UK) and United States (US), have reported that individuals with PD and those 
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at risk are more likely to report a physical health comorbidity in general (El-
Gabalawy et al., 2010; Goldstein et al., 2008; Lee et al., 2010; Moran et al., 
2007; Powers & Oltmanns., 2012; Powers & Oltmanns., 2013), and more 
specifically CVD (Lee et al., 2010; Moran et al., 2007) or arthritis 
(McWilliams et al., 2008). However it is not clear whether all categorical PDs 
or dimensional PD features (e.g. individual symptoms and behaviors of PD, 
short of diagnostic threshold) are related to specific physical health conditions. 
Putative mechanisms that might modulate these associations include 
dysregulation of the stress hormone cortisol via the hypothalamus–pituitary 
adrenal axis (El-Gabalawy et al., 2010; Goldstein et al., 2008; Lee et al., 2010; 
Moran et al., 2007; Powers & Oltmanns., 2012; Powers & Oltmanns., 2013),
and potentially immune system dysregulation, promoting systemic 
inflammation. Other potential pathways might involve clustering of lifestyle 
risk factors that include cigarette smoking, physical inactivity, unhealthy levels 
of alcohol consumption and habitually unhealthy diets, all of which have been 
shown to be more prevalent among those with mental disorders, and might 
influence both the expression of mental and physical symptoms (Berk et al., 
2013; Jacka et al., 2014; Moylan, et al., 2013). 
Aim of the study 
If associations exist between PD with chronic physical health conditions, 
evaluating the current evidence base might have substantive public health and 
clinical significance, including greater detection and public health 
MANUSCRIPT IV. 
125 
 
understanding of PD. Yet to our knowledge, no such review of the evidence 
base exists. Therefore, we aimed to evaluate the current levels of evidence for 
associations between categorical PD and dimensional PD features and physical 
health comorbidities from high prevalence chronic disease groups including: 
CVDs, cancers, chronic respiratory conditions and musculoskeletal disorders. 
 
Material and methods 
 
This systematic review adheres to the guidelines outlined in the preferred 
reporting items for systematic reviews and meta-analyses (PRISMA) statement 
2009 (Moher, et al., 2009). 
 
Eligibility and exclusion criteria 
 
Articles were eligible for inclusion if they examined associations between PD 
and/or PD features from Diagnostic and Statistical Manual of Mental Disorders 
(DSM) Cluster A (paranoid, schizoid, schizotypal), Cluster B (antisocial, 
borderline, histrionic, narcissistic, Cluster C (avoidant, dependent, obsessive-
compulsive personality disorder) defined by the classification system of the 
DSM (III, IV or 5) (APA., 1980; APA., 2013) or, the International 
Classification of Diseases (ICD) (WHO., 2010) as well as the following self-
reported (clinically diagnosed or otherwise identified) physical conditions: 
CVDs, cancers, respiratory diseases, or musculoskeletal diseases. It was 
beyond the scope of this review to examine the diverse range metabolic 
disorders including glycaemic index and diabetes mellitus. The study samples 
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examined adult population (aged ≥ 18 years). Furthermore, articles were 
eligible if they were: (i) full-text articles; (ii) observational studies with cohort, 
case-control or cross-sectional study designs; (iii) presented adjusted analyses; 
and (iv) published in English. Studies were excluded if they: (i) were published 
in languages other than English; (ii) employed qualitative methodology; (iii) 
were randomized control trials (iv) were case studies or case reports; (v) 
published abstracts or letters to the editor; (vii) were dissertations; or (viii) grey 
literature. 
Identification of studies 
A computerized search strategy using Medline (PubMed), CINAHL, and 
PsycINFO was conducted to identify relevant articles, accessible between 1960 
and August 30, 2012. 
A combination of MeSH headings and keywords were utilized to complete the 
final search strategy: “personality disorder” OR “personality” OR “personality 
features” OR “personality traits” OR “personality cluster” AND “medical 
conditions” OR “chronic illness” OR “chronic diseases” OR “cardiovascular 
diseases” OR “neoplasms” OR “respiratory tract diseases” OR “respiratory 
diseases” OR “musculoskeletal diseases”. The search strategy was confirmed 
by two reviewers (SEQ and SLB). One reviewer performed the final search 
(SEQ). The reference lists of studies considered eligible were also manually 
searched. Complete details regarding development of the search strategy can be 
requested from the corresponding author. Two reviewers confirmed the 
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selection of studies (SEQ and LB) based on thorough readings of the full-text 
articles, and a third reviewer (SLB) provided final judgment where the 
eligibility of studies was considered ambiguous. Figure 1 presents the adapted 
version of the PRISMA flow diagram (Moher et al., 2009). 
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Citations retrieved from electronic search of Medline, PsycINFO and CINAHL: 
n=2,454 
Duplicate publications excluded  (n=297) 
Initial screening of titles and abstracts (n=2,157) 
Excluded on basis of review of title and/or abstract 
(n=2,109) 
Studies assessed for eligibility (n=31) 
Inclusion criteria not met (n= 10) 
Published in languages other than English (n=17) 
Studies included in this review (n= 4), comprising: 
Cohort studies (n=1) 
Cross-sectional studies (n=3) 
Figure 1: Flow of systematic search presented as an adapted PRIMA flow 
diagram (Moher et al., 2009) 
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Assessment of methodological quality of the selected studies 
The eligible studies were assessed for their methodological quality, using an 
adapted scoring system (Lievense et al., 2001; Lievense et al., 2002) previously 
utilized in systematic reviews published extensively in psychiatry and 
biomedical fields (Brennan et al., 2009; Brennan et al., 2011; Lievense et al., 
2001; Lievense et al., 2002; O’Neil et al., 2014; Quirk et al., 2012). The 
methodological scoring system includes 15 criteria concerning the study 
population, exposure and outcome variables under investigation, study design 
and data analysis and presentation (Table 1).  Each criterion is scored as 
present (1), absent (0), or unclear/missing (?) which ultimately resulted in a “0” 
score being assigned. Scores were summed and percentages were calculated 
based on the highest possible number of criteria for that particular study 
design. Cohort studies were the preferred design, followed by case-control 
studies, and then cross-sectional. The strength of the study design was evident 
in the maximum possible score. Several of the criteria were not applicable to 
certain study types, thus, the maximum score for each study was based only on 
the items applicable to that particular type of study design (Table 1). The 
methodological quality of each study was independently assessed by two 
experienced reviewers (SEQ and SLB), and discrepancies in scores were 
resolved at one consensus meeting.
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Table 1: Criteria list for the assessment of study quality, modified from 
Lievense et al (Lievense et al., 2001; Lievense et al., 2002) 
Item Criteria C/CC/CS†
Study population
1 Selection at uniform point C/CC/CS
2 Cases and controls drawn from the same population CC
3 Participation rate >80% for cases/cohort C/CC
4 Participation rate >80% for controls CC
Assessment of exposure variable of interest (personality disorders)
5 Exposure assessment blinded C/CC/CS
6 Exposure measured identically for cases and 
controls
CC
7 Exposure assessed according to validated measures C/CC/CS
Assessment of outcome variables of interests (physical health conditions) 
8 Outcome assessed identically in studied population C/CC/CS
9 Outcome reproducibly C/CC/CS
10 Outcome assessed according to validated measures C/CC/CS
Study design
11 Prospective design used C/CC
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12 Follow-up time ≥12 months C
13 Withdrawals <20% C
Analysis and data presentation
14 Appropriate analysis techniques used C/CC/CS
15 Adjusted for at least age, and gender C/CC/CS
†C = applicable to cohort studies, CC = applicable to case-control studies, CS 
= applicable to cross-sectional 
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Data analysis and synthesis 
Given the paucity of data and the heterogeneity in available studies, we 
undertook a synthesis rather than a meta-analysis. This synthesis consisted of 
five levels of evidence ranging from strong evidence to no evidence (Table 2), 
and primarily reflected the study designs used. 
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Table 2: Criteria for ascertainment of evidence level for synthesis, adapted 
from Lievense et al (Lievense et al., 2001; Lievense et al., 2002) 
Level of Evidence Criteria for synthesis
Strong evidence Generally consistent findings in:
Multiple high-quality cohort studies
Moderate evidence Generally consistent findings in:
One high-quality cohort study and >2 high quality case-
control studies
Limited evidence Generally consistent findings in:
Single cohort study
One or two case-control studies or
Multiple cross-sectional studies
Conflicting evidence Inconsistent findings in <75 % of the trials
No evidence No studies could be found
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Results 
Selection of studies 
The search strategy returned a total of 2,454 articles, of which four studies met 
the eligibility criteria (El-Gabalawy et al., 2010; Goldstein et al., 2008; Lee et 
al., 2010; Powers & Oltmanns, 2013) (Figure 1). Reasons for studies failing to 
meet the eligibility criteria were due to examining bone mineral density (BMD) 
levels rather osteoporosis defined by BMD cut-off for determining 
osteoporosis (Kahl et al., 2006) and the age range overlapping with adolescents 
(16-74 years) (Moran et al., 2007). A small number of studies were also 
excluded that investigated the prevalence of PD in existing medical patients 
rather than associations (Bauer et al., 1998; Derogatis et al., 1983; Ekselius et 
al., 1996; Marcenaro et al., 1999), and one study that addressed the reverse
association (McWilliams et al., 2008). The remaining studies failed to meet 
eligibility criteria due to having: (i) used non DSM or ICD criteria; (ii) 
aggregated psychiatric diagnose or medical morbidity. No additional articles 
were retrieved from the manual search of reference lists from the studies 
deemed eligible for inclusion. 
Methodological quality 
Across the four reviewed studies (comprising 69 separate analyses), two 
reviewers independently scored 36 criteria and independently agreed on 34 
items (94.4%). The discrepancies were resolved in a consensus meeting. The 
methodological quality scores were all high and ranged from 83.3% (Lee et al., 
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2010) to 87.5% (El-Gabalawy et al., 2010; Goldsetin et al., 2008; Powers & 
Oltmanns, 2013). The mean quality score for all the scores was 86.45%. 
Description of included studies 
A summary of the reviewed studies is presented in Table 3. All studies were 
published in the past seven years; 2008 (Goldstein et al., 2008), 2010 (El-
Gabalawy et al., 2010; Lee et al., 2010) and 2012 (E-pub ahead of print) 
(Powers & Oltmanns, 2013). One study was of a longitudinal cohort design 
(Lee et al., 2010), and the remaining three were cross-sectional (El-Gabalawy 
et al., 2010; Goldsetin et al., 2008; Powers & Oltmanns, 2013). All studies had 
been conducted within the US (including the District of Columbia, Alaska and 
Hawaii) and were population-based. Analyses derived from the longitudinal 
cohort study (Lee et al., 2010) were undertaken as part of Waves 1 and 4 of the 
National Institute of Mental Health (NIMH) Baltimore Epidemiological 
Catchment Area Program conducted by Johns Hopkins Medical Institutions 
(1981-2004). Two of the cross-sectional studies utilized data from the 
NESARC; one using data from Wave 1 (2001-2002) (Goldstein et al., 2008),
and the other from Wave 2 (2004-2005) (El-Gabalaway et al., 2010). The other 
cross-sectional study was conducted as part of the St. Louis Personality and 
Aging Network (SPAN) study (Powers & Oltmanns, 2013). The smallest 
sample size was for the longitudinal cohort study (n=244) (Lee et al., 2010), 
with populations ranging from 1,021 (Powers & Oltmanns, 2013) to 43,093 
(Goldstein et al., 2008) in the cross-sectional studies. 
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Table 3: Characteristics of reviewed studies, presented according to study design, publication year and author 
 
    Personality disorder assessment    
Author, 
country 
of study, 
year 
n=subjects 
(% 
female) 
Age, 
years; 
Mean 
(±SD) 
or 
range 
Population 
description, 
recruitment 
 
Assessment 
 
Nomenclature 
 
Diagnosis, 
traits/features 
 
Physical 
conditions 
 
Quality 
score% 
Cohort         
Lee et al, 
US, 2010 
[26] 
244  
(69.3) 
34.4 
(11.9)   
 
Residents 
participating 
in the 
Baltimore 
ECA 
program 
conducted at 
the Johns 
Wave 1 (1981) 
Screening 
conducted by 
trained lay-
interviewers for 
psychopathology 
using the (DIS), 
psychiatrists 
DSM-III  Diagnosis and 
traits 
Self-reported in 
Wave 4 (2004) 
“Have you ever 
heart trouble?”, 
“what kind of 
heart trouble 
have you had?” 
Probing positive 
83.3% 
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Hopkins 
Medical 
Institutions 
diagnosed using 
semi-structure 
format and 
clinical 
reappraisals 
using The 
Standardized 
Psychiatric 
Examination, 
dimensional 
scores and 
diagnoses 
generated by 
algorithms 
responses to list 
of rheumatic 
fever, rheumatic 
heart disease, 
angina pectoris, 
CHF, MI. Self-
reported 
angioplasty, 
CABG surgery. 
Incident CVD 
defined as self-
reported “heart 
attack”, CHF, or 
having 
angioplasty or 
CABG surgery 
by Wave 4. 
Cross-sectional 
Goldstein 43,093 ≥20  Population-  AUDADIS-IV, DSM-IV  Diagnosis and Self-report of 87.5% 
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et al, US, 
2008 [23] 
(57.0) 
 
 
based adults 
residing in 
the US 
including  
Districts of  
Colombia, 
Alaska and 
Hawaii who 
participated 
in Wave 1 
(2001-2002) 
of the 
NESARC 
validated, 
administered by 
lay-interviewers 
features being diagnosed 
by a health 
professional 
during the past 
year: Coronary 
heart disease 
(arteriosclerosis, 
MI, angina 
pectoris), other 
heart disease 
(tachycardia, 
any other form 
of heart disease, 
hypertension, 
arthritic 
diseases 
 
El-
Gabalawy 
34,653 
(52.1) 
20-90  Population-
based adult 
AUDADIS-IV, 
validated, 
DSM-IV  Diagnosis Self-report of 
being diagnosed 
87.5% 
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et al., 
Canada, 
US data,  
2010, 
[22] 
 
 
residing in 
the US 
including  
Districts of  
Colombia, 
Alaska and 
Hawaii who 
participated 
in Wave 2 
(2004-2005) 
of the 
NESARC 
administered by 
lay-interviewers 
by a health 
professional: 
Arteriosclerosis 
or hypertension, 
CVD (chest 
pain or angina 
pectoris, 
tachycardia, MI, 
other form of 
heart disease, 
stroke Arthritis,  
Powers & 
Oltmanns, 
US, 2013 
[25] 
1,021 
(53.0) 
 
59.4 
(2.7) 
 
Community-
based adults 
residing in 
St. Louis 
area, US 
participating 
in SPAN 
Structured 
Interview for 
DSM-IV 
Personality, 
Multisource 
Assessment of 
Personality 
DSM-IV  Diagnosis and 
features 
Self-report of 
being under 
doctors care for, 
heart disease, 
stroke, arthritis 
87.5% 
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study Pathology 
 
Criterion acronyms: AUDADIS-IV = Alcohol Use Disorders and Associated Disabilities Interview Schedule IV; DIS = Diagnostic 
Interview Schedule; DSM-III = Diagnostic and Statistical Manual of Mental Disorders, Third Edition; DSM-IV = Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition.  
Study acronyms: ECA = Epidemiological Catchment Area; NESARC = National Epidemiological Survey on Alcohol and Related 
Conditions; St. Louis Personality and Aging Network (SPAN) 
Disease acronyms: CABG = coronary artery bypass graft; CHF = congestive heart failure; CVD = cardiovascular disease; MI= 
myocardial infarction 
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While each study utilized a validated and/or structured assessment of PD, there 
was considerable heterogeneity with regards to the interview schedules that 
were administered. The longitudinal cohort study (Lee et al., 2010) used a 
combination of assessment procedures including NIMH Diagnostic Interview 
Schedule to screen for psychopathology, Standardized Psychiatric 
Examination, clinical interviews and algorithms generated DSM-III PD 
diagnoses and dimensional traits based on a probability sample. Two cross-
sectional studies (El-Gabalawy et al., 2010; Goldstein et al., 2008) used the 
NIAAA developed Alcohol Use Disorder and Associated Disabilities Interview 
Schedule – DSM-IV Version (AUDADIS-IV) for use by trained lay-
interviewers. The other cross-sectional study used the Structured Interview for 
DSM-IV Personality (SIDP-IV) and the Multisource Assessment of Personality 
Pathology (MAPP); a multi-source approach of self-reported, informant- and 
interviewer-rated assessment of PD (Powers & Oltmanns, 2013). Furthermore, 
the longitudinal cohort study investigated PDs grouped as “any”, “Clusters” as 
well as individual PDs (diagnostic and traits) (Lee et al., 2010). Two cross-
sectional studies examined borderline PD only; one at diagnostic level (El-
Gabalawy et al., 2010), and the other examined borderline PD traits/features 
(Powers & Oltmanns, 2013). The other cross-sectional study examined both 
diagnostic antisocial PD and traits/features (Goldstein et al., 2008). A majority 
of the studies assessed PD according to DSM-IV nomenclature (El-Gabalawy 
et al., 2010; Goldstein et al., 2008; Powers & Oltmanns, 2013), except for the 
longitudinal cohort study that assessed PD according to DSM-III criteria (Lee 
et al., 2010). 
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With respect to the classification of physical health comorbidities, all studies 
used participant self-report of being diagnosed by a healthcare professional. 
Data pertaining to CVD was available from each of the four reviewed studies, 
however, there was substantial heterogeneity regarding the measurement and 
definition of CVD. One study defined CVD according to self-reported “heart 
attack”, coronary heart failure, or having angioplasty or CABG surgery (Lee et 
al., 2010). Similarly, one cross-sectional study defined coronary heart disease 
as including arteriosclerosis, angina pectoris, and myocardial infarction, and 
“any other form of heart disease” including tachycardia (Goldstein et al., 
2008). The other cross-sectional study defined CVD as including chest pain or 
angina pectoris, tachycardia, myocardial infarction, any other form of heart 
disease, stroke, and examined arteriosclerosis or hypertension, separately (El-
Gabalawy et al., 2010). The other cross-sectional conducted separate analyses 
examining heart disease and stroke (Powers & Oltmanns, 2013). Three studies 
also examined self-reported arthritis (El-Gabalawy et al., 2010; Goldstein et al., 
Powers & Oltmanns, 2013). Our search strategy did not identify any studies 
that had examined associations between PDs and cancers or chronic respiratory 
conditions. 
Presentation of findings/study groupings 
The results of the four reviewed studies are presented in Table 4; where 
available, results are presented as the adjusted odds ratios (OR) with 95% or 
99% confidence intervals (CI). The studies are presented by the disease groups 
MANUSCRIPT IV 
143 
 
of CVDs and arthritis, and according to diagnosis/traits of any PD, Clusters and 
individual PDs. 
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Table 4: Associations between PDs and physical health conditions presented by outcome, publication year and author 
Author,
country of 
study, year
n = or (Prevalence %) 
Total (PDs), or range of 
trait scores
OR (95%CI) Models adjusted for: Summary of findings
Diagnosis Traits/
features
Diagnosis Traits/
features
Cardiovascular diseases
Cohort
Lee et al, 
US, 2010, 
[26]
Any PD
n= 32
(Ϯ) 1.99 (0.76, 5.19), - Model 1: age, gender, race, 
education, and marital status
Any PD not associated 
with CVD
2.17 (0.83, 5.67) - Model 2: BMI, hypertension, 
diabetes and smoking 1+ pack/day
Any PD not associated 
with CVD
2.30 (0.86, 2.14) - Model 3: age, diabetes and smoking 
1+ pack/day
Any PD not associated 
with CVD
- 1.04 (1.00, 1.08) Model 1 (as above) Any PD traits associated 
with CVD
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   - 1.04 (1.00, 1.08) Model 2 (as above) Any PD traits associated 
with CVD 
   - 1.05 (1.01, 1.10) Model 3: (as above) Any PD traits associated 
with CVD 
   - 1.00 (0.85, 1.17) Model 1: (as above) Any Cluster A traits not 
associated with CVD 
   - 1.01 (0.86, 1.02) Model 2: (as above) Any Cluster A traits not 
associated with CVD 
   - 1.03 (0.87, 1.22) Model 3: (as above) Any Cluster A traits not 
associated with CVD 
 Cluster B 
n=24 
 
 3.15 (1.15, 8.70) - Model 1: (as above) Cluster B PD associated 
with CVD 
   3.26 (1.20, 8.87) - Model 2: (as above) Cluster B PDs 
associated with CVD 
   4.14 (1.41, 12.14) - Model 3: (as above) Cluster B PDs 
associated with CVD 
   - 1.05 (1.01, 1.10) Model 1: (as above) Cluster B PD traits 
associated CVD 
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   - 1.06 (1.01, 1.11) Model 2: (as above) Cluster B PD traits 
associated with CVD 
   - 1.07 (1.02, 1.12) Model 3: (as above) Cluster B PD traits 
associated with CVD 
   - 1.09 (1.01, 1.18) Model 1: (as above) Antisocial PD traits 
associated with CVD 
   - 1.07 (0.99, 1.16) Model 2: (as above) Antisocial PD traits not 
associated with CVD 
   - 1.09 (1.01, 1.19) Model 3: (as above) Antisocial PD traits 
associated with CVD 
   - 1.20 (0.99, 1.46) Model 1: (as above) Borderline PD traits not 
associated with CVD 
   - 1.21 (1.00, 1.51) Model 2: (as above) Borderline PD traits 
associated with CVD 
   - 1.23 (1.01, 1.51) Model 3: (as above) Borderline PD traits 
associated with CVD 
   - 1.08 (0.98, 1.19) Model 1: (as above) Histrionic PD traits not 
associated with CVD 
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   - *1.10 (1.00, 1.20) Model 2: (as above) Histrionic PD traits not 
associated with CVD 
   - 1.08 (0.99, 1.20) Model 3: (as above) Histrionic PD traits not 
associated with CVD 
   - 1.20 (0.73, 1.99) Model 1: (as above) Narcissistic PD traits 
not associated with 
CVD 
   - 1.37 (0.75, 2.47) Model 2: (as above) Narcissistic PD traits 
not associated with 
CVD 
   - 1.81 (0.94, 3.51) Model 3: (as above) Narcissistic PD traits 
not associated with 
CVD 
   - 1.06 (0.94, 1.20) Model 1: (as above) Cluster C PD traits not 
associated with CVD 
   - 1.11 (0.98, 1.14) Model 2: (as above) Cluster C PD traits not 
associated with CVD 
   - 1.10 (0.97, 1.24) Model 3: (as above) Cluster C PD traits not 
associated with CVD 
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Goldstein et 
al, US, 
2008, [23] 
Antisocial 
PD 
Men: 3.6 
±0.15 
Women: 
1.9 ± 0.11 
 1.5 (1.05-2.22)  Model 1: adjusted for age, 
race/ethnicity, marital status, 
education, past-year-income, current 
health insurance coverage, region and 
urbanicity of residence, comorbid 
Axis I & Axis II psychiatric 
diagnoses, consumption of tobacco, 
alcohol and non-alcohol substances 
ASPD associated with 
Coronary heart disease 
(arteriosclerosis, angina 
pectoris, myocardial 
infarction) 
   1.4 (0.98-1.86) - Model 1: (as above) ASPD not associated  
with any other form of 
heart disease and/or 
tachycardia 
   1.0 (0.80-1.35) - Model 1: (as above) ASPD not associated 
with hypertension  
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  AABS  Total: 
12.3 ±0.38 
Men: 16.5 
±0.53 
Women: 8.5 
±0.38 
- 1.3 (1.03-1.55) Model 1: (as above) AABS associated with 
Coronary heart disease 
(arteriosclerosis, angina 
pectoris, myocardial 
infarction)  
   - 1.3 (1.03-1.53) Model 1: (as above) AABS associated with 
any other form of heart 
disease and/or 
tachycardia 
   - 1.1 (0.99-1.27) Model 1: (as above) ASBD not associated 
with hypertension 
El-
Gabalawy et 
al, US, 
2010, [22] 
BPD 
Total: 5.9 
- 1.86 (1.60–2.16) - Model 1: adjusted for sex, ethnicity, 
education, marital status, income, age 
BPD associated with 
arteriosclerosis or 
hypertension  
   1.47 (1.25–1.73) - Model 2: (as above) + any anxiety, 
mood, substance use disorder 
BPD associated with 
arteriosclerosis or 
hypertension  
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   1.46 (1.23–1.73) - Model 3: (as above) + any PD other 
than BPD 
BPD associated with 
arteriosclerosis or 
hypertension  
   2.78 (2.35–3.29) - Model 1: (as above) BPD associated with 
CVD 
   1.83 (1.53–2.19) - Model 2: (as above) BPD associated with 
CVD 
   1.68 (1.40–2.02) - Model 3: (as above) BPD associated with 
CVD 
   1.89 (1.08–3.31) - Model 1: (as above) BPD associated with 
stroke 
   1.58 (0.79–3.15) 
 
1.42 (0.63–3.17) 
- 
 
- 
Model 2: (as above) 
 
 
Model 3: (as above) 
BPD not associated with 
stroke 
 
BPD not associated with 
stroke 
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Power & 
Oltmanns, 
US, 2012 
- BPD features: 
Range 0–1.78 
M= 0.13 ±0.21 
- 2.64 (0.96–7.28) Model 1: adjusted for sex, age, race, 
marital status, education 
Interviewer-rated BPD 
features not associated 
with heart disease 
   - 2.09 (0.70–6.21) Model 2: (as above) + any 
lifetime MDD, alcohol dependence, 
or drug dependence 
Interviewer-rated BPD 
features not associated 
with heart disease 
   - 3.72 (0.96–14.44) Model 3: (as above) + any PD other 
than BPD 
Interviewer-rated BPD 
features not associated 
with heart disease 
  BPD features: 
Range 0–1.78 
M= 0.13 ±0.21 
- 1.14 (0.12–10.81) 
 
Model 1: (as above) Interviewer-rated BPD 
features not associated 
with stroke 
   - 0.65 (0.06–7.54) 
 
Model 2: (as above)  
 
Interviewer-rated BPD 
features not associated 
with stroke 
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   - 0.44 (0.03–6.92) 
 
Model 3: (as above)  Interviewer-rated BPD 
features not associated 
with stroke 
  BPD features: 
Range 0–3.22 
M=0.43±0.40 
- 2.22 (1.29–3.81) 
 
Model 1: (as above) Self-report BPD 
features associated with 
heart disease 
   - 2.07 (1.19–3.60) Model 2: (as above)  
 
Self-report BPD 
features associated with 
heart disease 
   - 4.02 (1.46–11.06) 
 
Model 3: (as above) Self-report BPD 
features associated with 
heart disease 
  BPD features: 
Range 0–3.22 
M=0.43±0.40 
- 0.99 (0.34–2.91) 
 
Model 1: (as above) Self-report BPD 
features not associated 
stroke 
   - 0.88 (0.30–2.67) 
 
Model 2: (as above)  
 
Self-report BPD 
features not associated 
with stroke 
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   - 0.82 (0.13–5.24) 
 
Model 3: (as above)  Self-report BPD 
features not associated 
with stroke 
  BPD features: 
Range 0–3.11 
M=0.56±0.54 
- 1.99 (1.33–2.98) Model 1: (as above) Informant-rated BPD 
features associated with 
heart disease 
   - 1.82 (1.20–2.76) 
 
Model 2: (as above)  
 
Informant-rated BPD 
features associated with 
heart disease 
   - 1.40 (0.63–3.17) 
 
Model 3: (as above) Informant-rated BPD 
features not associated 
with heart disease 
  BPD features: 
Range 0–3.11 
M=0.56±0.54 
- 1.15 (0.49–2.69) 
 
Model 1: (as above) Informant-rated BPD 
features not associated 
with stroke 
   - 0.95 (0.41–2.27) 
 
Model 2: (as above)  
 
Informant-rated BPD 
features not associated 
with stroke 
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   - 1.72 (0.31–9.51) 
 
Model 3: (as above)  Informant-rated BPD 
features not associated 
with stroke 
Musculoskeletal disorders 
Cross-
sectional 
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Goldstein et 
al, US, 2008
Antisocial 
PD
Men: 3.6 
±0.15
-
-
AABS  Total: 
12.3 ±0.38
Men: 16.5 
±0.53
2.20 (1.69-2.76)
-
-
1.4 (1.20-1.73)
Model 1: adjusted for age, 
race/ethnicity, marital status, 
education, past-year-income, current 
health insurance coverage, region and 
urbanicity of residence, comorbid 
Axis I & Axis II psychiatric 
diagnoses, consumption of tobacco, 
alcohol and non-alcohol substances
Model 1: (as above)
ASPD in men 
associated with arthritis
AABS in men is 
associated with arthritis
Women: 
1.9 ± 0.11
- 1.4 (1.03-1.96) - Model 1: (as above) ASPD in women is 
associated with arthritis
- Women: 8.5 
±0.38
- 1.20 (0.95-1.42) Model 1: (as above) AABS in women not 
associated with arthritis
El-
Gabalawy et 
al, US, 2010
BPD
Total: 5.9
- 2.38 (2.03–2.79) - Model 1: adjusted for sex, ethnicity, 
education, marital status, income, age
BPD associated with 
arthritis
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   1.62 (1.36–1.93) - Model 2: (as above) any anxiety, 
mood, substance use disorder 
BPD associated with 
arthritis 
   1.56 (1.31–1.85) - Model 3: (as above) + any PD other 
than BPD 
BPD associated with 
arthritis 
Power et al, 
US, 2012 
 BPD features: 
Range 0–1.78m 
M= 0.13 ±0.21 
- 2.67 (1.34–5.34 Model 1: adjusted for sex, age, race, 
marital status, education 
Interviewer-rated BPD 
features associated with 
arthritis 
   - 2.23 (1.07–4.67) Model 2: (as above) + any 
lifetime MDD, alcohol dependence, 
or drug dependence 
Interviewer-rated BPD 
features associated with 
arthritis 
   - 2.64 (1.06–6.57 Model 3: (as above) + any PD other 
than BPD 
Interviewer-rated BPD 
features associated with 
arthritis 
  BPD features: 
Range 0–3.22 
M=0.43±0.40 
- 1.54 (1.07–2.22) Model 1: (as above) Self-report BPD 
features associated with 
arthritis 
 157 
 
   - 1.42 (0.97–2.08) Model 2: (as above)  
 
Self-report BPD 
features not associated 
with arthritis 
   - 1.41 (0.74–2.68) 
 
Model 3: (as above)  Self-report BPD 
features not associated 
with arthritis 
  BPD features: 
Range 0–3.11 
M=0.56±0.54 
- 1.35 (1.02–1.77) Model 1: (as above) Informant-rated BPD 
features associated with 
arthritis 
   - 1.26 (0.95–1.68) Model 2: (as above)  
 
Informant-rated BPD 
features not associated 
with arthritis  
   - 1.76 (1.05–2.95) Model 3: (as above) + any PD other 
than BPD 
Informant-rated BPD 
features associated with 
arthritis 
 
Note: Boldface indicates significance; * unrounded figures crossed zero; 
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Data from all studies and synthesis 
Three analyses from one cohort study showed no association between 
categorical PD and incident CVD over 24-years (Lee et al., 2010). However, 
when measured as dimensional personality traits, three separate additional 
analyses reported significant associations. When rated against the criteria for 
evidence, the studies were judged to indicate limited evidence. 
In regard to PD Clusters and the association with CVD, three analyses from 
one cohort study identified that Cluster A traits were not associated with 
incident CVD (Lee et al., 2010). Six separate analyses showed that categorical 
Cluster B disorder and dimensional Cluster B traits (three analyses each) were 
associated with incident CVD (Lee et al., 2010). Three analyses showed no 
association between Cluster C traits and incident CVD (Lee et al., 2010), 
which indicated limited evidence. When rated against the criteria for evidence, 
these associations were also deemed to indicate limited evidence. 
For categorical antisocial PD, one cross-sectional study reported a single 
analysis identifying an association with CVD (coronary heart disease), and no 
association between antisocial and CVD in two further separate analyses (any 
other form of heart disease and/or tachycardia and hypertension) (Goldstein et 
al., 2008). In regard to dimensional antisocial PD traits, two analyses from one 
cohort study demonstrated an association, with increased odds of incident CVD 
(Lee et al., 2010), as did one analyses from one cross-sectional study (any other 
form of heart disease and/or tachycardia). In contrast, one analysis from the 
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same cohort study (Lee et al., 2010) reported no association with antisocial 
traits and incident CVD, and two analyses from the same cross-sectional study 
also reported no association with CVD (coronary heart disease and 
hypertension) (Goldstein et al., 2008). According to the criteria for evidence, 
this indicates conflicting evidence for associations between both diagnostic 
antisocial PD and antisocial traits and CVD. 
One cross-sectional study found categorical borderline PD was associated with 
arteriosclerosis or hypertension and CVD across six separate analyses (El-
Gabalawy et al., 2010). Two additional analyses identified an association 
between categorical borderline PD and stroke. In contrast, another analysis 
found no association (El-Gabalawy et al., 2010). Two analyses from one cohort 
study revealed associations between dimensional borderline traits and 
increased incident CVD (Lee et al., 2010), as did five analyses from one cross-
sectional study (self-reported borderline traits and heart disease) (Powers & 
Oltmanns, 2013). In contrast the same cohort study also reported no association 
in an additional analyses (Lee et al., 2010), and the cross-sectional study 
reported no association for interviewer-rated dimensional borderline traits and 
heart disease and stroke (three analyses each), self-reported dimensional 
borderline traits and stroke (three analyses), and informant-rated dimensional 
borderline PD traits heart disease and stroke (five analyses) (Powers & 
Oltmanns, 2013). When rated against the criteria for evidence, associations 
between categorical borderline PD and CVD indicate limited evidence and 
borderline dimensional PD traits and CVD indicate conflicting evidence. 
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Histrionic and narcissistic dimensional traits were not associated with incident 
CVD in three analyses each from one cohort study (Lee et al., 2010), indicating 
limited evidence. 
 
In regard to arthritis as the outcome variable in the models, one cross-sectional 
study reported that antisocial PD was associated with arthritis in both men and 
women in separate analyses (Goldstein et al., 2008). The same study reported 
associations for dimensional antisocial traits and arthritis for men but not for 
women. When rated against the criteria for evidence, these associations 
indicate limited evidence. 
 
Finally, one cross-sectional study found categorical borderline PD was 
associated with arthritis in three separate analyses (El-Gabalawy et al., 2010), 
indicating limited evidence for this association.  Associations between 
dimensional borderline PD traits (interviewer-rated and self-reported) and 
arthritis were identified in one cross-sectional study in five separate analyses 
(Powers & Oltmanns, 2013). In contrast, the same study reported no 
association between dimensional borderline PD traits (self-reported and 
informant-rated) and arthritis (three analyses) (Powers & Oltmanns, 2013), as 
such indicating limited evidence for dimensional borderline PD traits and 
arthritis. 
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Discussion 
 
To our knowledge, this is the first systematic review to examine PD and its 
associations with common physical health conditions. Our results indicate that 
there was limited evidence to support associations for PD and CVD 
specifically for: (i) any PD, (ii) Cluster A traits, (iii) threshold Cluster B, iv) 
Cluster B traits, (v) Cluster C traits, (vi) categorical borderline PD, (vii) 
histrionic traits, (viii) narcissistic traits. We also report a conflicting level of 
evidence for an association for PDs and CVD for (i) dimensional antisocial 
traits, (ii) dimensional borderline traits. Moreover, we report limited evidence 
to support association between PD and the outcome of arthritis, specifically for 
(i) categorical borderline PD, (ii) dimensional borderline traits, (iii) categorical 
antisocial, and (iv) dimensional antisocial traits. However, the evidence base is 
limited, which highlights the opportunity to widen the study of population 
mental health with a focus on PD and comorbidities. This review also 
identified that no studies investigated the relationship between PDs and cancers 
or chronic respiratory diseases, indicating a critical need for research in this 
area. As such, our discussion is limited to the extant data regarding the 
outcomes of CVD and arthritis. 
 
Mechanisms 
 
Despite our synthesis summarizing limited and conflicting evidence for 
individual categorical PDs and CVD, this is likely due to the paucity of 
available literature. There are a number of plausible mechanisms that might 
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underlie those associations that were observed between PD and increased risk 
for CVD. First, PD is known to be highly comorbid with mood disorders 
(Friborg et al., 2014), namely depression (Gunderson et al., 2008), which is a 
robust risk factor for cardio metabolic diseases (Rotella et al., 2013;Van der 
Kooy et al., 2007). The comorbidities among those with depression and CVD, 
in particular, have been hypothesized to be modulated by dysregulation of 
shared inflammatory and oxidative and nitrosative stress pathways and immune 
system functions Maes et al., 2011; Van der Kooy et al., 2007; Irwin et al., 
2007). Given these mechanisms, it is plausible that positive associations 
between some individuals’ PD (particularly from Cluster B) and CVD might be 
mediated or moderated by co-existing depression. Investigation of these 
potentially mediating and/or moderating pathways warrants further 
investigation. PD might also be having an unmeasured effect on associations 
between depression and CVD observed in prior studies. 
Second, unhealthy lifestyle behaviors, particularly smoking and substance 
misuse, which are disproportionately higher among those with psychiatric 
disorders, affect biological systems and mechanisms that underpin the 
expression of both psychiatric symptoms and physical illness, including 
inflammatory pathways, oxidative processes, and functioning of the immune 
system (Jacka et al., 2014; Maes et al., 2011; Moylan et al., 2013). While less 
is known in regard to lifestyle behaviors and characteristics of those with PD, 
recent data suggests a propensity for those with coexisting cannabis misuse and 
nicotine dependence for psychiatric comorbidity including Cluster A and B 
diagnoses (Peters et al., 2014), which might also be a mediating or moderating 
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factor. One study also reported that adolescents with borderline PD were more 
likely to commence cigarette smoking at a younger age compared with those 
with other PDs (Chanen, Jovev, & Jackson, 2007). Moreover, atypical 
antipsychotic medications, which are commonly used among psychiatric 
patients, have been shown to incite cardio-metabolic disturbances including 
tachycardia, myocarditis and cardiomyopathy (Hyde et al., 2015), and weight 
gain (Zimmerman et al., 2003). 
 
Our synthesis also found limited and conflicting evidence for associations 
between PD and arthritis, which might also be indicative of the limited 
evidence base, rather than reflecting true associations. We can speculate that 
individual socioeconomic factors might combine to amplify the susceptibility 
to arthritic diseases and thus increase the risk seen in those with borderline and 
antisocial PDs (Brennan & Turrell, 2012). Also, by definition, given that risk 
taking behaviors are core features of antisocial and borderline PDs (APA, 
2013), it is plausible that these disorders might increase the likelihood of 
trauma to joints from activities such as traumatic blows or injuries. Joint 
trauma increases the likelihood of developing bone marrow lesions, a factor 
well-documented as being associated with osteoarthritis (Felson et al., 2012). 
Furthermore, it also possible that those with PD might be less likely to adopt 
adaptive health-related behaviors (Powers & Oltmanns, 2013), and therefore 
less likely to adhere to lifestyles that might reduce the onset of arthritis, 
including modifiable factors that comprise regular physical activity and/or 
lower caloric intake to avoid obesity. 
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For men, both categorical antisocial PD and dimensional antisocial traits 
appear to be important in the relationship with arthritis. For women, we 
observed only diagnostic levels of antisocial PD to be associated with 
increased odds of arthritis, indicating that potentially more clinically severe 
symptoms and behaviors of this disorder might be relevant to risk for arthritis. 
Other studies have shown that risk-taking behaviors that are associated with 
antisocial PD, including violent behaviors, substance misuse and dependence, 
and hazardous drinking, are more common among antisocial men than 
antisocial women (Coid et al., 2006; Yang & Coid, 2007), which might in part, 
explain our findings. The potential cumulative burden associated with 
comorbid antisocial PD and chronic disease is large for both the individual and 
society, and thus warrants further research attention. Moreover, the elevated 
prevalence of arthritis in women (Theis, Helmick, & Hootman, 2007) 
highlights that further research is needed examining the associated health risks 
among women with antisocial PD to improve outcomes for a group of 
individuals already facing a disproportionate burden of disease. 
Finally, adverse childhood experiences including childhood maltreatment have 
been shown be associated with greater likelihood of PD (Afifi et al., 2011; 
Waxman et al., 2014), and also increased risk of diverse physical health 
conditions, including arthritis and markers for CVD in adulthood (Afifi et al., 
2011; Su et al., 2014). It is possible that there might be a developmental period 
during which children and adolescents are particularly susceptible to the effects 
of environmental and lifestyle risk factors, which subsequently disrupt 
personality development and exacerbate chronic psychiatric and physical 
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symptoms. There are opportunities for future studies to investigate the role of 
adverse childhood experiences and childhood maltreatment as potential 
moderating factors in the relationship between PD and adverse physical health 
conditions. 
Methodological considerations
Several plausible themes emerged to explain the apparent inconsistencies in 
findings between the studies. While it is acknowledged that all of the reviewed 
studies were rated as achieving robust methodological quality scores, high 
levels of heterogeneity existed. Firstly, there was considerable heterogeneity 
among the assessment of PD and the groupings of self-reported physical health 
conditions. For example, the only cohort study identified for this review (Lee et 
al., 2010) utilized structured interviews conducted by trained psychiatrists, 
which required a high level of skill to administer, and thus increased the 
reliability and validity of the diagnoses. Alternatively, for the studies that 
utilized data from separate Waves of the NESARC (El-Gabalawy et al., 2010; 
Goldstein et al., 2008), PD was assessed by lay-interviewers, which has been 
suggested to produce low diagnostic thresholds for diagnoses (Trull et al., 
2010). Lengthy clinical interviews would be impractical in study designs that 
use large population samples, such as NESARC. However, alternative 
algorithms for generating diagnose have now been proposed (Trull et al., 
2010). It also remains possible that the variations in training and different 
levels of thresholds for obtaining diagnoses between the instruments might 
contribute to inconsistencies in study findings, or have introduced biases. 
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Furthermore, diagnostic thresholds might attenuate or inflate the prevalence of 
PDs and confound true associations with physical comorbidities. Despite 
attempts to introduce dimensional scoring for PD into the DSM-5, the 
categorical diagnostic versus dimensional/trait approach to the assessment of 
PD remains complex and lacks consensus (Newton-Howes et al., 2015). As 
such, there were inconsistencies in the approach to measuring PD across the 
reviewed studies, which precluded statistical pooling and/or undertaking a 
meta-analyses. 
Considerable heterogeneity also existed in the groupings of the physical health 
outcomes in regard to CVDs. In particular, the studies that examined the 
relationship between PD and stroke, as distinct from being grouped with other 
forms of CVD, reported no association (El-Gabalawy et al., 2010; Powers &
Oltmanns., 2013). This suggests that associations might have been diluted 
when stroke was grouped with other forms of CVD in other studies. Moreover, 
all studies relied on the use of self-report of a physical health condition being 
diagnosed by a health care professional. This method of assessing physical 
health conditions is widely used and practical for large-scale epidemiological 
surveys, and has demonstrated reasonably good concordance with medical 
records (Baumeister et al., 2010). However, there remains the potential for bias 
inherent in the use of self-reported data, including under- or over-reporting of 
physical health conditions according to mental health status. The addition of 
studies utilizing clinical indicators or data linkage with medical records to 
ascertain incident physical health conditions might overcome some of the 
methodological shortcomings identified within the existing evidence base. 
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There are also opportunities for future studies to incorporate the use of 
anthropometry measures to increase diagnostic validity. To date, there are 
limited population-based studies describing the health characteristics of those 
with PD. 
 
Overall, studies were comparable in regard to the country investigated (the 
US), all included a similar proportion of sexes, and three studies utilized 
probability samples (El-Gabalawy et al., 2010l Goldsetin et al., 2008; Lee et 
al., 2010) thus increasing the generalizability of the findings (for the US 
population only). All studies applied the adjustment for sex in statistical 
models, and one study reported findings for the relationship between PD and 
physical health conditions stratified by sex (Goldstein et al., 2008). 
 
Other methodological considerations include variation in statistical methods, 
such as regression modelling and use of covariates to investigate associations 
between PDs and physical health comorbidities, which might help explain the 
inconsistencies observed. It is plausible that co-occurring episodes of other 
mental disorders might act as confounders or moderators in the observed in 
relationship, which might be the case in studies that did not adjust for lifetime 
or current mental disorders (Lee et al., 2010). In particular, one study (Powers 
& Oltmanns, 2013) reported that associations were no longer significant 
between borderline PD (as rated by the interviewer) and heart disease in the 
final model after applying adjustments for lifetime history of MDD, alcohol 
dependence, drug dependence and any PD other than borderline (in addition to 
pertinent socio-demographic variables). However, in the other study examining 
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borderline PD (El-Gabalawy et al., 2010), associations were sustained after 
applying adjustment for lifetime history of anxiety, mood, and substance use 
disorder and PDs other than borderline. The findings of the separate studies 
might also be explained by differences between dimensional features of 
borderline PD, as examined in the former study, and categorical borderline PD 
in the latter, whereby a greater number of borderline features might have 
further increased the risk for physical health conditions. However, even 1 
criterion of borderline PD has been shown to be associated with a greater 
number of other mental state disorders, suicidal behaviors, hospitalizations and 
reduced functional capacities (Zimmerman et al., 2012). It is clear that further 
studies are warranted that examine dimensionally rated borderline PD and its 
relationship with risk factors and the development of physical health 
conditions. 
While all studies could be considered to have adjusted for proxy variables in 
statistical models, including use of medication use such as antidepressants 
(adjusted for mood and anxiety disorders) and alcohol and tobacco 
consumption (alcohol and non-alcohol substance use disorders), only one study 
adjusted for daily smoking (Lee et al., 2010), which is a shared risk factor for a 
number of physical health conditions. However there are additional unhealthy 
behaviors that might be important considerations for future studies including 
physical inactivity and poor diet, which might play a role in increasing blood 
pressure, blood glucose, blood lipids, weight, thus predisposing development 
for CVD and arthritis. 
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Separate analyses included in the review were all adjusted for the pertinent 
demographic variables of age and sex. Moreover, all studies adjusted for 
indicators of socioeconomic status, including levels of education, income status 
and/or other indicators of social disadvantage, which is particularly important 
given the disruptions to education, employment and housing that individuals 
with PD often encounter (Fazel et al., 2008; Sareen et al., 2011). 
It was beyond the scope of this review to examine the reverse associations 
between physical health conditions and an increased risk for PDs. However, 
given that the majority of studies reviewed were cross-sectional in design, we 
cannot rule out that possibility. Indeed, it could be possible that the reverse 
association exists between physical health conditions and the development of 
PD via their effects upon personality development. For instance, one study 
(McWilliams et al., 2008) has suggested that the association between arthritis 
and PD might be explained by the pain associated with arthritis, which in turn 
might precipitate the onset of personality pathology. Moreover, it is possible 
that personality pathology might have a bi-directional role in the etiology and 
expression of physical health conditions. As with mental state disorders, the 
stress associated with adverse physical health might lead to personality 
pathology. However, there is now robust evidence demonstrating that most 
personality pathology emerges in adolescence and/or early adulthood and that 
PD can be reliably diagnosed in adolescents (Chanen & McCutcheon, 2013; 
Newton-Howes et al., 2015). Thus, personality usually has its onset prior to the 
onset of many chronic physical health conditions. 
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It must be noted that the sparse coverage of PDs that were assessed, within and 
across the reviewed studies, reduced our ability to draw further comparisons. 
Borderline PD was the most commonly examined but there were no studies 
that assessed the full range of categorical PDs. Such studies would enable 
investigations as to whether individual PDs have a specific relationships to 
physical health conditions, or whether the relationship might be explained by 
PD as a unitary disorder. Finally, while grey literature and dissertations might 
provide a wider source of evidence, it was beyond the scope to systematically 
analyze data deriving from these sources. Finally, while the search strategy was 
comprehensive and reproducible, we cannot rule out that new evidence might 
not be included in this review. 
 
A strength of this review is the first synthesis of the current epidemiological 
evidence regarding associations between PD and physical health comorbidities. 
However, in order to understand these associations globally, it is necessary that 
longitudinal studies are conducted among populations other than the US. Our 
review highlights the need for continued research in this emerging and 
potentially clinically important field of research. High quality cohort studies 
are urgently needed that include clinical diagnoses of physical health 
conditions. Alternatively, studies that employ large-scale data-linkage might 
enhance the current evidence-base and further our understanding of the 
relationships between PDs and physical health comorbidities. 
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Conclusions 
Greater recognition of PD and the increased risks for adverse physical health 
outcomes will be important for optimizing overall patient health care in regard 
to health screening, engagement in and adherence to treatment regimens, and 
monitoring and modifying health behaviors such as physical activity, smoking, 
alcohol consumption and dietary intake. In summary, this systematic review 
provided a critical synthesis of the emerging evidence-base regarding the 
associations between PD and physical health conditions. Further studies are 
required to understand potential causal pathways. 
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Abstract
Purpose There is a paucity of research examining the
relationship between personality disorders (PDs) and
chronic physical comorbidities. Consequently, we investi-
gated associations between individual PDs and PD Clus-
ters, and various common disease groups [cardiovascular
disease (CVD), diabetes, arthritis and gastrointestinal dis-
ease (GI)] in a nationally representative survey of adults
from the United States.
Methods This study utilized pooled data (n = 34,653;
C20 years) from Waves 1 and 2 of the National Epide-
miologic Survey on Alcohol and Related Conditions. PDs
were assessed using the Alcohol Use Disorder and Asso-
ciated Disabilities Interview Schedule- Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition.
Physical conditions were based on self-reports of being
diagnosed by a health professional. Unadjusted and
adjusted logistic regressions examined the relationship
between PDs and physical conditions.
Results After adjustment (sociodemographic factors,
past-year mood, anxiety and substance use disorders),
Clusters A, B and C PDs were each associated with
physical conditions (all p B 0.01). Of the individual PDs,
schizoid, schizotypal, narcissistic, borderline and obses-
sive–compulsive PDs were associated with CVD (all
p B 0.01) among younger adults. Paranoid, antisocial,
borderline and avoidant PDs and younger adults with
schizoid, schizotypal and obsessive–compulsive PDs were
each associated with arthritis (all p B 0.01). Signiﬁcant
associations were seen between paranoid, schizoid and
schizotypal PDs and diabetes (all p B 0.01). Finally,
schizotypal, antisocial, borderline and narcissistic PDs
were associated with GI conditions (all p B 0.01).
Conclusions PDs were consistently associated with
physical conditions. Investigation of PDs and their rela-
tionship with physical health outcomes warrant further
research attention as these ﬁndings have important clinical
implications.
Keywords Personality disorders  Comorbidity  Physical
conditions  NESARC
Introduction
Personality disorder (PD) is characterized by marked and
relatively enduring impairments in self-organization and
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interpersonal relating that deviate from cultural norms
[1]. The DSM-5 has continued the DSM-IV deﬁnition of
PD as a group of 10 disorders that are organized into
three Clusters, based on similar features among these
disorders. Cluster A encompasses odd or eccentric fea-
tures; Cluster B encompasses dramatic, emotional, and
impulsive features; and Cluster C encompasses anxious
and fearful features [1]. The prevalence of these PDs in
the community is estimated to be between 4.4 and
13.4 % [2–5]. PD is increasingly recognized as having
signiﬁcant public health implications in its own right and
due to high rates of co-occurrence with and effects upon
other psychiatric disorders and high levels of functional
impairment and physical disability [6, 7]. Furthermore,
PD has been linked with adverse consequences in other
public health domains, such as education and employ-
ment [8] and crime [9]. However, little is known about
the effects of PD on physical health.
Both psychiatric disorders and many common and
chronic diseases including cardiovascular diseases (CVD),
diabetes, gastrointestinal (GI) diseases and musculoskeletal
disorders are national health priorities in many countries,
due to their signiﬁcant health and economic burden. An
increasing body of population-based research has demon-
strated that there is an important and complex link between
psychiatric disorders and physical conditions. For example,
mood and psychotic disorders in particular, and to a lesser
extent anxiety and substance use disorders have been
associated with an increased risk of physical conditions,
which are hypothesized to be mediated by a host of bio-
logical, psychological and social factors [10–15]. Pre-
liminary research also suggests that PD is associated with
physical conditions [16–20]. For example, data from a
national household survey of Great Britain found adoles-
cents and adults (16–74 years) who screened positive for
PD were more likely to report having ischemic heart dis-
ease or stroke [16]. Due to the brief measures used to
screen for PD, the ﬁndings from that study were discussed
in the context of those ‘‘at risk’’ only; it is imperative that
studies utilize structured, validated measures of PD, in
order to overcome prior methodological limitations.
Moreover, longitudinal data (23-year follow-up) from
adults in the United States Baltimore Epidemiological
Catchment Area study revealed that DSM-III Cluster B PD
was associated with incident self-reported CVD [20] and
CVD related mortality. It was reported that methodological
shortcomings precluded further analyses examining asso-
ciations between Clusters A and C PD with CVD, which
led the authors to call for large-scale epidemiological
studies with sufﬁcient statistical power to undertake these
analyses [20]. These investigations might be particularly
important given that Cluster A PDs and features [21, 22],
and Cluster C [21] have been shown to be associated with
higher prevalence of cigarette smoking (a robust risk factor
for CVD and type 2 diabetes).
Others have shown individual PDs (chieﬂy from Cluster
B) to be associated with increased risk for CVD, hepatic
diseases, GI diseases, venereal disease, and overall medical
burden [17, 19]. However, there are inconsistencies among
study ﬁndings as to whether PD presents unique risk for
physical comorbidities independent of the effects of other
co-occurring mental disorder including depression [19, 20,
23] which has been shown to be associated with the
development of CVD [24]. Furthermore, it is unknown
whether each DSM-IV PD is associated with increased risk
of a variety of commonly occurring physical conditions
independent of other mental disorders.
It is also plausible that inconsistencies in the literature
might be explained by age; with sample characteristics of
prior studies varying considerably in age ranges such as
16–74 years [16], C18 years [17, 25], and 55–65 years in
another [23]. However, prior studies have not further
extrapolated the relationship between PDs and physical
comorbidities by investigating these associations in
younger and older age strata.
Therefore, the aim of this study was to examine whether
each of the DSM-IV PDs and each of the Cluster A, B, and
C PD groups is associated with CVD, arthritis, diabetes and
GI disease, utilizing data from a nationally representative
sample of US adults enrolled in the National Epidemiol-
ogic Survey on Alcohol and Related Conditions (NES-
ARC). Furthermore, while prior studies have reported
promising preliminary data, we sought to extend their
ﬁndings to determine whether both age and/or gender may
be an effect modiﬁer in the relationship between PDs and
physical comorbidities. Such analyses might provide a
context for identifying whether the risk for physical health
conditions is age and/or gender dependent, and whether PD
might present a unique risk above the known risks of other
psychiatric disorders in the expression of physical health
conditions not only in older adult populations but also
much earlier in the lifespan. The current study aims to
address a current gap in the evidence-base by undertaking a
structured and validated examination of all current PDs,
along with high prevalence physical comorbidities utilizing
a representative, US population-based cohort.
Materials and methods
Sample and procedures
We analyzed data from waves 1 (2001–2002) and 2
(2004–2005) of the NESARC, a nationally representative
sample of community-dwelling American adults
(C20 years) residing in the US including the Districts of
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Columbia, Alaska, and Hawaii. A total of 34,653 partici-
pants responded to both waves, which resulted in a
response rate of 86.7 % for wave 2 (i.e., 86.7 % of eligible
participants from wave 1 responded at wave 2). The
cumulative response rate was 70.2 %, which equals the
product of the wave 1 (81.0 %) and wave 2 (86.7 %)
response rates.
The sample excludes adults who were deceased, depor-
ted, institutionalized or on active military duty on follow-
up. Trained lay interviewers from the US Census Bureau
with at least 5 years of experience conducted face-to-face
interviews and written informed consent was obtained from
all participants. The US Census Bureau and the US Ofﬁce of
Management and Budget reviewed the research protocol
and provided full ethical approval. A more detailed
description of methodology and sampling procedures of the
NESARC can be found elsewhere [26, 27].
Psychiatric disorders
DSM-IV axis I and II disorders were assessed using the
Alcohol Use Disorders and Associated Disabilities Inter-
view Schedule IV (AUDADIS-IV), a reliable and valid
instrument designed for administration to the general
population by lay interviewers [28].
The primary variables of interest were lifetime DSM-IV
PDs. During wave 1, seven PDs were assessed (avoidant,
dependent, obsessive–compulsive, paranoid, schizoid, his-
trionic and antisocial PDs), and the other three were assessed
in wave 2 (borderline, schizotypal, and narcissistic PDs).
Past-year diagnoses of any mood disorder (i.e., major
depression, dysthymia, and mania or hypomania), any anx-
iety disorder (i.e., panic disorder with and without agora-
phobia, social phobia, speciﬁc phobia, generalized anxiety
disorder, and posttraumatic stress disorder), and any sub-
stance use disorder (i.e., alcohol abuse and dependence,
nicotine dependence, and drug abuse and dependence) were
also assessed at wave 2. [29]. Derived from US population-
based samples, test–retest reliability coefﬁcients for diag-
noses of the individual PDs assessed in wave 1 were in the
fair to good range (k = 0.40–0.67); and slightly higher
(k = 0.67–0.71) for those assessed inwave 2 [29]. Similarly,
test–retest reliability coefﬁcients for other lifetime and past-
yearDSM-IVmental disorderswere in the fair to good range:
substance use (k = 0.60–0.74), mood (k = 0.58–0.65), and
anxiety disorders (k = 0.40–0.52) [28]. In addition, there is
some support for the classiﬁcation of PDs into Clusters A, B,
and C using the AUDADIS-IV [30].
Physical conditions
Past-year prevalence of physical conditions was assessed at
wave 2 and included CVDs (chest pain or angina pectoris,
rapid heartbeat or tachycardia, a heart attack or myocardial
infarction (MI), stroke, hypertension, arteriosclerosis, or
any other form of heart disease), diabetes, arthritis and GI
diseases (stomach ulcer or gastritis). The survey assessed
physical conditions by ﬁrst having respondents indicate if
they had one of the physical conditions in the past year. If
they endorsed having the physical condition, they were
subsequently asked if a physician or other health profes-
sional made the diagnosis. In this study, the latter (more
stringent criterion) was used. These measures of physical
conditions have been used in several previous studies [17,
19, 31], and self-reported data have been shown to have
acceptable concordance with medical records of diagnosed
physical conditions [32]. Details of data collection
regarding the independent and dependent variables of
interest are published in greater detail elsewhere [19].
Socio-demographics
In the present study, we examined the following wave 2
socio-demographic variables as covariates: age, sex, race/
ethnicity, education, household income, and marital status.
In part, aging populations have inﬂuenced epidemiological
patterns of increasing non-communicable diseases world-
wide [33]. Age has also been shown to have moderating
effects upon the relationship between psychiatric and
physical comorbidities [34]. Therefore, we also examined
age as an interaction term in our analyses. For the covar-
iates, we assessed age as a continuous variable and cate-
gorized sex, race/ethnicity (White, Black, American
Indian/Alaska Native, Asian/Native Hawaiian/Other Paci-
ﬁc Islander, and Hispanic, other), educational attainment
(less than high school, high school, some college or
higher), household income in $US (0–$19,999, $20,000–
$34,999, $35,000–$59,999, and $60,000?), and marital
status (married or living with someone as if married,
widowed/separated/divorced, never married). To examine
interactions between age, PDs and comorbidities, we
applied the dichotomized categories of\55 and C55 years
of age, to maintain consistency with prior research exam-
ining other mental disorders and outcomes related to
physical health and service utilization [25, 35–37]. Fur-
thermore, some studies have suggested that epidemiologi-
cal transitions such as earlier-and later-age to retirement,
reduce the relevancy of a traditional cut-point of 65 years
[36–38].
Statistics
We calculated cross tabulations, which provided weighted
prevalence rates for the primary variables of interest across
each of the assessed physical conditions. PDs were also
categorized into Cluster A (paranoid, schizoid, and
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schizotypal), Cluster B (antisocial, borderline, histrionic,
and narcissistic), Cluster C (avoidant, dependent, and
obsessive–compulsive), and any PD.
Bivariate logistic regressions ﬁrst examined the rela-
tionship between any PD, PD Clusters, and each speciﬁc
PD with past-year physical conditions. Multivariate logistic
regression further examined the relationship between life-
time PDs and physical conditions in a model adjusting for
the socio-demographic variables and any past-year mood,
anxiety, and substance use disorder. We performed inter-
actions with the dichotomous age variable (\55, C55 years
old) in the unadjusted model. For those interactions that
were signiﬁcant, data were stratiﬁed and the results are
displayed accordingly in both unadjusted and adjusted
models (Tables 2, 3, 4, 5).
To control for type I error and multiple comparisons, a
more conservative p value is reported (p B 0.001 or
p B 0.01) with associated 99 % conﬁdence intervals (99 %
CI). These data were analyzed using SUDAAN 10.0.1 [39],
which employs the Taylor series linearization method [40]
for variance estimation to account for the complex sam-
pling design of the NESARC. Appropriate weighting to
these data were applied to ensure representativeness of the
US population, which adjusted for socio-demographic
variables and response/nonresponse based on the 2,000 US
Census [41].
Results
Table 1 presents the characteristics of the study population,
stratiﬁed by the physical conditions (CVD, arthritis, dia-
betes and GI disease) and age (\55 and C55 years).
Cardiovascular disease
Of those with a PD, 29.1 % had comorbid CVD. When
stratiﬁed by Clusters, 32.1 % with a Cluster A PD had
CVD, 29.0 % of those with a Cluster B PD and 30.6 %
with a Cluster C PD.
In the bivariate analyses (Table 2), we observed sig-
niﬁcant and positive associations between younger adults
(\55 years) with PDs from Clusters A, B and C, and
CVDs. There were also signiﬁcant and positive associa-
tions for the individual PDs: schizoid, schizotypal and
CVD, and a signiﬁcant negative association for antisocial
and CVD. Among older adults (\55 years), signiﬁcant and
positive associations were observed for borderline, depen-
dent, and obsessive–compulsive PDs, and CVD.
In the adjusted model (Table 2), among younger adults,
Cluster A PDs showed the strongest positive association
with CVD (AOR 1.36, 99 % CI 1.14–1.63), followed by
Cluster B PDs (AOR 1.27, 99 % CI 1.07–1.50), and then C
(AOR 1.23, 99 % CI 1.03–1.46). Of the individual PDs,
signiﬁcantly greater odds for CVD were observed for
comorbid schizoid (AOR 1.50, 99 % CI 1.20–1.89),
schizotypal (AOR 1.64, 99 % CI 1.34–2.02), and narcis-
sistic PDs (AOR 1.20, 99 % CI 1.01–1.42). Signiﬁcant and
positive associations with CVD were also observed in the
younger age group for borderline (AOR 1.47, 99 % CI
1.17–1.85) and obsessive–compulsive PDs (AOR 1.25,
99 % CI 1.04–1.50). The association between antisocial
PD and CVDs was not sustained after adjustment
(Table 3).
Arthritis
Of those individuals with any PD, a Cluster A, B or C PD,
22.8, 24.7, 22.1 and 25 % had comorbid arthritis, respec-
tively. Signiﬁcant and positive associations were observed
between Cluster A and C PDs and arthritis among younger
adults, and both Cluster A and C PDs among older adults
(Table 3). Of the individual PDs, borderline, and avoidant
were each signiﬁcantly and positively associated with
arthritis. Signiﬁcant and positive associations were also
seen with arthritis among younger adults for obsessive–
compulsive and schizoid, and for both age groups for
schizotypal.
In the adjusted model (Table 3), younger adults with
Cluster A PDs showed the strongest positive association
with comorbid arthritis (AOR 1.38, 99 % CI 1.11–1.75),
followed by those of any age with PDs in Cluster B (AOR
1.38, 99 % CI 1.18–1.60), and C among younger adults
(AOR 1.35, 99 % CI 1.08–1.69). Of the individual PDs,
there was an increased odds of arthritis for those meeting
criteria for paranoid (AOR 1.28, 99 % CI 1.02–1.61),
antisocial (AOR 1.61, 99 % CI 1.24–2.07), borderline
(AOR 1.59, 99 % CI 1.27–1.98) and avoidant PDs (AOR
1.47, 99 % CI 1.11–1.96). There were also signiﬁcantly
increased odds for arthritis among younger adults with
schizoid (AOR 1.62, 99 % CI 1.16–2.26), schizotypal
(AOR 1.58, 99 % CI 1.18–2.13) and obsessive–compulsive
PDs (AOR 1.41, 99 % CI 1.12–1.79).
Diabetes
Of those individuals with any PD, 8.5 % had comorbid
diabetes. 10.2 % with Cluster A had diabetes, 8.1 % of
those with Cluster B and 8.5 % with Cluster C PDs.
In bivariate analyses (Table 2), only Cluster A PDs and
schizotypal were signiﬁcantly associated with diabetes.
In multivariate analyses, the only PD Cluster to show a
signiﬁcant association with diabetes was Cluster A (AOR
1.50, 99 % CI 1.21–1.88) (Table 4). We also observed
signiﬁcant associations with diabetes in those of all ages
from paranoid (AOR 1.46, 99 % CI 1.08–1.98, schizoid
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(AOR 1.44, 99 % CI 1.02–2.03) and schizotypal PDs
(AOR 1.51, 99 % CI 1.12–2.04) (Table 4).
Gastrointestinal disease
Of individuals with any PD, the overall proportion with
comorbid GI diseases was 8.8 %. We observed 10.5 % of
individuals with Cluster A, 9.7 % of those with Cluster B
and 8.9 % from Cluster C to have GI diseases.
In the bivariate analyses (Table 5), there were signiﬁ-
cant and positive associations between GI diseases and
Cluster A, B and C PDs. With the exception of histrionic
PD, there were also signiﬁcant and positive associations
between all PDs and GI diseases.
After adjustment, there was an increased risk of GI
disease for those with a Cluster A (AOR 1.41, 99 % CI
1.16–1.72) and Cluster B PD (AOR 1.48, 99 % CI
1.20–1.81) (Table 5). Of the individual PDs, paranoid
Table 1 Socio-demographic characteristics of the study population (n = 34,653), lifetime prevalence of DSM-IV axis I and physical conditions,
presented as frequencies and percentages
Total
n (%)
(n = 34,653)
Cardiovascular
disease
n (%)
(n = 10,687)
Arthritis
n (%)
(n = 7,826)
Diabetes
n (%)
(n = 3,201)
Gastrointestinal
disease
n (%)
(n = 2,408)
Gender
Women 20,089 (52.1) 6,485 (30.8) 5,332 (26.0) 1,880 (8.4) 1,630 (7.7)
Men 14,564 (47.9) 4,202 (27.3) 2,494 (17.1) 1,321 (8.0) 778 (5.1)
Age
\55 years 22,341 (66.1) 3,805 (16.2) 2,391 (10.8) 989 (3.9) 1,153 (5.0)
C55 years 12,312 (34.0) 6,882 (54.4) 5,435 (43.1) 2,212 (16.4) 1,255 (9.3)
Race/ethnicity
White, non-hispanic 20,161 (70.9) 6,296 (30.4) 5,016 (23.9) 1,577 (7.6) 1,324 (6.4)
Black, non-hispanic 6,587 (11.1) 2,617 (34.3) 1,661 (21.2) 880 (11.5) 467 (6.1)
American Indian/Alaska Native, non-hispanic 578 (2.2) 179 (32.8) 149 (26.6) 76 (12.3) 52 (9.9)
Asian/Native/Hawaiian/Paciﬁc Islander, non-
hispanic
968 (4.3) 185 (21.2) 114 (11.4) 51 (5.9) 40 (4.3)
Hispanic/other 6,359 (11.6) 1,410 (18.9) 886 (11.8) 617 (8.5) 525 (7.3)
Education
Less than high school 5,514 (14.0) 2,273 (38.3) 1,838 (31.8) 848 (13.6) 593 (9.8)
High school or equivalent 9,452 (27.5) 3,265 (33.1) 2,467 (25.8) 1,000 (9.9) 706 (7.2)
Some college or more 19,687 (58.5) 5,149 (25.1) 3,521 (17.4) 1,353 (6.1) 1,109 (5.3)
Marital status
Married/living together as if married 18,866 (63.8) 5,343 (28.9) 3,757 (21.0) 1,570 (7.9) 1,218 (6.2)
Widowed/separated/divorced 9,149 (18.9) 4,139 (43.6) 3,300 (35.5) 1,265 (12.7) 873 (9.3)
Never married 6,638 (17.4) 1,205 (14.6) 769 (9.5) 366 (4.4) 317 (4.0)
Annual household income ($US)
B$19,999 8,031 (18.6) 3,498 (40.2) 2,836 (32.6) 1,174 (13.2) 891 (9.9)
$20,000–$34,999 6,882 (18.5) 2,259 (32.6) 1,705 (26.2) 700 (9.4) 518 (7.6)
$35,000–$59,999 8,444 (25.2) 2,361 (28.4) 1,594 (19.6) 714 (8.2) 468 (5.5)
C$60,000 11,296 (37.8) 2,569 (22.6) 1,691 (15.6) 613 (5.1) 531 (4.8)
Psychiatric disorders
Past-year mood disorder 3,795 (10.4) 1,317 (32.8) 1,050 (27.1) 383 (8.7) 489 (12.1)
Past-year anxiety disorder 5,524 (15.1) 2,008 (34.3) 1,607 (27.9) 596 (9.4) 677 (11.3)
Past-year substance disorder 6,905 (21.2) 1,803 (24.2) 1,378 (19.1) 479 (5.7) 562 (7.8)
n = presented are raw. Percentages are weighted and indicate the proportion of those with the particular variable or variable level (e.g., gender)
that have the physical condition (column) stratiﬁed by age:\55 and C55 years. Past-year mood disorder = major depression, dysthymia, mania,
hypomania; past-year anxiety disorder = panic disorder with and without agoraphobia, social phobia, speciﬁc phobia, generalised anxiety
disorder, posttraumatic stress disorder; past-year substance disorder = alcohol abuse and dependence, nicotine dependence, drug abuse and
dependence
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Table 2 Prevalence, odds ratios (OR) and 99 % conﬁdence intervals (99 % CI) of personality disorders predicting co-occurring cardiovascular
disease (CVD)
Personality disorder Total n (%) PD yes n = (%) PD no n = (%) Cardiovascular disease
CVD yes CVD yes Bivariate OR (99 % CI) Model 1: AOR (99 % CI)
Any personality disorder
All 7,783 (21.5) 24,012 (9.1) 8,286 (29.2) – –
\55 years – – – 1.55 (1.37–1.75)** 1.25 (1.09–1.43)**
C55 years – – – 1.10 (0.93–1.30) 1.03 (0.86–1.23)
Any Cluster A personality disorder
All 3,449 (9.0) 1,154 (32.0) 9,553 (28.9) – –
\55 years – – – 1.80 (1.53–2.11)** 1.36 (1.14–1.63)**
C55 years – – – 1.33 (1.03–1.72)* 1.14 (0.87–1.49)
Paranoid
All 1,689 (4.3) 513 (28.2) 10,174 (29.1) 0.96 (0.78–1.17) 1.17 (0.93–1.47)
Schizoid
All 1,144 (3.1) 399 (35.4) 10,288 (28.9) 1.35 (1.10–1.66)** 1.50 (1.20–1.89)**
Schizotypal
All 1,534 (3.9) 575 (37.5) 10,112 (28.8) 1.48 (1.26–1.75)** 1.64 (1.34–2.02)**
Any Cluster B personality disorder
All 4,843 (13.3) 1,494 (29.0) 9,189 (29.1) – –
\55 years – – – 1.62 (1.40–1.88)** 1.27 (1.07–1.50)**
C55 years – – – 1.12 (0.91–1.38) 1.03 (0.83–1.28)
Antisocial
All 1,226 (3.8) 303 (24.6) 10,384 (29.3) 0.79 (0.63–0.98)* 1.25 (0.97–1.62)
Borderline
All 2,231 (5.9) 744 (34.0) 9,913 (28.8) – –
\55 years – – – 2.16 (1.81–2.58)** 1.47 (1.17–1.85)**
C55 years – – – 1.29 (0.94–1.76) 1.05 (0.75–1.47)
Histrionic
All 651 (1.8) 181 (25.9) 10,506 (29.2) 0.85 (0.63–1.14) 1.31 (0.96–1.79)
Narcissistic
All 2,449 (6.2) 781 (29.5) 9,906 (29.1) 1.02 (0.86–1.20) 1.20 (1.01–1.42)*
Any Cluster C personality disorder
All 3,244 (9.4) 1,040 (30.6) 9,647 (30.0) – –
\55 years – – – 1.49 (1.26–1.75)** 1.23 (1.03–1.46)*
C55 years – – – 1.06 (0.84–1.33) 1.02 (0.80–1.29)
Avoidant
All 821 (2.3) 262 (29.1) 10,425 (29.1) 1.00 (0.78–1.28) 1.19 (0.89–1.59)
Dependent
All 147 (0.4) 50 (30.3) 10,637 (29.1) – 1.35 (0.63–2.89)
\55 years – – – 2.34 (1.0–5.22)** –
C55 years – – – 0.60 (0.21–1.76) –
Obsessive–compulsive
All 2,753 (8.1) 889 (31.2) 9,798 (29.0) – –
\55 years – – – 1.76 (1.41–2.20)** 1.25 (1.04–1.50)*
C55 years – – – 1.14 (0.89–1.46) 1.06 (0.84–1.36)
Total n = presented are raw, prevalence (%) for personality disorders and for CVD ‘‘yes’’ among those with and without the speciﬁc personality
disorder (column) are weighted. Signiﬁcant age interactions are stratiﬁed:\55 and C55 years. * p B 0.01, ** p B 0.001. Model 1 AOR: adjusted
for sex, race/ethnicity, marital status, education, income, age (continuous), past-year mood, anxiety and substance use disorders
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(AOR 1.31, 99 % CI 1.00–1.73), schizoid (AOR 1.37,
99 % CI 0.99–1.91), schizotypal (AOR 1.64, 99 % CI
1.24–2.15), antisocial (AOR 1.63, 99 % CI 1.14–2.33),
borderline (AOR 1.38, 99 % CI 1.06–1.81) and narcissistic
PDs (AOR 1.34, 99 % CI 1.04–1.72) each were associated
with an increased odds of GI disease. No further signiﬁcant
Table 3 Prevalence, odds ratios (OR) and 99 % conﬁdence intervals (99 % CI) of personality disorders predicting co-occurring arthritis
Personality disorder Total n (%) PD yes n = (%) PD no n = (%) Arthritis
Arthritis yes Arthritis yes Bivariate OR (99 % CI) Model 1: AOR (99 % CI)
Any personality disorder
All 7,783 (21.5) 616 (27.2) 7,210 (21.4) – –
\55 years – – – 1.75 (1.50–2.05)** 1.36 (1.13–1.64)**
C55 years – – – 1.27 (1.08–1.49)** 1.22 (1.03–1.43)*
Any Cluster A personality disorder
All 3,449 (9.0) 875 (24.7) 6,951 (21.4) – –
\55 years – – – 1.98 (1.62–2.42)** 1.39 (1.11–1.75)**
C55 years – – – 1.36 (1.05–1.76)* 1.15 (0.89–1.48)
Paranoid
All 1,689 (4.3) 22.9 % 21.7 % 1.08 (0.89–1.30) 1.28 (1.02–1.61)*
Schizoid
All 1,144 (3.1) 297 (27.5) 7,529 (21.6) – –
\55 years – – – 2.22 (1.60–3.06)** 1.62 (1.16–2.26)**
C55 years – – – 1.29 (0.91–1.82) 1.18 (0.83–1.68)
Schizotypal
All 1,534 (3.9) 446 (28.0) 7,380 (21.5) – –
\55 years – – – 2.42 (1.87–3.13)** 1.58 (1.18–2.13)**
C55 years – – – 1.47 (0.99–2.16)* 1.16 (0.78–1.72)
Any Cluster B personality disorder
All 4,843 (13.3) 1,112 (22.1) 6,714 (21.7) 1.03 (0.91–1.15) 1.38 (1.18–1.60)**
Antisocial
All 1,226 (3.8) 235 (20.3) 7,591 (21.8 %) 0.92 (0.73–1.15) 1.61 (1.24–2.07)**
Borderline
All 2,231 (5.9) 616 (27.7) 7,210 (21.4) 1.41 (1.21–1.65)** 1.59 (1.27–1.98)**
Histrionic
All 651 (1.8) 134 (18.5) 7,692 (21.8) 1.82 (0.58–1.14) 1.17 (0.81–1.70)
Narcissistic
All 2,449 (6.2) 559 (21.0) 7,267 (21.8) 0.96 (0.81–1.12) 1.19 (0.98–1.44)
Any Cluster C personality disorder
All 3,244 (9.4) 824 (22.8) 7,002 (21.4) 1.75 (1.43–2.16)** 1.35 (1.08–1.69)**
\55 years – – – 1.26 (1.00–1.60)* 1.20 (0.93–1.54)
C55 years – – – 1.08 (0.89–1.30) 1.28 (1.02–1.61)*
Avoidant
All 821 (2.3) 231 (26.5) 7,595 (21.6) 1.31 (1.01–1.70)* 1.47 (1.11–1.96)**
Dependent
All 147 (0.4) 44 (30.0) 7,782 (21.8) 1.48 (0.78–2.79) 1.39 (0.68–2.85)
Obsessive–compulsive
All 2,753 (8.1) 685 (24.8) 7,141 (21.5) – –
\55 years – – – 1.76 (1.41–2.20)** 1.41 (1.12–1.79)**
C55 years – – – 1.14 (0.89–1.46) 1.11 (0.85–1.45)
Total n = presented are raw, prevalence (%) for personality disorders and for arthritis ‘‘yes’’ among those with and without the speciﬁc
personality disorder (column) are weighted. Signiﬁcant age interactions are stratiﬁed:\55 and C55 years. * p B 0.01, ** p B 0.001. Model 1
AOR: adjusted for sex, race/ethnicity, marital status, education, income, age (continuous), past-year mood, anxiety and substance use disorders
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associations were seen for avoidant, dependent and
obsessive–compulsive PDs.
Discussion
This study investigated the associations between the full
range of DSM-IV PDs and PD Clusters and common,
chronic physical comorbidities among a large representa-
tive sample of US adults. The associations reported were
independent of other frequently co-occurring DSM-IV axis
I disorders and socio-demographic factors, indicating a
potential role for PDs as a risk factor of poorer physical
health. The major ﬁndings to emerge from the study
include signiﬁcant associations between individual PDs
from Cluster A and diabetes and GI diseases, respectively.
In addition, we observed a relationship between several
individual PDs (schizoid, schizotypal, borderline,
obsessive–compulsive) and CVD and/or arthritis in the
younger. To the best of our knowledge, these data are the
ﬁrst to report these associations. In addition, we also
observed associations between a range of individual PDs
and CVD and arthritis, contributing to the relatively sparse
evidence-base in this area of enquiry.
Cardiovascular disease
Our data are consistent with other population-based studies
reporting signiﬁcant associations between any PD, PD
Clusters and individual PDs with CVD in adults [16, 17,
19, 20]. Individuals who screened positive for any DSM-IV
PD in the National Psychiatric Morbidity Survey of Great
Britain were more likely to have self-reported stroke or
ischemic heart disease after adjusting for age, sex, occu-
pation, smoking and alcohol use, hypertension or diabetes
[16]. Furthermore, individuals with antisocial PD were
Table 4 Prevalence, odds
ratios (OR) and 99 %
conﬁdence intervals (99 % CI)
of personality disorders
predicting co-occurring diabetes
Total n = presented are raw,
prevalence (%) for personality
disorders and for diabetes ‘‘yes’’
among those with and without
the speciﬁc personality disorder
(column) are weighted.
Signiﬁcant age interactions are
stratiﬁed:\55 and C55 years.
* p B 0.01, ** p B 0.001.
Model 1 AOR: adjusted for sex,
race/ethnicity, marital status,
education, income, age
(continuous), past-year mood,
anxiety and substance use
disorders
Personality
disorder
Total
n = (%)
PD yes
n = (%)
PD no
n = (%)
Diabetes
Diabetes yes Diabetes
yes
Bivariate OR
(99 % CI)
Model 1: AOR
(99 % CI)
Any personality disorder
All 7,783 (21.5) 735 (8.5) 2,466 (8.1) 1.06 (0.92–1.21) 1.28 (1.08–1.51)**
Any Cluster A personality disorder
All 3,449 (9.0) 391 (10.2) 2,810 (8.0) 1.32 (1.09–1.59)** 1.50 (1.21–1.88)**
Paranoid
All 1,689 (4.3) 184 (9.9) 3,017 (8.1) 1.24 (0.94–1.64) 1.46 (1.08–1.98)*
Schizoid
All 1,144 (3.1) 123 (10.6) 3,078 (8.1) 1.35 (0.98–1.84) 1.44 (1.02–2.03)*
Schizotypal
All 1,534 (3.9) 191 (11.2) 3,010 (8.1) 1.44 (1.11–1.85)** 1.51 (1.12–2.04)**
Any Cluster B personality disorder
All 4,843 (13.3) 442 (8.1) 2,759 (8.2) 0.99 (0.81–1.19) 1.21 (0.97–1.52)
Antisocial
All 1,226 (3.8) 93 (7.0) 3,108 (8.2) 0.84 (0.60–1.16) 1.21 (0.86–1.70)
Borderline
All 2,231 (5.9) 244 (9.3) 2,977 (8.1) 1.17 (0.91–1.50) 1.35 (1.00–1.83)*
Histrionic
All 651 (1.8) 51 (6.1) 3,150 (8.1) 0.72 (0.46–1.13) 1.04 (0.66–1.65)
Narcissistic
All 2,449 (6.2) 246 (9.3) 2,955 (8.1) 1.17 (0.88–1.55) 1.29 (0.96–1.74)
Any Cluster C personality disorder
All 3,244 (9.4) 314 (8.5) 2,887 (8.2) 1.04 (0.86–1.26) 1.17 (0.95–1.45)
Avoidant
All 821 (2.3) 82 (8.3) 3,119 (8.2) 1.01 (0.69–1.48) 1.20 (0.79–1.82)
Dependent
All 147 (0.4) 13 (8.4) 3,118 (8.2) 1.03 (0.36–2.99) 1.13 (0.38–3.36)
Obsessive–compulsive
All 2,753 (8.1) 264 (8.6) 2,937 (8.1) 1.06 (0.86–1.30) 1.17 (0.93–1.48)
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reported to have increased odds of coronary heart disease
(CHD) in Wave 1 of the NESARC [17], as was seen in the
present study when grouped with other CVDs. In NESARC
(wave 2), borderline PD was associated with self-reported
diagnosis of CVD (chest pain or angina pectoris, rapid
heartbeat or tachycardia, MI, or any other form of heart
disease), but not stroke [19]. Moreover, US adults in the St
Louis Personality and Aging Network study (n = 1,051,
55–64 years), with interviewer-rated borderline PD fea-
tures had a three to fourfold increase odds of self-reported
heart disease [23].
Finally, the National Institute of Mental Health Epide-
miological Catchment Area study reported that DSM-III
Cluster B PDs were associated with approximately fourfold
increased risk of incident self-reported CVD (rheumatic
fever, rheumatic heart disease, angina pectoris, congestive
heart failure, MI) in adults (18–64 years). Moreover, those
with Cluster B PDs had approximately a sixfold increased
risk of CHD mortality over the 23 years of follow-up [20].
We extend prior studies by providing new evidence for
associations between younger adults (\55 years) with
borderline PD and CVD, indicating that borderline PD
might present a unique risk for CVD for younger adults.
Arthritis
To our knowledge this is the ﬁrst study to report associa-
tions between PDs from Cluster A with increased odds of
Table 5 Prevalence, odds ratios (OR) and 99 % conﬁdence intervals (99 % CI) of personality disorders predicting co-occurring gastrointestinal
(GI) diseases
Personality disorder Total n (%) PD yes n = (%) PD no n = (%) Gastrointestinal disease
GI disease yes GI disease yes Bivariate OR (99 % CI) Model 1: AOR (99 % CI)
Any personality disorder
All 7,783 (21.5) 749 (8.9) 1,659 (5.8) 1.57 (1.36–1.81)** 1.36 (1.15–1.62)**
Any Cluster A personality disorder
All 3,449 (9.0) 403 (10.5) 2,005 (6.0) 1.83 (1.53–2.19)** 1.41 (1.16–1.72)**
Paranoid
All 1,689 (4.3) 195 (10.3) 2,213 (6.3) 1.73 (1.33–2.24)** 1.31 (1.00–1.73)*
Schizoid
All 1,144 (3.1) 124 (10.7) 2,284 (6.3) 1.78 (1.29–2.45)** 1.37 (0.99–1.91)*
Schizotypal
All 1,534 (3.9) 218 (13.3) 2,190 (6.2) 2.34 (1.83–2.99)** 1.64 (1.24–2.15)**
Any Cluster B personality disorder
All 4,843 (13.3) 507 (9.7) 1,901 (5.9) 1.71 (1.44–2.03)** 1.48 (1.20–1.81)**
Antisocial
All 1,226 (3.8) 125 (9.7) 2,283 (6.3) 1.59 (1.15–2.18)** 1.63 (1.14–2.33)**
Borderline
All 2,231 (5.9) 296 (12.1) 2,112 (6.0) 2.13 (1.71–2.66)** 1.38 (1.06–1.81)*
Histrionic
All 651 (1.8) 64 (9.0) 2,344 (6.4) 1.45 (0.91–2.29) 1.25 (0.78–2.02)
Narcissistic
All 2,449 (6.2) 246 (9.4) 2,162 (6.2) 1.57 (1.25–1.97)** 1.34 (1.04–1.72)*
Any Cluster C personality disorder
All 3,244 (9.4) 319 (8.9) 2,098 (6.2) 1.49 (1.20–1.83)** 1.25 (1.00–1.56)*
Avoidant
All 821 (2.3) 106 (10.3) 2,302 (6.3) 1.96 (1.33–2.88)** 1.40 (0.94–2.09)
Dependent
All 147 (0.4) 25 (17.3) 2,383 (6.4) 3.06 (1.27–7.41)** 1.79 (0.75–4.28)
Obsessive–compulsive
All 2,753 (8.1) 255 (8.6) 2,153 (6.3) 1.41 (1.12–1.78)** 1.22 (0.96–1.55)
Total n = presented are raw, prevalence (%) for personality disorders and for gastrointestinal disease ‘‘yes’’ among those with and without the
speciﬁc personality disorder (column) are weighted. Signiﬁcant age interactions are stratiﬁed:\55 and C55 years. * p B 0.01, ** p B 0.001.
Model 1 AOR: adjusted for sex, race/ethnicity, marital status, education, income, age (continuous), past-year mood, anxiety and substance use
disorders
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arthritis. In other studies using NESARC data from wave 1,
antisocial PD features were associated with past-year
arthritis [17], as was borderline PD in wave 2 [19]. In
contrast, others have suggested that chronic pain could
potentially play a role in exacerbating personality pathol-
ogy in those with arthritis [18, 43]. In NESARC (wave 1),
past-year arthritis, assessed as the exposure variable of
interest, was associated with increased odds of several
individual PDs (paranoid, schizoid, antisocial, histrionic,
and obsessive–compulsive PDs). Given that the brief data
to date relating to the association between PDs and arthritis
is cross-sectional [17–19], longitudinal studies are required
to ascertain causal associations. However, the current study
extends prior studies by demonstrating among younger
individuals an effect modiﬁcation of age in the relationship
between several PDs and arthritis. By deﬁnition, features of
personality disorder are known to emerge in adolescence
and early adulthood [1]. Our preliminary analyses suggest
that it might be more likely that PDs might be associated
with the development of arthritis, given that the common
sequelae of many arthritic diseases are older age.
Diabetes
To the best of our knowledge, these data are the ﬁrst to
indicate signiﬁcant and positive associations between PDs
from Cluster A and diabetes in a representative population-
based study. Similarly, data from the World Health Survey
reported that increasing numbers of psychotic symptoms
were associated with increased likelihood of diabetes [44].
Potentially, individuals with PDs from Cluster A might
have a greater propensity for metabolic abnormalities, in
turn, increasing the risk for developing type 2 diabetes. For
example, individuals with schizophrenia have an increased
frequency of type 2 diabetes. This appears to be modulated
by impaired fasting glucose tolerance and increased insulin
resistance, independent of antipsychotic medication use
[45]. It is also plausible that unhealthy lifestyle behaviors
and obesity, which are also known health risk factors for
diabetes [46], might have a role in mediating the associa-
tions between PDs from Cluster A with diabetes. For
example, body mass index (BMI) (C30) has been reported
to mediate the relationship between other PD features
(borderline) and self-reported chronic physical conditions
[23]. However, given the evidence base is limited further
studies are required to replicate these cross-sectional
observations and extend these ﬁndings using longitudinal
study designs.
Gastrointestinal disease
Cluster A PDs and speciﬁcally schizotypal PD showed the
strongest association with GI diseases across the lifespan.
Additionally, individuals with PDs from Cluster B (anti-
social, borderline and narcissistic PDs) and Cluster C
(obsessive–compulsive PD) were also more likely to report
being diagnosed with GI disease than individuals without
those PDs. Previous analyses from wave 2 NESARC
examining borderline PD only, reported increased odds of
GI disease for those with this PD [19], an association
postulated to be mediated via dysregulation of brain-gut
neuroenteric systems. Furthermore the current study
extended these observations to examine the relationship
with all PDs and whether age moderated these associations.
Moreover, PDs from all Clusters were associated with GI
disease, indicating PDs as a group of psychiatric disorders
might have a general rather than speciﬁc relationship with
GI disease. Given the cross-sectional nature of the current
evidence base, the reverse association, of GI disease
exacerbating PD symptomatology cannot be ruled out.
Mechanisms
It is well-known that increasing age is associated with
declines in physical functioning and increased overall
medical burden. However, in our current study, age was an
effect modiﬁer in the relationship between several indi-
vidual PDs with CVD and/or arthritis, whereby younger
individuals were shown to have increased risk. This age-
related ﬁnding is important, given that both CVD and
arthritis are commonly diagnosed among older age groups.
Due to the paucity of extant data, few comparisons can be
made with prior studies. However, we can speculate that the
emergence of PD features in adolescence and early adult-
hood might increase the risk for joint trauma via risk-taking
behaviors and injuries. Trauma to the joints increases the
risk for developing lesions of the bone marrow [47].
Moreover, it is biologically plausible that even after taking
into account adult lifestyle risk factors and exposure to
signiﬁcant traumatic events during sensitive periods in
personality development might lead to chronic physical
conditions and increase overall mortality [48]. For example,
adverse childhood events have been shown to be associated
with a marker of constricting blood vessel health (elevated
plasma endothelin-1 levels) in young adulthood [49].
Other shared risk factors for both CVD and (to a lesser
extent) arthritis, include cigarette smoking. While we
adjusted for past-year nicotine dependence, it was not
possible to account for earlier smoking behaviors. It has
been shown that adolescents with borderline PD have an
earlier age of onset of smoking [42], thus increasing the
risk for these conditions much earlier in life. Smoking is
also a known robust risk factor for diabetes; however, such
risk factors in the presence of PD earlier in the lifespan
might a have distinct role in precipitating the pathophysi-
ological expression of CVD and arthritis compared to
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diabetes and GI. Alternatively, is it possible that the reverse
relationship might exist, where rarer physical conditions in
young adulthood, might be associated with maladaptive
coping styles and have effects upon the development of
personality pathology. As such there is a need for longi-
tudinal studies that examine PDs and cardio-metabolic
conditions across the full age range, including adolescents.
Despite our data suggesting that there might be unique
pathological mechanisms in the relationship between PDs
and some physical conditions in younger adults, there
might be other shared risk factors and pathways demon-
strating that PDs and physical health conditions from the
studied disease groups share common antecedents. For
example several of the physical conditions examined in this
study have etiological origins in inﬂammatory processes.
There is evidence to suggest that patients with mood dis-
orders and psychiatric comorbidities have been shown have
elevated levels of pro-inﬂammatory cytokines which pro-
mote systemic inﬂammation [50, 51]. To date little is
known regarding the association between inﬂammation and
PDs. Although it is possible that PDs directly affect
physiological dysregulation such as inﬂammatory pro-
cesses, it is possible that there is a secondary mediator.
Speciﬁcally, it is possible that known lifestyle and behavior
correlates of individuals with PDs such as harmful levels of
alcohol consumption, cigarette smoking and medication
use might modulate biological processes promoting sys-
temic inﬂammation [50, 52] and thus mediate the rela-
tionship between PDs and physical comorbidities. These
unhealthy lifestyle factors are also simultaneously linked to
a dysregulation in both peripheral immune function and the
stress-response system [52], increasing the risk for physical
disease.
Weight gain is also a common correlate of typical and
atypical antipsychotics, mood stabilizers and tricyclic
antidepressants commonly used to treat psychotic disor-
ders, bipolar disorder, and psychiatric comorbidities
including PDs [53]. Metabolic disturbances such as obesity
thus increase the risk for physical disease inclusive of CVD
and diabetes. Interestingly, PDs from Cluster A share ‘‘odd/
eccentric’’ features which more closely resemble psychotic
symptoms than PDs from Clusters B or C, showed the
strongest association with diabetes than the other physical
conditions examined in the current study. Unfortunately,
this study did not have access to respondents’ medication
histories, and thus we are unable to examine the possibility
that medication use might have had an unmeasured medi-
ation effect on the observed associations between PDs and
CVD and diabetes.
The interaction between PDs and medical comorbidity
might also be mediated by other health behaviors. It is
known that people with PDs have poorer levels of
adherence and engagement in treatment, which might be a
potential pathway [54]. Further, it is also well known that
individuals with PDs suffer signiﬁcant social disadvantage
such as disruption to education and employment. Specif-
ically PDs as a group are associated with lower educa-
tional attainment [8], household income [35] and are
prevalent among the homeless [55]. Socially disadvan-
taged individuals are also more likely to have poorer
health literacy which is consistently associated with
poorer physical health and treatment adherence outcomes
[56]. While little is known of the relationship between
PDs and health literacy, it is possible that social disad-
vantage plays a role in the risk for physical disease for
those with PDs, via poorer access to care and barriers to
effective treatment and management of both mental and
physical disorders. It is also possible that disturbances in
cognition and affect which are reﬂective of PDs could
impact upon competencies to appraise health information
and engage in appropriate help-seeking behaviors. Finally,
current classiﬁcation systems postulate that PD symptoms
and behaviors typically manifest in adolescents or early
adulthood, thus we predicted that PDs increase the risk
for physical comorbidities. However, our analyses of
these associations were cross-sectional, and we cannot
rule out the potential that chronic diseases of the young,
such as diabetes, might be associated with the develop-
ment of PD via their effects upon personality
development.
Strengths/limitations
This study has notable strengths. The study used a large
and representative sample of adults from the US, along
with validated tools for the assessment of PDs and psy-
chiatric comorbidities among this population. Furthermore,
when considering the robust link between depression (a
common mental disorder which is also highly comorbid
with PD) and CVD, our ﬁndings (adjusted for a variety of
mood, anxiety and substance use disorders) suggest that the
effects of PD on the risk for physical conditions are not
simply driven by the effects of other mental disorders.
Notwithstanding the methodological strengths of the
NESARC, we acknowledge there are some limitations to
consider upon interpreting our data. We utilized pooled
data from waves 1 and 2 of the NESARC and as such, the
full range of PDs was not assessed at a uniﬁed point in time
(2001–2002 and 2004–2007 respectively). It might be that
there is a longitudinal relationship between some PDs that
were assessed in wave 1 and physical comorbidities.
However, it was not possible to ascertain this because of
the cross-sectional nature of the present study, which
examines lifetime PDs and past-year physical conditions.
Additionally, despite the wide use of the AUDADIS-IV in
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NESARC, it has been suggested that the threshold for
diagnosing PDs is too low, potentially inﬂating prevalence
rates (21.5 % for any PD) compared with prior studies [57].
In the absence of clinical data to inform assessment of
physical comorbidities, this study used self-reported
information of being diagnosed by a health professional.
As previously published [19], self-reported data has
acceptable concordance with medical records of diagnosed
physical conditions [32]. However, we cannot rule out the
potential for recall bias, or the risk of differential reporting
of physical conditions by PD status. Moreover, while we
adjusted for the potential effects of substance use disorders
(i.e. a proxy for harmful alcohol and tobacco use), and
mood and anxiety disorders (i.e. proxy for medication use,
such as antidepressants), we did not adjust for other
important lifestyle correlates that are likely to be risk
factors for chronic physical comorbidities. These include
levels of physical activity, BMI and other prescription or
non-prescription medication use. As such, additional
studies examining the mediating or moderating effects of
lifestyle correlates in the relationship between PDs and
physical comorbidities are needed.
Conclusions
Physical comorbidities in individuals with PDs are severely
under-recognized. Our study provides preliminary evi-
dence of associations between individual PDs and PD
Clusters with a range of physical comorbidities from
diverse chronic disease groups. Furthermore, these ﬁndings
strengthen the sparse evidence base in this growing ﬁeld of
enquiry. However, there is a clear need for further inves-
tigations regarding the relationship between PDs and
physical comorbidities. This might determine whether
screening for physical conditions is warranted in individ-
uals with PDs in general health care systems. This will in
turn, generate appropriate referrals to optimize overall
patient health. Furthermore, a more comprehensive
understanding of the relationship between physical
comorbidities in those with PDs across the lifespan might
further improve prevention and treatment options and
outcomes for these individuals.
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Abstract
Background: There is a burgeoning evidence base examining associations 
between personality disorders (PDs) and physical health comorbidities in a 
general population setting; yet finding to date are inconsistent. This study 
reports physical health characteristics in a population-based study, and 
investigates associations with a number of important physical health 
conditions, and high physical morbidity. 
Methods: This study examined data collected from women (n=765; ≥20 years) 
participating in a population-based study located in south-eastern Australia. 
Lifetime history of psychiatric disorders was assessed using the Structured 
Clinical Interview Research Version, Non-patient edition (SCID-I/NP) and 
SCID-II (personality disorders). The presence of physical health conditions 
(lifetime) were identified via a combination of self-report, medical records, 
medication use and clinical data. Socio-economic status (SES), and 
information regarding medication use, lifestyle behaviors, and pertinent 
sociodemographic information was collected via questionnaires. Logistic 
regression models were used to investigate associations before and after 
adjustment. 
Results: After adjustment for sociodemographic variables (age, socioeconomic 
status) and health risk factors (body mass index, physical activity, smoking, 
psychotropic medication use), PDs were consistently associated with a range of 
physical health conditions. Novel associations were observed between Cluster 
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A PDs and gastro-oesophageal reflux disease (GORD); Cluster B PDs with 
syncope and seizures, as well as arthritis; and Cluster C PDs with GORD and 
recurrent headaches. 
Conclusions: PDs were associated with physical comorbidity. The current data 
contribute to a growing evidence base demonstrating associations between PDs 
and a number of physical health conditions independent of psychiatric 
comorbidity, sociodemographic and lifestyle factors. Longitudinal studies are 
now required to investigate causal relationships, as are studies determining 
mechanism of action. 
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PHYSICAL HEALTH COMORBIDITIES IN WOMEN WITH 
PERSONALITY DISORDERS: DATA FROM THE GEELONG 
OSTEOPROSIS STUDY 
Introduction
There is an increasing evidence base that suggests personality disorders (PDs) 
are associated with a number of physical health conditions, including 
cardiovascular disease (CVD) (El-Gabalawy et al., 2010; Lee et al., 2010;
Moran et al., 2007; Quirk et al., 2015), arthritis (El-Gabalawy et al., 2010; 
McWilliams et al., 2008; Goldstein et al., 2008; Quirk et al., 2015), liver 
disease (El-Gabalawy et al., 2010), gastrointestinal disease and diabetes (El-
Gabalawy et al., 2010; Quirk et al., 2015). It has been hypothesized that 
lifestyle and environmental health risk factors (Afifi et al., 2013; Chanen et al., 
2007), adaptive social functioning (Chanen et al., 2007; Skodol et al., 2005) as 
well as biological mechanisms (such as dysregulation of the hypothalamic-
pituitary axis, immune system, serotonergic, metabolic and endocrine system 
functions, and maturation of neural inhibitory mechanisms) underpin many of 
these associations (Kiecolt-Glaser et al., 2002; Streeck-Fischer and van der 
Kolk, 2000); although causal pathways are not completely understood. 
Improving the evidence base regarding associations between PDs and physical 
comorbidities are necessary, given the potential for substantial added disability, 
implications for treatment management, and high direct and indirect costs 
(Rendu et al., 2002). PDs are highly prevalent and estimated to be present in 
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approximately 13% of the general population (Quirk et al.; Samuels, 2011) and 
are responsible for significant mental and physical disability (Jackson and 
Burgess, 2002), and long term impairments in social functioning (Gunderson et 
al., 2011). It is also possible that the prevalence and associated physical 
disability of PD might be different between sexes, with PD being reported to be 
present in approximately 8%-22% of women (Trull et al., 2010; Quirk et al.). 
The non-communicable diseases including cardiovascular diseases, diabetes, 
chronic respiratory diseases, and cancers account for approximately 18 million 
deaths per year in women, and pose significant socioeconomic challenges and 
disadvantage (World Health Organization, 2004). 
It appears the recent consideration of mental and physical comorbidity in 
regard to PD in the general population is warranted, given the recognized link 
between the common mental disorders (Sanna et al., 2013a; Sanna et al., 
2013b; El-Gabalawy et al., 2014) and psychotic symptoms and disorders 
(Moreno et al., 2013; Nuevo et al., 2011; Partti et al., 2015) with adverse 
physical health outcomes in both older (El-Gabalawy et al., 2014; Sanna et al., 
2013a; Sanna et al., 2013b) and younger adult populations (Sanna et al., 
2013b). PDs are also well known to be associated with high levels of 
psychiatric comorbidity in the general population (Lenzenweger et al., 2007). 
It is already well established that mood disorders, particularly depressive 
disorders, are a robust risk factor for cardio metabolic syndromes (Van der 
Kooy et al., 2007). Individuals with mood disorders have also been suggested 
to have an increased risk of neurological symptoms, and pulmonary disease, 
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while those with anxiety disorders and symptoms have been shown to have an 
increased risk of gastro-oesophageal reflux disease (GORD), psoriasis, and 
thyroid disease (Sanna et al., 2013a; Sanna et al., 2013b). 
Thus far, these associations have not been have been investigated in individuals 
with PDs. Moreover, the evidence to date regarding associations between PD 
and specific health conditions has been derived chiefly from self-reported 
information. More robust sources of information are needed to ascertain the 
presence of physical illness, with potentially moderating pathways of 
coexisting psychiatric disorders and health risk factors explored. Improving our 
understanding of these comorbidities might also generate greater awareness for 
PDs in the mental and physical health nexus – as well as establishing future 
health needs for women with these disorders. 
Therefore, we aimed to investigate associations between PDs and physical 
health comorbidities in a well-defined population-based sample of women aged 
≥20 years residing in Australia.
Method 
Participants 
Data were collected from the most recent follow-up phase of the Geelong 
Osteoporosis Study (GOS) (2011-2014) (Pasco et al., 2012). Originally (1993-
1997), an age-stratified, population-based sample of women (n=1,494; ≥20 
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years) was randomly-selected from the Australian Electoral Commission rolls 
for the Barwon Statistical Division (BSD) (located in south-eastern Australia), 
a region comprising semi-rural and urban communities. Using the same 
recruitment methodology, an additional sample of adult women (n=246, 20-29 
years) was recruited (2006-2008), to account for an ageing cohort (Pasco et al., 
2012). 
Of the potential pool of remaining eligible participants, 849 women returned. 
Details of the recruitment methodology and participation, and reasons for loss 
to follow-up are published elsewhere (Quirk et al., 2015). For the current 
analyses, participants who did not provide complete psychiatric data (n=81), or 
information regarding medical history (n=4) were excluded, resulting in a final 
sample of 765 of women (aged ≥20 years). This study was approved by the 
Human Research Ethics Committees of Barwon Health and Deakin University, 
and written informed consent was obtained from all participants. 
Measures 
Psychiatric measures 
The Structured Clinical Interview for DSM-IV-TR Research Version, Non-
patient edition (SCID-I/NP) (First et al., 2002) was used to assess the presence 
of lifetime mood disorders including, major depressive disorder, bipolar 
disorder (I, II and not otherwise specified), minor depression, dysthymia, mood 
disorder due to a medical condition, substance induced mood disorder; anxiety 
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disorders including panic disorder (with and without agoraphobia), 
agoraphobia, social phobia, specific phobia, obsessive-compulsive disorder, 
generalized anxiety disorder, post-traumatic stress disorder, and anxiety 
disorder not otherwise specified; eating disorders including anorexia nervosa, 
bulimia nervosa, and binge eating disorder; alcohol and substance use disorders 
including alcohol abuse, alcohol dependence, non-alcohol abuse and non-
alcohol dependence. 
 
The Structured Clinical Interview for DSM-IV Axis II PDs (SCID-II) (First et 
al., 1997) was also administered to identify DSM-IV PDs including paranoid, 
schizoid, schizotypal, histrionic, narcissistic, borderline, antisocial, avoidant, 
dependent, and obsessive-compulsive (First et al., 1997). All interviews were 
conducted by personnel with postgraduate qualifications in psychology, who 
were trained using live and videotaped interviews under the supervision of a 
psychiatrist. 
 
Anthropometry 
 
Height and weight was measured to the nearest 0.1 cm and 0.1 kg, respectively. 
Body mass index [BMI (kg/m2)] was calculated from these measures. 
 
Physical health conditions 
 
Lifetime physical health conditions were ascertained by a combination of self-
report, detailed medical and medication histories, and anthropometric data. 
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Blood was also collected following an overnight fast and blood glucose 
measured. Medication use was ascertained via self-report and confirmed by 
requesting that participants bring a list of medications, prescriptions and/or 
containers at the time of assessment. Physical health conditions were 
categorized according to the following disease groups by an experienced 
physician, and as previously published (Sanna et al., 2013a): 
i) Arthritis: self-reported osteoarthritis, ankylosing spondylitis,
psoriatic arthritis, rheumatoid arthritis, or treated gout 
(medications used for gout or hyperuricaemia). 
ii) Thyroid disorders: self-reported or treated (thyroid hormones
and anti-thyroid medications) hyperthyroidism, hypothyroidism, 
Graves’ disease, Hashimoto’s disease, thyroiditis and/or other 
thyroid conditions. 
iii) Metabolic disorders: self-reported, treated diabetes (oral
hypoglycemic medications and insulin preparations) and/or 
fasting blood sugar level 7 mmol/L or higher, obesity (BMI >30 
kg/m2), self-reported or treated hypercholesterolemia 
(cholesterol-lowering medications); self-reported, treated 
hypertension (antihypertensive, beta-adrenergic blocking agents 
and diuretics), and/or or a systolic blood pressure of >140 
mmHg or diastolic blood pressure of >90 mmHg. 
iv) GORD: indicated by self-report
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v) Gastrointestinal disorders: self-reported gastrointestinal diseases
including peptic ulcer, chronic gastritis, and causes of 
malabsorption (pancreatitis, gastric surgery, chronic diarrhea,
irritable bowel syndrome, inflammatory bowel syndrome and/or 
coeliac disease). 
vi) Recurrent headaches: self-reported migraine, and/or recurrent
headaches. 
vii) Syncope and seizures: self-reported epilepsy, blackouts, fainting
and dizzy spells 
viii) CVD: hypertension (previously defined), self-reported or treated
(beta-adrenergic blocking medications, diuretics, anti-
arrhythmic, anti-angina, cardiac inotropic medications, 
adrenergic stimulants, or other cardiovascular medications), 
stroke, transient ischemic attack (TIA), ischemic 
cardiomyopathy, arrhythmia, and/or other valve and vascular 
diseases. 
ix) Pulmonary diseases: self-reported asthma, emphysema, and/or
chronic bronchitis. 
x) Liver diseases: self-reported fatty liver, hepatitis, cirrhosis
and/or liver failure. 
MANUSCRIPT VI 
204
xi) Cancers: self-reported malignant tumor, non-melanoma skin
cancer, and/or other cancers. 
xii) Psoriasis: indicated via elf-report.
Lifestyle information 
Smoking and habitual physical activity status were obtained by self-report. 
Ever smoking status (yes/no) was defined by current or past cigarette smoking. 
Participants were defined as active (yes/no), if a positive response was 
endorsed for items pertaining to light to vigorous activity on a regular basis. 
Socioeconomic status (SES) was determined using the Index of Relative Socio-
economic Advantage and Disadvantage (IRSAD), which was calculated from 
the Socio-Economic Index For Areas (SEIFA) scores to determine the relative 
socioeconomic conditions of individuals and households at the area-level, as 
previously published (Brennan et al., 2009; Williams et al., 2011). A lower 
score (Quintile 1) indicated greater disadvantage, and a higher score indicated 
greater advantage (Quintile 5). 
Statistical Analysis 
Differences in sociodemographic and lifestyle characteristics between those 
with and without any PD were compared using chi-square analyses for 
categorical variables and Mann-Whitney, and two-sample t-tests, where 
appropriate. 
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Logistic regression models examined associations (age adjusted and fully 
adjusted models) between PDs (any, Cluster A, Cluster B, Cluster C) and 
lifetime physical health conditions in comparison to those without PDs. Models 
were adjusted for: age (Model 1); then for age, BMI, SES, physical activity, 
smoking status, psychiatric disorders (ever), and psychotropic medication use 
(ever) (Model 2). Interactions between the exposure variables (PD variables), 
each predictor variable, and outcome variables (physical health conditions) 
were also examined. Data are present as adjusted odd ratios (OR) with 95% 
confidence intervals (95%CI), with values of p<0.05 being considered 
significant. All statistical analyses were performed using Minitab (version 16; 
Minitab, State College, PA). 
Results 
Of the current sample, 20.4% (n=156) individuals had a PD (median age 52.8 
(38.4-63.4) years), 4.6% (n=35) had a Cluster A PD (median age 48.3 (33.5-
57.6) years), 2.8% (n=21) had a Cluster B PD (median age 47.5 (31.7-56.6) 
years), and the most frequent PDs were Cluster C with 16.7% (n=128) (median 
age 53.9 (42.5-64.8) years). Of those with any PD, 73.5% (n=115) had a co-
occurring lifetime psychiatric disorder, with 41.1% (n=64) reporting a history 
of psychotropic medication use (Table 1). Individuals with PD were also 
younger (p<0.0001), had a greater BMI (p<0.05); individuals with and without 
PDs were similar in terms of socioeconomic status, and physical activity and 
smoking status. 
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Any PD 
After adjustment for age (Model 1), any PD was associated with increased 
likelihood of GORD (OR 2.03, 95%CI 1.23-3.37, p = 0.01), gastrointestinal 
disease (OR 1.97, 95%CI 1.30-2.99, p = 0.001), recurrent headaches (OR 1.97, 
95%CI 1.30-2.99, p = 0.001), syncope and seizures (OR 1.86, 95%CI 1.20-
2.89, p = 0.006). With the exception of GORD and gastrointestinal disease, 
these associations were sustained after further adjustment (Model 2) for BMI, 
SES, physical activity, smoking status, psychiatric disorders (ever), 
psychotropic medication use (ever), and interactions (Table 2) (all p<0.05). No 
association was observed between any PD and arthritis, thyroid disorders, 
metabolic disorders, cardiovascular disease, pulmonary disease, liver disease, 
cancer or psoriasis.
Cluster A PDs 
In age-adjusted models (Model 1), Cluster A PDs were associated with 
increased odds of GORD (OR 4.41, 95%CI 1.87-10.40), and syncope and 
seizures (OR 3.07, 95%CI 1.47-6.43) respectively (both p≤0.003); both these 
associations were sustained in the fully adjusted models, as well as adjustment 
for interactions (both p<0.02) (Table 2). 
Cluster B PDs 
After age-adjustment, Cluster B PDs were associated with increased odds of 
arthritis (OR 4.37, 95%CI 1.53-12.48), syncope and seizures (OR 4.37, 95%CI 
1.78-10.74), and cancers (OR 3.01, 95%CI 1.01-9.00) (all p<0.05). 
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Associations between Cluster B PDs with arthritis, and syncope and seizures, 
but not cancer, were sustained in Model 2 (Table 2). Cluster B PDs were also 
associated with increased odds of psoriasis in Model 2 and adjusting for 
observed interactions (OR 4.41, 95%CI 1.03-18.90, p<0.05). 
Cluster C PDs 
After adjustment for age, Cluster C PDs were associated with GORD (OR 
1.91, 95%CI 1.13-3.25, p = 0.02), gastrointestinal disease (OR 1.94, 95%CI 
1.25-3.00, p = 0.003), and recurrent headaches (OR 1.94, 95%CI 1.25-3.00, p = 
0.003). Associations between Cluster C PDs, and GORD and gastrointestinal 
disease were nullified once adjustments were applied in the final Model; 
however, associations with recurrent headaches increased in Model 2 and after 
adjusting for interactions (Table 2). 
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Table 1: Characteristics of the total study population (n=765) and according to PD status 
 
 Personality disorder  
 Total No Yes p 
 n=765 n=609 n=156  
Age at interview (years) 56.8 (42.7-68.9) 58.07 (43.6-70.4) 52.8 (38.4-63.4) 0.001 
Socioeconomic status*     0.57 
Quintile 1 116 (15.2) 87 (14.3) 29 (18.6)  
Quintile 2 87 (11.4) 67 (11.0) 20 (12.8)  
Quintile 3 293 (38.3) 239 (39.2) 54 (34.6)  
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Quintile 4 143 (18.7) 113 (18.6) 30 (19.2)  
Quintile 5 126 (16.5) 103 (16.9) 23 (14.7)  
BMI (kg/m2) 27.0 (24.0-32.0) 27.0 (24.0-32.0) 29.0 (25.0-34.0) 0.005 
Physically active 549 (73.1) 447 (74.6) 102 (67.1) 0.06 
Smoking (ever) 293 (38.55) 225 (37.2) 68 (43.9) 0.13 
Psychotropic medication use 
(ever) 
228 (30.0) 164 (27.1) 64 (41.1) <0.001 
Psychiatric disorders (ever) 364 (47.6) 249 (40.9) 115 (73.7) <0.001 
Physical conditions (ever)     
  Arthritis 242 (31.6) 195 (32.0) 47 (30.13) 0.65 
  Thyroid disorders 80 (10.5) 64 (10.5) 16 (10.3) 0.93 
  Metabolic disorders 518 (67.7) 412 (67.7) 106 (68.0) 0.94 
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  GORD 108 (14.2) 80 (13.1) 28 (18.0) 0.12 
  Gastrointestinal disorders 145 (19.0) 102 (16.8) 43 (27.6) 0.002 
  Recurrent headache 84 (11.0) 57 (9.4) 27 (17.3) 0.01 
  Syncope and Seizures 122 (16.0) 86 (14.1) 36 (23.1) 0.01 
  Cardiovascular disease 436 (57.0) 352 (57.8) 84 (53.9) 0.37 
  Pulmonary disease 201 (26.3) 154 (25.3) 47 (30.1) 0.22 
  Liver disease 30 (3.9) 24 (3.9) 6 (3.9) 0.96 
  Cancer 141 (18.4) 113 (18.6) 28 (18.0) 0.86 
  Psoriasis 38 (5.0) 27 (4.4) 11 (7.1) 0.18 
*Quintile 1 (most disadvantaged) – Quintile 5 (most advantageous); BMI = body mass index; psychiatric disorder (ever) = lifetime mood 
disorders, lifetime anxiety disorders, lifetime eating disorders, lifetime non-alcohol substance use disorders, lifetime alcohol use disorders; 
GORD = gastro-oesophageal reflux disease; boldface indicates statistical significance (p<0.05); values are given as median (interquartile range) 
or frequencies (%); missing data: BMI (n=26); physically active (n=14); smoking (n=5); psychotropic medication use (n=6). 
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Table 2: Age adjusted (Model 1) and fully-adjusted (Model 2) odds ratios for physical health comorbidities in women, according to PD status 
 
Disease group Any PD Cluster A Cluster B Cluster C 
 OR 95% CI p  OR 95% CI p  OR 95% CI p  OR 95% CI p  
Arthritis             
Model 1 1.49 0.95-2.34 0.09 1.83 0.75-4.46 0.18 4.37 1.53-12.48 0.01 1.43 0.89-2.30 0.14 
Model 2 1.07* 0.65-1.75 0.80 1.36* 0.53-3.45 0.52 4.25* 1.34-13.44 0.01 1.04* 0.62-1.75 0.88 
Thyroid disorders             
Model 1 1.05 0.59-1.89 0.86 0.59 0.14- 2.52 0.47 0.49 0.06-3.76 0.49 1.01 0.54-1.89 0.98 
Model 2 1.12** 0.59- 2.13 0.74 0.69** 0.15-3.12 0.63 0.67** 0.08-5.53 0.71 0.99** 0.50- 1.97 0.98 
Metabolic             
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disorders 
Model 1 1.41 0.93-2.14 0.11 1.51 0.70-3.29 0.30 1.16 0.44-3.03 0.77 1.39 0.88-2.19 0.16 
Model 2 0.87*** 0.51-1.50 0.62 0.21† 0.04-1.19 0.08 1.04‡ 0.38-2.83 0.95 1.28‡ 0.78-2.11 0.33 
GORD             
Model 1 2.03 1.23-3.37 0.01 4.41 1.87-
10.40 
0.001 2.80 0.87-8.99 0.08 1.91 1.13-3.25 0.02 
Model 2 1.49§ 0.85-2.61 0.15 3.66§ 1.47-9.13 0.005 2.51§ 0.64-9.84 0.19 1.38§ 0.77-2.46 0.28 
Gastrointestinal 
disease 
            
Model 1 1.97 1.30-2.99 0.001 1.37 0.60-3.10 0.45 1.87 0.71-4.95 0.21 1.94 1.25-3.00 0.003 
Model 2 1.46 0.92-2.33 0.11 0.84 0.35-1.99 0.68 1.69 0.59-4.83 0.33 1.49 1.92-2.44 0.11 
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Recurrent  
headaches 
            
Model 1 1.97 1.30-2.99 0.001 1.37 0.60-3.10 0.45 1.87 0.71-4.95 0.21 1.94 1.25-3.00 0.003 
Model 2 5.43¶ 1.40-21.14 0.02 1.44\\ 0.56-3.71 0.45 1.65\\ 0.49-5.57 0.42 6.27¶ 1.60-
24.45 
0.008 
Syncope 
and seizures 
            
Model 1 1.86 1.20-2.89 0.006 3.07 1.47-6.43 0.003 4.37 1.78-10.74 0.001 1.53 0.95-2.48 0.08 
Model 2 1.62†† 1.00-2.63 0.049 2.55†† 1.15-5.63 0.02 4.50†† 1.69-12.20 0.003 1.27†† 0.76-2.12 0.36 
Cardiovascular 
disease 
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Model 1 1.20 0.80-1.80 0.39 1.41 0.65-3.07 0.38 1.41 0.53-3.74 0.68 1.23 0.79-1.90 0.35 
Model 2 0.90‡‡ 0.56-1.43 0.65 1.04‡‡ 0.45-2.40 0.93 1.16‡‡ 0.38-3.52 0.79 0.94‡‡ 0.57-1.53 0.80 
Pulmonary 
disease 
            
Model 1 1.27 0.86-1.87 0.24 1.28 0.61-2.69 0.51 1.73 0.70-4.28 0.23 1.22 0.80-1.86 0.35 
Model 2 0.92 0.59-1.41 0.92 0.85 0.39-1.85 0.68 1.10 0.40-3.02 0.86 0.97 0.62-1.54 0.91 
Liver disease             
Model 1 1.01 0.44-2.77 0.84 1.97 0.44-8.87 0.38 1.61 0.20-12.69 0.65 1.07 0.40-2.87 0.89 
Model 2 0.97a 0.36-2.59 0.95 1.47a 0.30-7.18 0.63 0.99 0.11-8.58 0.99 0.94a 0.33-2.66 0.96 
Cancers             
Model 1 1.34 0.82-2.19 0.241 1.37 0.50-3.80 0.54 3.01 1.01-9.00 0.049 1.37 0.82-2.30 0.22 
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Model 2 1.35 0.80-2.28 0.27 1.25 0.44-3.60 0.68 3.00 0.94-9.58 0.06 1.42 0.82-2.44 0.21
Psoriasis
Model 1 1.67 0.80-3.48 0.17 1.94 0.56-6.79 0.30 3.57 0.98-12.98 0.05 1.86 0.88-3.95 0.10
Model 2 1.34b 0.60-3.01 0.48 2.13 b 0.54-8.32 0.28 4.41b 1.03-18.90 0.046 1.49 b 0.65-3.38 0.35
Note: Metabolic disorders not adjusted for BMI. 
Boldface indicates statistical significance (p<0.05); OR = odds ratio; 95%CI = 95% confidence interval; BMI = body mass index; psychiatric 
disorder (ever) = lifetime mood disorders, lifetime anxiety disorders, lifetime eating disorders, lifetime non-alcohol substance use disorders, 
lifetime alcohol use disorders; GORD = gastro-oesophageal reflux disease; SES = socioeconomic status; boldface indicates statistical 
significance (p<0.05); Model 1 adjusted for age; Model 2 adjusted for age, BMI, SES, physical activity, smoking status, and psychiatric disorder 
(ever);* Adjusted for Model 2 + IRSAD*smoking status + physical activity* psychiatric disorder (ever); + IRSAD*psychotropic medication use;
** Adjusted for Model 2 + Smoking status* psychiatric disorder (ever); *** Adjusted for Model 2 + Psychotropic medication use * psychiatric 
disorder (ever); † Adjusted for Model 2 + IRSAD*Cluster A+ Psychotropic medication use * psychiatric disorder (ever); ‡ Adjusted for Model 2
+ IRSAD* psychiatric disorder (ever) + Psychotropic medication use * psychiatric disorder (ever);
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§Adjusted for Model 2 + Physical activity status* psychiatric disorder (ever); ¶ Adjusted for Model 2 + IRSAD* any PD + Psychotropic 
medication use * psychiatric disorder (ever); \\ Adjusted for Model 2 + Psychotropic medication use * psychiatric disorder (ever);††Adjusted for 
Model 2 + physical activity status*age; ‡‡ Adjusted for Model 2 + IRSAD*BMI + Psychotropic medication use * psychiatric disorder (ever); a 
Adjusted for Model 2 + smoking status*BMI; b Adjusted for Model 2 + psychiatric disorder (ever);*age. 
SMHRS 
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Discussion 
The current population-based study contributes to the growing evidence base 
regarding associations between PDs and physical health comorbidities. The 
findings underscore the high physical morbidity potentially attributable to PDs 
in the general population. The increased risk for physical health conditions 
among women with Clusters A, B and C PDs varied. Specifically, women with 
Cluster A PDs appeared to have an increased risk of GORD, Cluster B PDs 
with syncope and seizures, psoriasis and arthritis, and Cluster C PDs with 
recurrent headaches (after multiple adjustments). To our knowledge, our study 
is the first to investigate associations between PDs, cancer and pulmonary 
diseases in a population setting among women – revealing no increased risk for 
these conditions. 
An additional novel finding – demonstrating an association between Cluster A 
PDs and GORD, is consistent with the population-based literature examining 
individuals with mood and anxiety disorders and gastro-oesophageal reflux 
symptoms in Norway (HUNT 1 and 2; n= 47,556, ≥20 years) (Jansson et al., 
2007) and Australia (n=942, 20-97 years) (Sanna et al., 2013a; Sanna et al., 
2013b), where individuals with anxiety were most at risk. By definition, 
individuals with Cluster A PDs also experience symptoms of social anxiety and 
withdrawal (American Psychiatric Association, 2000). The current study is 
concordant with prior examinations of Cluster C PDs and gastrointestinal 
disease in the NESARC (El-Gabalawy et al., 2010; Quirk et al., 2015), with 
associations hypothesized to be influenced via dysregulation of brain-gut 
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neuroenteric systems. However, in the current study, a range of health risk 
factors, other mental health related problems and history of psychotropic 
medication use, appeared to explain these findings in the fully adjusted model; 
of which are all plausible pathways. 
In contrast, we did not replicate prior findings derived from the NESARC, a 
nationally, representative survey of the US (Wave 1 n= 43,093; ≥20 years), 
which suggested Cluster A PDs were associated with an increased risk for self-
reported CVD, diabetes, gastrointestinal disease, and arthritis (Quirk et al., 
2015). In the current study, diabetes were grouped with other metabolic 
conditions, of which, a high proportion of the overall sample had elevated 
BMI, thus potentially diluting associations. Still, our findings extend previous 
analyses, by utilizing fasting blood glucose samples, to improve the validity of 
our cases. 
Personality traits, particularly neuroticism have long been associated with 
somatic and neurological complaints (Silberstein et al., 1995). The present 
study, to our knowledge, is the first population-based study reporting an 
increased risk for neurological symptoms such as syncope, seizures or 
recurrent headaches among individuals with PDs. These neurological 
symptoms might, in part, be an expression of symptoms and behaviors that are 
characteristic of borderline PD, including dissociation and mood disturbance. 
In addition, impulsivity, depression, and suicidality could be mediated by 
central biochemical dysregulation, notably in serotonergic pathways in 
MANUSCRIPT VI 
219
individuals with borderline PD, which might be one potential pathway 
(Silberstein et al., 1995). We also cannot rule out brain pathology, which may 
have given rise to psychological symptoms, or influence personality change. 
The clinically-based literature also indicates that patients with borderline PD 
report experiences of chronic pain more frequently compared to other PDs, 
with increased severity being associated with presence of major depression and 
history of childhood maltreatment (Biskin et al., 2014). A population-based 
study from the US (National Comorbidity Survey Replication; n=5692), 
addressed the reverse association, whereby a history of self-reported pain 
conditions was associated with severity of borderline PD symptomatology 
(McWilliams et al., 2008). Thus, it is possible that pain might be a confounding 
or moderating factor in associations between PDs and neurological symptoms. 
Our findings are consistent with previous analyses using data from Waves 1 
(n=43,093) (Goldstein et al., 2008), and 2 (n=34,563, ≥20 years) of the 
NESARC (El-Gabalawy et al., 2010; Quirk et al., 2015) in demonstrating that 
Cluster B PDs and features were associated with increased odds of self-
reported arthritis. Additional analyses derived from a community based study 
situated in St Louis in the US (n=1051, 55-65 years) reported that BMI 
mediated the relationship between PDs and arthritis (Powers and Oltmanns, 
2013). In the current study, associations between Cluster B PDs and arthritis 
were sustained after adjustment for several factors including sociodemographic 
variables, health risk factors such as BMI, psychotropic medication use and 
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history of other mental health problems or investigation of possible 
interactions. A further extension of these findings might be to investigate 
whether PDs are associated with arthritic conditions with autoimmune or 
systemic inflammatory origins. There is also a suggestion that individuals with 
borderline PD have reduced bone mineral density (Kahl et al., 2006; Kahl et 
al., 2005), yet little remains known regarding PD and musculoskeletal health. 
Still, it is also possible that the expression of physical health conditions, 
particularly neurological features and arthritis, might be influenced by trauma, 
or other acute infections (Butler and Zeman, 2005), that were not measured in 
the current study. As such, the psychological and behavioral sequelae of 
physical health conditions requires further investigations. 
Previous clinically-based evidence indicates that individuals with PDs, notably 
borderline PD have frequently co-occurring substance misuse problems, 
obesity, and commence smoking at a younger age (Chanen et al., 2007) – all of 
which contribute to increased physical morbidity (Frankenburg and Zanarini, 
2011). Yet, in the current study associations were sustained after taking into 
account history of smoking, BMI, and lifetime psychiatric disorders including 
substance misuse, use of psychotropic medications and interactions among 
these factors. 
Moreover, in the current study, PDs were not associated with disease groups 
(i.e. cancers, metabolic disorders, liver disease, CVD, and pulmonary disease), 
which share common and known health risk factors such as higher age, 
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smoking, BMI, as well as a history of psychiatric disorders (including misuse 
of alcohol and other substances). In contrast, several prior studies have 
reported associations between PDs and CVD (El-Gabalawy et al., 2010; Quirk 
et al., 2015; Powers and Oltmanns, 2013; Lee et al., 2010; Moran et al., 2007). 
The discrepancies between our findings with the previous literature, may be 
due to heterogeneous groupings. In particular, we grouped hypertension with 
CVD, which was prevalent in the overall sample, and thus might have diluted 
associations. Other disease groups, for which we did not detect a relationship 
with PD included thyroid disorders and psoriasis (with the exception of Cluster 
B).
Strengths of the current study include the age-stratified, population-based 
sample, which spans the full adult age range, and extends past studies with 
restricted age ranges. Further strengths include utilizing semi-structured 
clinical interviews (SCID-I/NP, SCID-II), a gold standard tool, and more 
robust measures of ascertainment to inform the presence of some physical 
conditions. As with all observational studies, certain methodological 
considerations should be taken into account when interpreting the findings. 
First, there is the potential for unmeasured confounding to bias our findings, 
including psychotic disorders, cognitive decline, and psychosomatic 
conditions. Also, in this phase, we examined women only, and thus sex 
differences could not be investigated. Our sample might be biased by attrition, 
thus comparison with other populations, including men, might not be 
generalizable. Given the cross-sectional nature of the current study, we cannot 
comment on the causal direction, yet it is possible that bidirectional 
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relationships might exist. Moreover, precision of the estimates among less 
frequent PDs, and the potential for recall and information bias must also be 
considered. Others have also highlighted that the burden of mental and physical 
comorbidity, might not be independent of the overall socioeconomic 
development of the country or health systems (Moreno et al., 2013). As such 
further information is needed regarding the influence of PD and physical 
comorbidity on types of healthcare service utilization, particularly in different 
populations. 
To conclude, these data provide further population-based evidence supporting 
associations between PDs and the increased risk for physical morbidity in 
women. Recognizing the importance of the added physical disability attributed 
by PD is important for the detection, monitoring, and the development of 
integrated treatment approaches of mental and physical comorbidities including 
PD. Longitudinal investigations are now needed, including the examination of 
potential sex differences.
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CHAPTER SIX: ASSOCIATIONS BETWEEN 
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Abstract
Background: There is a paucity of data investigating associations between 
personality disorders (PDs) and healthcare service utilization derived from 
linked, population-based epidemiological studies. In particular, less is known 
regarding the utilization of both mental and physical health-related services 
among women with PDs. This study aimed to investigate associations between 
personality disorders and mental and physical health-related service utilization. 
Methods: Data were collected from 665 women participating in the Geelong 
Osteoporosis Study (2011-2014). Lifetime psychiatric disorders were assessed 
using semi-structured clinical interviews (SCID-I/NP and SCID II) and 
healthcare service utilization was determined using linked data routinely 
collected from Medicare (Australia). Socio-demographic information (age, 
marital status, education, country of birth) was collected by self-report and 
area-based socioeconomic status (SES) was determined. Associations between 
PDs and mental and physical health-related service use were examined using 
negative binomial regression before and after adjustment for 
sociodemographics and lifetime psychiatric disorders. 
Results: Following adjustments (sociodemographics, lifetime psychiatric 
disorders), Cluster C PDs were associated with increased utilization of mental 
health-related services provided by general practitioners (IRR 1.70, 95%CI 
1.01,2.88), and Cluster A PDs were associated with increased utilization of 
physical health-related services provided by general practitioners (IRR 1.40, 
95% 1.10,1.78). 
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Conclusions: These data underscore the increased burden on the public 
healthcare system accounted for by individuals with PD, and might be useful 
for healthcare service planning and delivery. 
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UTILIZATION OF HEALTH SERVICES BY WOMEN WITH 
PERSONALITY DISORDER: A POPULATION-BASED STUDY 
Introduction 
Personality disorders (PD) are common and burdensome mental disorders. 
They are estimated to be present in up to 13% of community samples 
(Samuels, 2011), and are associated with long standing psychological and 
functional impairment (Gunderson et al., 2011). The course of PDs are 
relatively more enduring compared to psychiatric disorders such as major 
depressive disorder (MDD) (Gunderson et al., 2011). Patients with PD, notably 
borderline PD, frequently utilize intensive forms of psychological treatment 
(Zanarini, Frankenburg, Hennen, & Silk, 2004). There is also some indication 
that individuals with PD living in the community are heavy consumers of 
physical health services, although findings in this respect are somewhat 
inconsistent, probably reflecting methodological differences (Coid et al., 2009; 
Jackson & Burgess, 2002, 2004; Moran, Jenkins, Tylee, Blizard, & Mann, 
2000; Moran, Rendu, Jenkins, Tylee, & Mann, 2001). 
In the publically available healthcare system, women frequently access more 
subsidised mental health-related services from a variety of service providers, at 
a rate approximately double that of males in the Australian population (Britt et 
al., 2013). It is also becoming increasingly understood that the common 
psychiatric disorders, notably depression, which is highly prevalent among 
women, is the most managed mental-health related encounter by general 
practitioners (GPs) (Britt et al., 2013).
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Yet, there is a need to characterize the frequency and type of services accessed 
by individuals with PD using robust ascertainment methods, and which extend 
self-reported accounts. Population-based studies arguably provide the most 
representative picture of the correlates of a health condition, free from selection 
and referral biases. With this in mind, we set out to examine the associations 
between PDs and mental and physical health-related service utilization in the 
public health care system, ascertained from the Medicare Benefits Schedule 
(MBS) (governed by Medicare Australia) in a randomly-selected, population-
based sample of adult women aged ≥20 years. 
Methods 
The Geelong Osteoporosis Study 
The Geelong Osteoporosis Study (GOS) is an on-going population-based 
cohort study, originally designed to investigate the epidemiology of 
osteoporosis and since expanded to investigate an extensive range of mental 
and physical health research areas (Pasco, Nicholson, & Kotowicz, 2012). The 
GOS was established via an age-stratified sampling method, with participants 
randomly selected from the Australian electoral rolls for Geelong and the 
surrounding areas, located in south-eastern Australia (Barwon Statistical 
Division). Details of the recruitment methodology, participation, and reasons 
for loss to follow-up are published elsewhere (Pasco et al., 2012). 
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Participants and methodology 
This study utilized data collected from women participating in the most recent 
follow-up (2011-2014) (Figure 1). Originally, 1,494 eligible women 
participated at baseline (1994-1997), and 246 additional women aged 20-29 
years were recruited using the same methodology (2006-2008) to allow 
continued investigation spanning the full adult age range (Pasco et al., 2012). 
Of the remaining eligible women, 849 returned for the most recent follow-up. 
Originally, 1,494 eligible women were recruited at baseline (1994-1997, 
response 77.1%), and 246 additional women aged 20-29 years were recruited 
using the same methodology (2006-2008) to allow continued  investigation 
spanning the full adult age range (9) (Figure 1). 
Of the 1,740 women eligible for assessment 2011-2014, 849 participated. 
Reasons for non-participation included: death (n=392), migration from the 
region (n=94) or inability to be contacted (n=128). A further 277 women 
declined to participate citing the following reasons: personal reasons (n=124), 
old age/inability to cope with involvement (n=79), time constraints (n=36), 
illness (n=21), distance to travel (n=4), failure to keep appointment (n=4), 
language barrier (n=1), and for reasons unstated (n=8). 
Participants for whom psychiatric or MBS data were not available were 
excluded from the analyses (n=194), resulting in a final sample of 655 women. 
This study received ethical approval from Barwon Health Human Research 
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Ethics Committee; Deakin University Human Research Ethics Committee; and 
the Department of Human Services External Request Evaluation Committee. 
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Figure 1: Recruitment flow diagram showing number of participants included 
in the current analyses
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Psychiatric disorders 
Participants were assessed using validated semi-structured clinical interviews. 
The Structured Clinical Interview for the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth edition, Text-Revised, Research Version, Non-
patient Edition (SCID-I/NP) (First, et al., 2002), was used to determine the 
lifetime history of the following psychiatric disorders: a) mood disorders 
(major depressive disorder, minor depression, dysthymia, mood disorder due to 
a medical condition, substance induced mood disorder, and bipolar disorders I, 
II and not otherwise specified); b) anxiety disorders (panic disorder, 
agoraphobia, social phobia, specific phobia, obsessive-compulsive disorder, 
generalized anxiety disorder, post-traumatic stress disorder, and anxiety 
disorder not otherwise specified); c) eating disorders (anorexia nervosa, 
bulimia nervosa, and binge eating disorders, and; d) alcohol and substance use 
disorders (alcohol abuse, alcohol dependence, non-alcohol abuse and non-
alcohol dependence). 
The Structured Clinical Interview for DSM-IV Axis II PDs (SCID-II) was used 
to identify DSM-IV PDs: paranoid, schizoid, schizotypal, histrionic, 
narcissistic, borderline, antisocial, avoidant, dependent, and obsessive-
compulsive (MB First, Gibbon, Spitzer, Williams, & Benjamin, 1997). 
Interviewers with postgraduate qualifications in psychology completed SCID 
training procedures recommended by First et al (First et al., 2002; First et al., 
1997), and strictly followed the SCID-II protocol to minimize information bias. 
Regular supervision and census meetings were held with an experienced 
psychiatrist. 
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Data Linkage 
Data linkage was performed by the Department of Human Services for the 
Australian Bureau of Statistics. For each participant, a 4.5 year period of data 
between 01/09/2008 and 31/12/2013 was provided. The outcome variables of 
interest were mental and physical health-related service utilizations according 
to the MBS DoHA, 2011). Healthcare services reported in this study were 
provided in the public healthcare system, typically in primary care and in the 
community setting, rather than in hospitals (DoHA, 2011).
In accordance with the MBS and as previously published (Britt et al., 2013; 
DoHA, 2011), mental and physical health-related services were analyzed in the 
following groups: 
Mental health-related service performed by a GP. Mental health treatment 
plans, focused psychological therapies, family group therapies (whereby a 
formal intervention with a specific therapeutic outcome, such as improved 
family function and/or communication, is undertaken), performed by a GP or 
medical practitioner according to the MBS. 
Mental health-related service performed by a psychiatrist. Initial 
consultations of a new patient, patient attendances in a consulting room, patient 
attendances in a hospital, patient attendances other than consulting room or 
hospital, group psychotherapy, interview with non-patient, tele psychiatry, case 
conferencing, referred consultation for assessment, diagnosis and development 
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of a treatment and management plan for autism or any other pervasive 
developmental disorder, and electroconvulsive therapy. 
Mental health-related service performed by a clinical psychologist. Any 
psychological therapy service according to the MBS. 
Mental health-related service performed by a general psychologist. General 
psychologists performed enhanced primary care under focused psychological 
strategies, assessment and treatment of a pervasive developmental disorder. 
Mental health-related service performed by allied health-care professionals.
Focused psychological strategies by occupational therapists and/or social 
workers, and follow-up allied health services for Aboriginal and Torres Strait 
Islander peoples by mental health workers. 
Any mental-health related services. Services performed by GPs, psychiatrists, 
clinical psychologists, other psychologists and/or allied health care 
professionals according to the MBS. 
Physical health-related services performed by GPs. Physical health-related 
services performed by a GP or non-specialist physician including consultation 
at consulting rooms, consultation at a place other than a consulting room, 
urgent attendances after hours, health assessments, and/or health assessment 
for Aboriginal and Torres Strait Islander peoples. 
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Questionnaire information 
Socio-demographic information was collected via self-reported questionnaires 
including age (years), marital status (single/never married, married, living with 
partner, separated/divorced, widowed), country of birth (Australia and New 
Zealand, UK and Northern Ireland, Europe, low- and middle-income countries) 
and highest level of education achieved (completed primary school, did not 
complete secondary school, completed secondary school, completed post-
secondary qualification). Area-based socioeconomic status (SES) was 
ascertained by cross-matching residential addresses to the Australian Bureau of 
Statistics (ABS) Census Collection District for 2011. ABS software was then 
utilized to determine the Socio-Economic Index for Areas (SEIFA) values for 
each respondent, from which the SEIFA Index of Relative Socioeconomic 
Advantage and Disadvantage (IRSAD) was ascertained. The IRSAD identifies 
individual areas on a scale ranging from those most disadvantaged (represented 
by a lower score) to those most advantaged (represented by a higher score), as 
previously published in regard to other diseases and mental disorders (Brennan 
et al., 2009; Williams et al., 2011). 
Statistical analyses
The presence of “any PD” was categorized by any one or more specific PDs. 
PD Clusters were also examined in line with the DSM-IV/5: “Cluster A” 
included paranoid, schizotypal, and/or schizoid PDs; “Cluster B” included 
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histrionic, narcissistic, borderline, and/or antisocial PDs; “Cluster C” included 
avoidant, dependent, and/or obsessive-compulsive PDs (APA, 2013). 
The study population was stratified according to PD status (Yes/No) and 
differences on socio-demographic characteristics (age, marital status, country 
of birth, highest level of education achieved, SES) and lifetime psychiatric 
disorders were examined using a combination of Mann–Whitney, Kruskall 
Wallis and cross-tabulations with chi-square tests where appropriate. 
First, cross-tabulations examined the frequencies (n) and percentages (%) of 
types of services utilised (mental health-related services performed by GPs, 
psychiatrists, clinical and general psychologists and other allied healthcare 
professionals; physical health-related services performed by GPs) according to 
PD status (Yes/No any PD, Cluster A, Cluster B, Cluster C, individual PDs). 
Second, associations between PDs (any), each PD Cluster and the outcome 
variables (counts of any mental health-related service events, mental health-
related service events performed by GPs, and physical health-related service 
events performed by GPs, respectively) were examined using negative 
binomial regression. This modelling was used to account for over-dispersed 
count outcome variables. Negative binomial regression models were adjusted 
for age (Model 1); age, marital status, highest level of education attained, 
country of birth, and SES (Model II); and age, marital status, highest level of 
education attained, country of birth, SES, and lifetime psychiatric disorders 
(Model III) with data presented as incident rate ratios (IRR), p-values and 95% 
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confidence intervals (95%CI) for the IRRs. Statistical analyses were performed 
using Stata Statistical Software. Interactions between the exposure variables 
(PDs), “any lifetime psychiatric disorder” and outcome variables (service 
events) were also examined. 
Results 
Table 1 presents the sample characteristics, presented according to PD status. 
Those with any PD were younger and more likely to have a lifetime history of 
mood, anxiety, alcohol-use, substance-use, and eating disorders (all p<0.05). 
Individuals with and without PD were similar in regard to SES, education, and 
country of birth. The frequencies (%) of PD in the sample were: 20.5% any 
PD, 4.5% Cluster A, 2.4% Cluster B, and 16.8% Cluster C. 
Table 2 presents the frequencies and percentages of the types of mental and 
physical health-related services utilized according to PD status. Individuals 
with Cluster B PDs appeared to have the highest proportion of utilizing ≥10 
mental-health services over the study period, followed by Cluster A, then C 
PDs. Specifically, individuals with Cluster B PDs utilized the highest 
proportion of mental health-related services performed by GPs, psychiatrists, 
and clinical psychologists. For physical health-related services performed by 
GPs, individuals with Cluster B PDs used the highest proportion of these 
services, followed by Cluster A, then Cluster C PDs. 
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Table 1: Socio-demographic characteristics of the study sample (n= 655), lifetime prevalence of mental disorders presented as median 
(interquartile range), mean (±standard deviation), or n (%), stratified by PD status 
Total sample Any personality disorder
(n=665) No (n=529) Yes (n=136) P value
Age at interview 55.9 (42.9-68.3) 58.0 (43.7-69.7) 53.0 (38.4-63.4) 0.006
Socioeconomic status 0.45
Quintile 1 (most disadvantaged) 104 (15.6) 78 (14.7) 26 (19.2)
Quintile 2 77 (11.6) 59 (11.2) 18 (13.2)
Quintile 3 256 (38.5) 211 (39.9) 45 (33.1)
Quintile 4 119 (17.9) 92 (17.4) 27 (19.9)
Quintile 5 (most advantaged) 109 (16.4) 89 (16.8) 20 (14.7)
Marital Status 0.01
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Single /never married 51 (7.7) 37 (7.0) 14 (10.3)
Married 426 (64.1) 347 (65.6) 79 (58.1)
Living with partner 53 (8.0) 43 (8.13) 10 (7.4)
Separated/ divorced 77 (11.6) 52 (9.8) 25 (18.4)
Widowed 58 (8.7) 50 (9.5) 8 (5.9)
Level of completed education 0.42
Primary school 21 (3.2) 19 (3.6) 2 (1.5)
Some secondary school 249 (37.4) 202 (38.2) 47 (35.6)
Secondary school 105 (15.8) 80 (15.1) 25 (18.4)
Post-secondary qualification 290 (43.6) 228 (43.1) 62 (45.6)
Country of birth 0.42
Australia and New Zealand 574 (86.3) 458 (86.6) 116 (85.3)
UK of Great Britain & Northern Ireland 46 (9.2) 33 (6.2) 13 (9.6)
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Europe 35 (5.3) 30 (5.7) 5 (3.7)
Other 10 (1.5) 8 (1.5) 2 (1.5)
Lifetime psychiatric disorders
Any lifetime psychiatric disorder 312 (46.9) 210 (39.7) 102 (75.0) <0.001
Any mood disorder 253 (38.1) 166 (31.4) 87 (64.0) <0.001
Any anxiety disorder 164 (24.7) 101 (19.1) 63 (46.3) <0.001
Any eating disorder 32 (4.8) 15 (2.8) 17 (12.5) <0.001
Any non-alcohol substance use disorder 15 (2.3) 6 (1.1) 9 (6.6) <0.001
Alcohol use disorder 15 (2.3) 4 (0.8) 11 (8.1) <0.001
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Table 2: Frequencies of mental and physical health-related services utilized according to any PD, and PD Cluster status 
Personality disorder Clusters
Total sample
n=665
No
n=529
Yes
n=136
Cluster A
n=30
Cluster B
n=16
Cluster C
n=112
Service utilizations
Any mental health-
related services
0 526 (79.1) 435 (82.2) 91 (66.9) 16 (53.3) 7 (43.8) 77 (68.8)
1-9 104 (15.6) 74 (14.0) 30 (22.1) 9 (30.0) 4 (25.0) 24 (21.4)
>10 35 (5.3) 20 (3.8) 15 (11.0) 5 (16.7) 5 (31.3) 11 (9.8)
Mental health-related 
services GP
0 539 (81.1) 443 (83.7) 96 (70.6) 19 (63.3) 9 (56.3) 780 (1.4)
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1 71 (10.7) 55 (10.4) 16 (11.8) 3 (10.0) 1 (6.3) 13 (11.6)
>2 55 (8.3) 31 (5.9) 24 (17.6) 8 (26.7) 6 (37.5) 19 (17.0)
Psychiatrist 
0 646 (97.1) 520 (98.3) 126 (92.7) 80 (24.0) 11 (68.8) 106 (94.6)
1 0.3 (2) 2 (0.4) 0 (0) 0 (0) 0 (0) 0 (0)
>2 17 (2.6) 7 (1.3) 10 (7.4) 20.0(6) 5 (31.3) 6 (5.4)
Clinical psychologist
0 642 (96.5) 512 (96.8) 130 (95.6) 27 (90.0) 13 (81.3) 108 (96.4)
1 2 (0.3) 2 (0.4) 0 (0) 0 (0) 0 (0) 0 (0)
>2 21 (3.2) 15 (2.8) 6 (4.4) 3 (10.0) 3 (18.8) 4 (3.6)
Other psychologist 
0 613 (92.2) 495 (93.6) 118 (86.8) 24 (80.0) 12 (75.0) 100 (89.3)
1 7 (1.1) 5 (1.0) 2 (1.5) 2 (6.7) 0 (0) 0 (0)
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>2 45 (6.8) 29 (5.5) 16 (13.9) 4 (13.1) 4 (25.0) 12 (10.7)
Allied professional
0 659 (99.1) 526 (99.4) 133 (97.8) 29 (96.7) 16 (100.0) 110 (98.2)
1 1 (0.2) 0 (0) 1 (0.7) 0 (0) 0 (0) 0 (0)
>2 5 (0.8) 3 (0.6) 2 (1.5) 1 (3.3) 0 (0) 1 (1.0)
Physical health-
related services GP
0 5 (0.75) 5 (1.0) 0 (0) 0 (0) 0 (0) 0 (0)
1-9 67 (10.1%) 55 (10.4) 12 (8.8) 1 (3.3) 2 (12.5) 11 (9.8)
10-19 203 (30.5) 166 (31.4) 37 (27.2) 6 (20.0) 3 (18.8) 33 (29.5)
20-29 155 (23.3) 125 (23.6) 30 (22.1) 6 (20.0) 1 (6.3) 24 (21.4)
>30 235 (35.3) 178 (33.7) 57 (41.9) 17 (56.7) 10 (62.5) 44 (39.3)
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In the unadjusted analyses, significant associations were observed between any 
PD and any mental health-related services (IRR 4.44, 95%CI 2.22-8.87, 
p<0.001). In addition, Cluster A (IRR 2.91, 95%CI 1.14- 7.43), Cluster B (IRR 
3.76, 95%CI 1.09- 12.98), and Cluster PDs (IRR 2.29, 95%CI 1.33- 3.94), 
were each associated with mental health-related services performed by GPs (all 
p<0.05). Moreover, Cluster A (IRR 1.77, 95%CI 1.39-2.24) and B (IRR 1.57, 
95%CI 1.13-2.17) (both p<0.05), but not C PDs were associated with physical 
health-related services performed by GPs. 
In the final multivariable models (Model III; Table 3), Cluster B (IRR 7.57, 
95%CI 1.36-42.23) and C (IRR 2.52, 95%CI 1.15-5.55), but not Cluster A PDs 
remained associated with any mental health-related services. Specifically, 
associations between Cluster C PDs and increased utilization of mental health-
related services performed by GPs were sustained (IRR 1.70, 95%CI 1.01-2.88, 
p<0.05), and Cluster A PDs remained associated with increased utilization of 
physical health-related services performed by GPs (1.40, 95%1.10-1.78, 
p<0.05). 
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Table 3: Associations between personality disorders and utilization of mental and physical health-related services, presented as incident rate 
ratio (IRR), and 95% confidence intervals (CI) 
Any PD Cluster A Cluster B Cluster C
IRR 95%CI p IRR 95%CI p IRR 95%CI p IRR 95%CI p
Any mental health-
related services
Model I 4.44 2.22-8.87 <0.001 2.70 0.62-11.73 0.19 10.12 1.60-64.10 0.014 4.66 2.19-9.93 <0.001
Model II 3.58 1.74-7.37 0.001 2.12 0.45-9.99 0.34 15.42 2.52-94.27 0.003 4.14 1.87-9.18 <0.001
Model III 2.08 *1.00-4.34 0.051 1.11 0.26-4.64 0.88 7.57 1.36-42.23 0.021 2.52 1.15-5.55 0.021
Mental health-
related services GP
Model I 2.55 1.55-4.18 <0.001 2.91 1.14-7.43 <0.001 3.76 1.09-12.98 0.036 2.29 1.33-3.94 0.003
Model II 2.14 1.30-3.54 0.003 2.37 0.91-6.16 0.08 3.08 0.93-10.20 0.07 2.17 1.25-3.77 0.006
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Model III 1.58 0.97-2.56 0.07 1.60 0.67-3.83 0.30 1.92 0.64-5.68 0.24 1.70 1.01-2.88 0.047
Physical health-
related services GP
Model I 1.17 1.03-1.33 0.013 1.77 1.39-2.24 <0.001 1.57 1.13-2.17 0.007 1.02 0.89-1.17 0.76
Model II 1.10 0.97-1.24 0.14 1.52 1.12-1.94 <0.001 1.40 1.02-1.93 0.038 0.99 0.87-1.13 0.90
Model III 1.02 0.91-1.16 0.70 1.40 1.10-1.78 0.006 1.28 0.93-1.75 0.132 0.94 0.83-1.07 0.37
Any lifetime psychiatric disorder = lifetime mood disorders, lifetime anxiety disorders, lifetime eating disorders, lifetime non-alcohol 
substance use disorders, lifetime alcohol use disorders; boldface indicates significant values; Incident rate ratio = IRR; Model I = adjusted for 
age; Model II = adjusted for age + marital status, SES, education, country of birth; Model III = as per Model II + any lifetime psychiatric 
disorder; *unrounded values crossed zero
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Discussion 
The aim of this study was to characterize contribution of PD to utilization of 
healthcare services in women. The current study reports novel data using our 
linked dataset (SCID-I and SCID-II diagnoses) with a comprehensive national 
healthcare claims registry (MBS, Australia). Among the key findings were that; 
I) individuals with Cluster B PDs were the most frequent users of mental
health-related services regardless of provider type; II) Cluster C PDs were 
associated with increased utilization of mental health-related services provided 
by GPs, and; III) Cluster A PDs were associated with increased utilization of 
services provided by GPs for physical health-related services. These findings 
remained after controlling for age, other mental health problems and a range of 
sociodemographic factors. Furthermore while approximately 30% of 
individuals with PDs accessed services for mental health-related problems over 
the study period, all individuals with PDs visited a GP at least once for a 
physical health-related concern. 
These data are concordant with previous clinically-based studies (Bender et al., 
2001; Zanarini et al., 2004), and comparable primary care-based literature 
(Moran et al., 2000; Moran et al., 2001) in reporting that individuals with PDs 
frequently utilize a variety of services for mental health-related problems. In 
particular, one prior study examining consecutive patients attending general 
practice clinics in the UK (n=303), reported that 24% of the sample were 
identified with PD, of which 61.1% and 52.8% sought consultations for 
persistent psychological and physical problems in the past-year, respectively 
(Moran et al., 2000). Upon follow-up (1-year), PDs were independently 
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associated with increased odds of being a frequent attender to general practice 
(Moran et al., 2001). 
Given that GPs provide the gate-keeping role for mental health-related 
problems in Australia, it is unsurprising that depression is the most commonly 
managed mental health-related problem by GPs (Britt et al., 2013). In the 
current study, the large majority of individuals with PDs (75.0%) were also 
identified as having a lifetime comorbidity of a mood, anxiety, eating, and/or 
substance use disorders. Taking this into account, the majority of associations 
between PDs and mental health-related services performed by GPs were not 
sustained once adjusting for lifetime history of these psychiatric disorders. One 
explanation might be that frequent mental health-related service utilization 
among individuals with PDs might be underscored by frequently co-occurring 
psychiatric disorders and the associations with disability and treatment 
refractoriness in those disorders previously reported (Newton-Howes, Tyrer, & 
Johnson, 2006). Indeed, the cost burden associated with PDs, do not appear to 
be independent of common mental disorders (Rendu et al., 2002). Economic 
analyses reporting the total costs for patients with PDs have demonstrated 
higher costs for individuals with PD compared to those without (19). Yet, a 
significant interaction was reported between the presence of PD and common 
mental disorders, whereby the presence of comorbid conditions significantly 
increased economic costs. The contention of the added burden associated with 
comorbidity, is also highlighted by recent data suggesting that the bulk of the 
costs associated with depression in particular are due to its comorbidities rather 
than the disorder itself (Greenberg, et al., 2015). 
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In a separate population-based study derived from a household survey of Great 
Britain (2000; n=8,397; 16-74 years), 52.7% of individuals with borderline 
PDs self-reported consultation with a GP for emotional problems in the past 
year (Coid et al., 2009). Specifically, borderline PD only was independently 
associated with self-reported service utilization provided by a GP after 
adjusting for no education, unemployment, age, housing status (renting), and 
psychiatric disorders (Coid et al., 2009). Other PDs including schizotypal, 
avoidant, and dependent PDs were not associated with service utilization after 
adjustment. An additional prospective (6-months) community-based study 
from the US also reported increased self-reported service utilization by those 
with PD, and specifically those with borderline PD features (Powers &
Oltmanns, 2012). Similar findings were reported in the only prior Australian 
study (1997 National Survey of Mental Health and Wellbeing), with borderline 
PD being more strongly associated with self-reported mental health 
consultations from GPs, in addition to psychiatrists, and psychologists, than 
other PDs, notably anankastic (cf. DSM-5 obsessive-compulsive PD). It is 
assumed that associated acute help-seeking symptoms and features including 
self-harm and suicidal behaviors demonstrated by individuals with Cluster B 
PDs, particularly borderline PD might explain these findings (Zanarini et al., 
2008). Yet, in the current study, Cluster C PDs were the only group of PDs to 
remain associated with mental health-related services provided by GPs above 
the effects of comorbid psychiatric disorders. One explanation might be that 
these disorders, particularly obsessive-compulsive PD might be less disabling 
(Jackson & Burgess, 2002, 2004; Skodol et al., 2005), and less likely to be 
referred for higher primary care services, and individuals with other severe 
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forms of PD might also utilize inpatient hospital services that were not 
measured in the current study. 
On the other hand, Cluster A PDs were associated with physical health-related 
services performed by a GP, and did not appear to be explained by other 
psychiatric disorders. This was surprising, given that individuals with Cluster 
A PDs might be considered less likely to seek help due to longstanding 
mistrust, interpersonal detachment, and symptoms related to social anxiety. 
One prior clinically-based study (Collaborative Longitudinal Personality 
Disorders study; n=664) reported that patients with schizotypal PD were more 
likely to receive treatment with antipsychotic medications than individuals with 
depression alone (Bender et al., 2001). Additionally, PDs are also increasingly 
associated with physical illness, with population-based data indicating that 
individuals with Cluster A PDs are associated with an increased risk of 
cardiovascular diseases, diabetes, arthritis, and gastrointestinal diseases, with 
individuals with severe forms of PD such as schizotypal PD being most at risk 
(Quirk et al., 2015). This has important implications for GP’s, as our data 
suggest they might be a key treatment contact for individuals with Cluster A 
PDs, of which increased awareness could improve the management of their 
comorbidities. Finally, an individuals’ self-perceived need for mental and 
physical health-related treatment is likely to be important (Sareen, Cox, Afifi, 
Clara, & Yu, 2005), and might differ according to PD status. 
Strengths/Limitations 
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Strengths of the current study include the random, age-stratified, population-
based sample that included a younger cohort to enable continued investigation 
of the full adult age range. Our study extends prior population-based data 
largely derived from self-reported service utilization. In particular, the capacity 
to capture services performed by a variety of service providers including GPs, 
psychiatrist, psychologists, and allied professionals is a notable strength, given 
that these data are not available in administrative datasets in many countries. 
Our findings also address a gap in the literature regarding associations with less 
studied forms of PD including Cluster A PDs and service utilization in a 
population setting. Finally, we accounted for the potential confounding effects 
of a history of psychiatric disorders. 
There are, however, methodological limitations to consider. First, the study is 
cross-sectional (despite Medicare data being collected over a 4.5 year period) 
and thus we cannot comment on causality. Furthermore, we were unable to 
ascertain the nature of the efficacy and/or quality of the services performed. 
Moreover, there remain a proportion of individuals in the current sample with 
PDs who did not access services, for reasons we could not extrapolate from the 
data. We did not have information regarding the claims history for services 
which were performed in public hospitals to public patients, nor did we have 
data for services provided in emergency departments, or the reasons for 
accessing these services. Our healthcare service utilization data also did not 
include privately provided non-Medicare funded services, or complementary 
and alternative facilities. As such, there remains a gap in the literature 
investigating the use of emergency and outpatients services, in addition to 
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privately funded services among those with PD. We were also unable to 
capture claims data for services which qualify for benefits under the 
Department of Veterans' Affairs National Treatment Account. As such, it is 
possible that the estimates of service utilization associated with PDs that we 
report in this study might be underrepresented. It is also possible that when 
utilizing health administrative data, that errors might be present in the captured 
data. 
We were unable to investigate associations with the other service providers 
(such as psychiatrists, psychologists, general psychologists, allied 
professionals) in multivariate models due to the frequency counts in these 
categories. Finally, our cohort was potentially biased by attrition including 
mortality, and non-participation, and we examined predominantly Caucasian 
women only. Thus, comparisons of our data with other populations should be 
made with caution, including generalizing these findings to men, younger 
adults, and culturally diverse populations. As such complimentary data 
investigating these associations in men are needed. 
Although it is encouraging that individuals with PDs consistently accessed 
physical health-related serviced during the studied period, there remained a 
proportion that did not access services for metal health-related concerns. Thus, 
it remains unclear whether the rate of health care service use is sustainable, or 
effective.  Further studies that investigate met versus unmet needs, availability 
to services, and costs in regards to PDs are needed. 
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It should also be noted that co-occurring physical illness was an unmeasured 
covariate in the present study. Additional investigations examining the 
potentially mediating or moderating role of PD in associations with common 
psychiatric disorders and service utilization warrants further exploration, and 
will explored in separate analyses. 
Improving detection of PDs in general practice might assist to generate 
appropriate referrals, and thus improve patient care. This might in turn reduce 
healthcare burden in the general practice setting and secondary prevention of 
mental and physical disability. These findings highlight the possibility that PDs 
might be a driver of mental and/or physical ill health in turn influencing the 
burden on mental and physical-health related services provided in the 
publically available healthcare system. 
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The overall objective of this thesis was to describe the epidemiology of PDs in 
the community. A narrative and systematic review of the literature, and 
analyses derived from two representative, population based-samples from 
Australia and the US were utilized to address the specific aims, which included 
investigating the prevalence and age distribution of PDs in Australia, and 
associations with mental and physical health conditions, and healthcare service 
utilization. 
7.1 Prevalence of personality disorders (Manuscript III) 
This study addressed Aim I, and provided evidence that PDs are common in 
the general population, more common among the younger and commonly 
comorbid with other psychiatric disorders. Among the key findings, were that 
22.7% (95% CI 18.8-26.7) of women were identified with one or more PDs, 
with Cluster C PDs being the most prevalent with 17.7% (95% CI 14.2-21.3), 
followed by Cluster A with 6.7% (95% CI 3.9-9.5) then Cluster B with 4.6% 
(95% CI 3.3-5.9). 
The overall prevalence estimates presented in Manuscript III were similar to 
data derived from the NESARC, which reported a pooled prevalence of 21.5% 
- albeit with arguably low thresholds for obtaining threshold level diagnoses 
(Grant et al., 2004; Trull et al., 2010). In comparison to other studies conducted 
in the UK (4.4%) (Coid et al., 2006), US (9.1%) (Lenzenweger et al., 2007), 
and Norway (13.4%) (Torgersen et al., 2001) our reported prevalence was 
somewhat higher. This is likely due to the overrepresentation of Cluster C PDs, 
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as the prevalence of Cluster A (Lenzenweger et al., 2007) and B PDs (Moran et 
al., 2006; Trull et al., 2010) were similar to prior surveys. The only prior 
Australian survey, which utilized screening measures to identify PD, indicated 
6.5% of the Australian population had a PD (Jackson & Burgess, 2000). 
The findings presented in Manuscript III are consistent with both the clinical 
(Gunderson et al., 2011; Zanarini et al., 2012; Zanarini et al., 2008) and 
population-based literature (Coid et al., 2006; Jackson & Burgess, 2000; 
Torgersen et al., 2001), in that individuals with PDs, notably Cluster B PDs, 
tended to be younger and were less frequent in the older age groups (Reynolds 
et al., 2015). Indeed, the prevalence was highest for each PD Cluster among the 
youngest age group (20-29 years). 
In line with the clinically-based (Zimmerman et al. 2005), and population-
based literature (Jackson & Burgess, 2000), the current study reported high 
levels of psychiatric comorbidity among individuals with PDs (73%), with
mood disorders, then anxiety disorders being the most common. Individuals 
with PDs also had prior psychiatric hospitalization and used psychotropic 
medications more frequently, than did those without PDs. 
These data filled a clear gap in the literature, by expanding on the only other 
Australian study to date to determine the prevalence of PDs in the community 
(Jackson & Burgess, 2000). In addition, a ‘gold standard’ semi-structured 
clinical interview was utilized, and the prevalence of less frequently examined 
PDs (for example Cluster A PDs), were investigated across the full adult age 
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range, which have not been adequately captured in prior surveys (Samuels et 
al., 1994; Samuels et al., 2002). However, limitations need to be taken into 
consideration when interpreting these findings. These included: the psychiatric 
profile of responders might have differed from non-responders, possibility of 
differential loss to follow-up in regard to PD status, precision of the estimates 
among less frequent PDs, and the potential for recall and information bias. 
In conclusion, methodological limitations notwithstanding, these findings are 
unique in that they provide epidemiological data utilizing the SCID-II in a 
sample of the adult female population in Australia. These data emphasize that 
PDs are common in the community, and that the added burden of psychiatric 
comorbidity have the potential to influence the utilization and need for 
healthcare service resources, particularly among younger adults. 
7.2 Associations with physical health comorbidities (Manuscript IV, V, 
VI) 
A systematic review of the literature (Manuscript IV), and analyses derived 
from a nationally representative population based of the US (Manuscript V) 
and Australia (Manuscript VI), addressed Aim II a), investigating associations 
between PDs and physical health comorbidities. 
First, a systematic review was undertaken to collate and assess the evidence to 
date. There were four studies that met eligibility criteria (El-Gabalawy et al., 
2010; Goldstein et al., 2008; Lee et al., 2010; Powers & Oltmanns, 2013). A 
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synthesis of the data identified that there was not only limited evidence, but a
conflicting level of evidence for some individual PDs with physical health 
conditions, namely CVD and arthritis (El-Gabalawy et al., 2010; Goldstein et 
al., 2008; Lee et al., 2010; Powers & Oltmanns, 2013). Gaps in the literature 
were identified, with no citations being retrieved that investigated associations 
between PDs and cancers or chronic respiratory diseases. 
While the reviewed studies were all deemed high quality according to the 
predetermined criteria for methodological quality, there was a paucity of data, 
and considerable heterogeneity existed among these studies. Additionally, all 
studies utilized self-reported information to determine the presence of physical 
conditions. 
Potential limitations of the systematic review, include that while the 
development of the search strategy was comprehensive and reproducible, we 
utilized stringent eligibility criteria, and cannot determine whether all possible 
sources of evidence were included. Yet, this systematic review was the first of 
its kind, and highlighted that the physical health of individuals living with PD 
were infrequently studied in the general population. 
Following on from Manuscript IV, the purpose to fill a clear gap in the 
literature, was addressed by undertaking an investigation regarding PDs and 
the increased risk for a range of physical health comorbidities, utilizing data 
from the NESARC (Manuscript V). 
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The findings presented in Manuscript V extended previous analyses suggesting 
that borderline PD is associated with self-reported hypertension, CVD, 
arthritis, hepatic disease, gastrointestinal disease, and venereal disease (El-
Gabalawy et al., 2010). Specifically, Manuscript V, identified that younger 
individuals with schizoid and schizotypal PDs were associated with increased 
risk of CVD and arthritis, and those both older and younger with these 
disorders had an increased risk of diabetes and gastrointestinal diseases (Quirk 
et al., 2015). With the exception of histrionic PD, all individual PDs were 
consistently associated with increased odds of at least one physical comorbidity 
(Quirk et al., 2015). 
Limitations of the data included self-reported accounts of physical health 
conditions, and potentially lower thresholds for diagnosing PD (Trull et al., 
2010). A valuable extension of this study might be to replicate these 
associations utilizing new algorithms for obtaining more stringent threshold 
level diagnoses (Trull et al. 2010).
Manuscript VI extended the current understandings of associations between 
PDs and physical health comorbidities, by investigating previously unexplored 
associations, and was not limited to self-reported data. The findings from 
Manuscript VI were concordant with prior studies, which found that Cluster B 
PDs were associated with increased risk of arthritis (El-Gabalawy et al., 2010; 
Goldstein et al., 2008; Powers & Oltmanns, 2013; Quirk et al., 2015), and 
Cluster C PDs with gastrointestinal disease (El-Gabalawy et al., 2010; Quirk et 
al., 2015). These associations did not appear to be explained by age, SES, or 
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health risk factors, or history of psychiatric disorders. In contrast with the 
previous literature, an association was not evident between PDs, particularly 
those from Clusters A or B and CVD (El-Gabalawy et al., 2010; Goldstein et 
al., 2008; Moran et al., 2007; Powers & Oltmanns, 2013), liver disease (El-
Gabalawy et al., 2010) or metabolic disorders (El-Gabalawy et al., 2010; Quirk 
et al., 2015) – potentially due to methodological differences, statistical 
modelling, and differences regarding the groupings of physical health 
conditions within disease groups. 
Novel associations were evident, suggesting an increased risk of GORD was 
shown for individuals with Cluster A PDs, syncope and/or seizures for 
individuals with B PDs, and recurrent headaches for individuals with Cluster C 
PDs. Importantly, PDs were consistently associated with increased physical 
morbidity, that did not appear to be explained by comorbidity with other 
psychiatric disorders, health risk factors or sociodemographic factors. We did 
not detect a relationship between PDs and cancers or thyroid disorders.
Relationships between PDs and cancer, thyroid disorders, nor pulmonary 
diseases were detected. 
The strengths of this study include a population-based sample, spanning the 
full adult age range, ability to adjust for several confounding factors, examine 
interactions, and utilize anthropometric and clinical data, rather than self-
reported information alone. Methodological considerations need to be taken 
into account when interpreting the findings. Recall errors are possible. There is 
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also the potential for differential reporting according to PD status. We also 
examined women only, and thus were not able not investigate sex differences. 
Overall, Chapter Five: associations between personality disorders and physical 
health comorbidities, underscores the disability of PDs and comorbid physical 
health conditions. Still, given the robust link between the common psychiatric 
disorders, namely depression and adverse physical health outcomes, and also 
the high levels of comorbidity between personality disorder and other 
psychiatric disorders - it is possible that severity of personality disturbance and
comorbidities are a driver of these associations. Future studies should attempt 
to model the proportion of variance explained by PD alone, then PD and 
psychiatric comorbidities to further extrapolate relationships with physical 
disorders. It was outside the scope of the present study to conduct these 
additional analyses. 
An increased understanding of these associations, might promote the 
monitoring of mental and physical comorbidity for individuals living with PD, 
and improve integration of treatment. This, in turn, has the capacity to improve 
the clinical course of both PD and physical illness. 
7.3 Associations with health service utilization (Manuscript VII) 
Manuscript VII addressed the final research aim, Aim II b), and provided 
evidence suggesting that PDs are associated with increased utilization of 
health-related services in the publically available healthcare system. Among 
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the key findings, were that Cluster C PDs were associated with increased 
utilization of mental health related services provided by GPs, and individuals 
with Cluster A PDs were associated with increased utilization of physical 
health-related services provided by GPs. 
The findings presented in Manuscript VII were consistent with prior 
community-based literature, in that individuals with PDs frequently utilize 
services for a range of mental and physical health concerns (Coid et al., 2006; 
Coid et al., 2009; Jackson & Burgess, 2002; Moran et al., 2000; Moran et al., 
2001). In contrast, previous literature have largely reported that borderline PD 
only was associated with increased odds of being a frequent service attender 
(Jackson & Burgess, 2002; Coid et al., 2009). Our data suggested that the 
health service utilizations patterns differed according to PD Clusters and 
comorbidities. We also had the capacity to extend prior self-reported 
information, and provided additional data regarding services provided by 
psychologists, psychiatrist, GPs, and allied professionals.
Moreover, we also did not capture health service events performed in hospitals, 
and thus it is possible that the estimates of service utilization PDs might be 
underrepresented. The clinical relevance of these data included that GPs 
appeared to be a key treatment contact for individuals with PDs, of which 
increased awareness could improve the management of their comorbidities. 
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This series of epidemiological studies investigating personality disorders 
provides novel data determining their prevalence and distribution in the 
community and cross-sectional evidence suggesting those living with PDs are 
at increased risk of greater physical morbidity, and frequently use health 
service resources. Individuals with Clusters A, B, C PDs appeared to have 
different physical health profiles and risks, and also varied in the type and 
frequency of health services utilized. 
While this thesis provides an important contribution to the literature in the field 
of PD research, it is premature to determine causal associations between PDs, 
physical health comorbidities, and healthcare service utilization, and as such 
questions remain to be answered. Longitudinal studies need to be conducted, as 
well as confirmatory research into potential mechanisms surrounding the 
associations. Indeed, the mechanisms and direct role of PDs as a group, as well 
as individual PDs, in the development of physical health comorbidities are not 
well understood. Moreover, it is also possible that personality pathology might 
have a bi-directional role in the etiology and expression of physical health 
conditions, the operative elements, pathways and interactions of which are yet 
to be explored. There is also the potential for unmeasured confounding to bias 
our findings, including psychotic disorders, cognitive decline, and other 
medically unexplained or psychosomatic disorders. Finally, an overall 
limitation is the use of a women only sample from the GOS studies, which 
limits generalizability to other populations. As such, the findings should be 
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interpreted with caution, and thus may not be generalizable to culturally 
diverse populations, nor younger women (<20 years), or men. 
A more robust evidence base is required to inform and promote population 
based intervention strategies in the future incorporating the needs of those with 
PDs, including the management of risk factors for physical illness, in order to 
improve long-term health outcomes for people living with PD, and 
sustainability of the utilization of healthcare service resources. Indeed, it is 
probable that PD’s are a major yet convert driver of health burden at a 
population level, and we have argued that they need to form part of health 
planning (Quirk et al., 2015). In order to do so, a more fine grained and 
comprehensive evidence base is essential. 
In conclusion, recognizing the disability attributable to PDs in the community 
is essential for anticipating and planning healthcare needs. This data is also 
useful for stimulating future health economic projects, which is important from 
a public health perspective. Finally, these findings highlight that the 
reconsideration of the public health importance of PDs is warranted. 
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